P-value | ln(P) | Term | GO Tree | GO ID | # of Genes in Term | # of Target Genes in Term | # of Total Genes | # of Target Genes | Common Genes |
5.657e-08 | -16.69 | cell periphery | cellular component | GO:0071944 | 6020 | 34 | 19108 | 49 |
GPC5,NRXN1,RYR3,BMPR1B,CDH20,SLC4A4,ATP1A2,SPARCL1,COL5A3,NKAIN3,AQP4,CTNND2,CKB,CTNNA2,LRIG1,DTNA,PREX2,ATP13A4,GPM6A,PARD3B,SLC1A3,GLUL,TNIK,NTM,SLC1A2,HPSE2,CST3,WWOX,PON2,LSAMP,ITPR2,ERBB4,ZNRF3,CLU |
5.733e-08 | -16.67 | nervous system development | biological process | GO:0007399 | 2185 | 21 | 18204 | 49 |
CAMK2G,NTM,SOX5,LRIG1,ATP1A2,ERBB4,RORA,CLU,BMPR1B,SLC1A3,NRXN1,TNIK,SLC1A2,CKB,GPM6A,CTNND2,MSI2,LSAMP,QKI,PREX2,CTNNA2 |
1.086e-07 | -16.04 | lymph_node | COSMIC cancer mutations | lymph_node | 1703 | 19 | 16828 | 49 |
LSAMP,PARD3B,GPC5,DTNA,CKB,CAMK2G,SOX5,WWOX,ATP13A4,CTNND2,SFXN5,GPM6A,NEBL,SLC1A3,ARHGAP24,TNIK,ITPR2,RYR3,ERBB4 |
1.092e-07 | -16.03 | Neurotransmitter uptake and Metabolism In Glial Cells | REACTOME pathways | R-HSA-112313 | 4 | 3 | 10285 | 32 |
GLUL,SLC1A3,SLC1A2 |
1.092e-07 | -16.03 | Astrocytic Glutamate-Glutamine Uptake And Metabolism | REACTOME pathways | R-HSA-210455 | 4 | 3 | 10285 | 32 |
SLC1A3,SLC1A2,GLUL |
3.509e-07 | -14.86 | multicellular organism development | biological process | GO:0007275 | 3957 | 27 | 18204 | 49 |
CKB,CTNND2,CTNNA2,BMPR1B,SLC1A3,NRXN1,TNIK,SLC1A2,SOX5,LRIG1,WWOX,ARHGAP24,GPM6A,MSI2,LSAMP,QKI,PREX2,NEBL,GLUL,CAMK2G,NTM,ERBB4,ATP1A2,RORA,CLU,ZNRF3,CDH20 |
6.436e-07 | -14.26 | plasma membrane | cellular component | GO:0005886 | 5538 | 31 | 19108 | 49 |
ATP1A2,NKAIN3,SLC4A4,RYR3,CDH20,BMPR1B,NRXN1,GPC5,GPM6A,ATP13A4,DTNA,PREX2,PARD3B,LRIG1,CTNNA2,CKB,CTNND2,AQP4,PON2,SLC1A2,HPSE2,WWOX,CST3,GLUL,TNIK,NTM,SLC1A3,ERBB4,ZNRF3,LSAMP,ITPR2 |
6.811e-07 | -14.20 | myelodysplastic_syndrome | COSMIC cancer mutations | myelodysplastic_syndrome | 1174 | 15 | 16828 | 49 |
FBXL7,HPSE2,ATP1A2,BMPR1B,SOX5,CAMK2G,LSAMP,NPAS3,PREX2,NKAIN3,SLC1A2,RYR3,COL5A3,ERBB4,TNIK |
6.811e-07 | -14.20 | haematopoietic_and_lymphoid_tissue-haematopoietic_neoplasm-myelodysplastic_syndrome | COSMIC cancer mutations | haematopoietic_and_lymphoid_tissue-haematopoietic_neoplasm-myelodysplastic_syndrome | 1174 | 15 | 16828 | 49 |
LSAMP,CAMK2G,SOX5,BMPR1B,ATP1A2,FBXL7,HPSE2,TNIK,RYR3,SLC1A2,COL5A3,ERBB4,NPAS3,PREX2,NKAIN3 |
6.920e-07 | -14.18 | system development | biological process | GO:0048731 | 3533 | 25 | 18204 | 49 |
NRXN1,TNIK,SLC1A2,BMPR1B,SLC1A3,CTNNA2,CKB,CTNND2,LRIG1,WWOX,SOX5,NEBL,LSAMP,QKI,PREX2,GPM6A,ARHGAP24,MSI2,ATP1A2,ERBB4,RORA,CLU,CAMK2G,NTM,GLUL |
1.130e-06 | -13.69 | brainstem | COSMIC cancer mutations | brainstem | 3102 | 24 | 16828 | 49 |
ZNRF3,SLC1A3,PREX2,NKAIN3,NPAS3,ITPR2,ERBB4,SLC1A2,LSAMP,FBXL7,CDH20,TNIK,GPM6A,RORA,RYR3,QKI,GPC5,ZBTB20,CTNND2,HPSE2,ATP13A4,SFXN5,WWOX,SOX5 |
1.377e-06 | -13.50 | haematopoietic_and_lymphoid_tissue-haematopoietic_neoplasm | COSMIC cancer mutations | haematopoietic_and_lymphoid_tissue-haematopoietic_neoplasm | 764 | 12 | 16828 | 49 |
ATP1A2,HPSE2,FBXL7,SOX5,LSAMP,GPC5,PREX2,NKAIN3,SLC1A2,COL5A3,RYR3,ERBB4 |
2.063e-06 | -13.09 | anatomical structure morphogenesis | biological process | GO:0009653 | 2225 | 19 | 18204 | 49 |
SLC1A3,BMPR1B,NEBL,TNIK,NRXN1,ARHGAP24,CTNND2,GPM6A,CTNNA2,PREX2,QKI,SOX5,CDH20,WWOX,CLU,RORA,ERBB4,LRIG1,GLUL |
2.644e-06 | -12.84 | central_nervous_system-brainstem-glioma-astrocytoma_Grade_IV | COSMIC cancer mutations | central_nervous_system-brainstem-glioma-astrocytoma_Grade_IV | 2531 | 21 | 16828 | 49 |
ERBB4,RYR3,ITPR2,NKAIN3,PREX2,SLC1A3,RORA,GPM6A,TNIK,ZNRF3,SOX5,SFXN5,CDH20,CTNND2,FBXL7,HPSE2,ATP13A4,ZBTB20,GPC5,QKI,LSAMP |
3.226e-06 | -12.64 | Burkitt_lymphoma | COSMIC cancer mutations | Burkitt_lymphoma | 2119 | 19 | 16828 | 49 |
PREX2,NKAIN3,NPAS3,LRIG1,ITPR2,ERBB4,SLC1A2,RYR3,GPM6A,SLC1A3,FBXL7,HPSE2,CTNND2,ATP13A4,NHSL1,BMPR1B,SOX5,GPC5,LSAMP |
3.226e-06 | -12.64 | haematopoietic_and_lymphoid_tissue-lymphoid_neoplasm-Burkitt_lymphoma | COSMIC cancer mutations | haematopoietic_and_lymphoid_tissue-lymphoid_neoplasm-Burkitt_lymphoma | 2119 | 19 | 16828 | 49 |
NKAIN3,PREX2,NPAS3,ITPR2,LRIG1,ERBB4,SLC1A2,RYR3,GPM6A,SLC1A3,HPSE2,FBXL7,CTNND2,ATP13A4,NHSL1,BMPR1B,SOX5,GPC5,LSAMP |
3.494e-06 | -12.56 | haematopoietic_and_lymphoid_tissue-haematopoietic_neoplasm-acute_myeloid_leukaemia_therapy_related | COSMIC cancer mutations | haematopoietic_and_lymphoid_tissue-haematopoietic_neoplasm-acute_myeloid_leukaemia_therapy_related | 1523 | 16 | 16828 | 49 |
FBXL7,CTNND2,HPSE2,SOX5,LSAMP,GPC5,QKI,NKAIN3,PREX2,ITPR2,COL5A3,RYR3,ERBB4,NEBL,RORA,SLC1A3 |
3.494e-06 | -12.56 | acute_myeloid_leukaemia_therapy_related | COSMIC cancer mutations | acute_myeloid_leukaemia_therapy_related | 1523 | 16 | 16828 | 49 |
RORA,NEBL,SLC1A3,ITPR2,COL5A3,RYR3,ERBB4,PREX2,NKAIN3,LSAMP,QKI,GPC5,SOX5,HPSE2,CTNND2,FBXL7 |
3.650e-06 | -12.52 | MAPT (microtubule associated protein tau) | protein interactions | 4137 | 948 | 12 | 19454 | 50 |
LSAMP,ATP1A2,CTNND2,NTM,TNIK,GPM6A,SLC1A2,SLC1A3,NEBL,CKB,CTNNA2,CLU |
3.755e-06 | -12.49 | acute_lymphoblastic_B_cell_leukaemia | COSMIC cancer mutations | acute_lymphoblastic_B_cell_leukaemia | 3828 | 26 | 16828 | 49 |
NEBL,SLC1A3,NKAIN3,PREX2,COL5A3,SLC1A2,ERBB4,ITPR2,NRXN1,LSAMP,FBXL7,TNIK,RORA,GPM6A,SLC4A4,RYR3,ZBTB20,NTM,GPC5,GLIS3,ATP13A4,HPSE2,CTNND2,SOX5,BMPR1B,PAMR1 |
3.755e-06 | -12.49 | haematopoietic_and_lymphoid_tissue-lymphoid_neoplasm-acute_lymphoblastic_B_cell_leukaemia | COSMIC cancer mutations | haematopoietic_and_lymphoid_tissue-lymphoid_neoplasm-acute_lymphoblastic_B_cell_leukaemia | 3828 | 26 | 16828 | 49 |
FBXL7,LSAMP,NRXN1,ITPR2,ERBB4,COL5A3,SLC1A2,NKAIN3,PREX2,SLC1A3,NEBL,BMPR1B,PAMR1,SOX5,CTNND2,HPSE2,ATP13A4,GLIS3,GPC5,NTM,ZBTB20,RYR3,SLC4A4,GPM6A,RORA,TNIK |
7.063e-06 | -11.86 | multicellular organismal process | biological process | GO:0032501 | 6177 | 32 | 18204 | 49 |
CAMK2G,NTM,RORA,CLU,ERBB4,ATP1A2,ZNRF3,CDH20,GLUL,NEBL,MSI2,GPM6A,ARHGAP24,LSAMP,PREX2,QKI,SOX5,LRIG1,WWOX,PTGDS,AQP4,RYR3,DTNA,BMPR1B,SLC1A3,SLC4A4,NRXN1,SLC1A2,TNIK,CKB,CTNND2,CTNNA2 |
7.103e-06 | -11.85 | neurogenesis | biological process | GO:0022008 | 1334 | 14 | 18204 | 49 |
TNIK,NRXN1,SLC1A3,BMPR1B,QKI,CTNNA2,PREX2,GPM6A,CTNND2,ERBB4,CLU,RORA,NTM,SOX5 |
7.570e-06 | -11.79 | anatomical structure development | biological process | GO:0048856 | 5207 | 29 | 18204 | 49 |
CTNNA2,CKB,CTNND2,NRXN1,SLC1A2,TNIK,COL5A3,SPARCL1,BMPR1B,SLC1A3,LRIG1,WWOX,SOX5,LSAMP,PREX2,QKI,MSI2,ARHGAP24,GPM6A,NEBL,GLUL,CLU,RORA,ATP1A2,ERBB4,ZNRF3,CDH20,CAMK2G,NTM |
1.002e-05 | -11.51 | cerebellum | COSMIC cancer mutations | cerebellum | 769 | 11 | 16828 | 49 |
NEBL,PARD3B,QKI,GPC5,NPAS3,HPSE2,CTNND2,RYR3,ERBB4,ITPR2,NRXN1 |
1.189e-05 | -11.34 | cell morphogenesis | biological process | GO:0000902 | 687 | 10 | 18204 | 49 |
PREX2,CTNNA2,GPM6A,CTNND2,TNIK,CDH20,NRXN1,CLU,SLC1A3,BMPR1B |
1.584e-05 | -11.05 | developmental process | biological process | GO:0032502 | 5716 | 30 | 18204 | 49 |
ZNRF3,CDH20,RORA,CLU,ERBB4,ATP1A2,NTM,CAMK2G,GLUL,NEBL,NHSL1,PREX2,QKI,LSAMP,MSI2,GPM6A,ARHGAP24,WWOX,LRIG1,SOX5,SLC1A2,TNIK,NRXN1,SLC1A3,SPARCL1,COL5A3,BMPR1B,CTNNA2,CTNND2,CKB |
1.766e-05 | -10.94 | PDZD2 (PDZ domain containing 2) | protein interactions | 23037 | 20 | 3 | 19454 | 50 |
CTNND2,NRXN1,CST3 |
1.779e-05 | -10.94 | mantle_cell_lymphoma | COSMIC cancer mutations | mantle_cell_lymphoma | 2849 | 21 | 16828 | 49 |
GPC5,PARD3B,LSAMP,SOX5,CTNND2,FBXL7,HPSE2,ATP13A4,SFXN5,GPM6A,SLC1A3,NEBL,ARHGAP24,ZNRF3,ITPR2,LRIG1,ERBB4,SLC1A2,RYR3,PREX2,NKAIN3 |
1.881e-05 | -10.88 | upper_aerodigestive_tract-larynx-carcinoma-squamous_cell_carcinoma | COSMIC cancer mutations | upper_aerodigestive_tract-larynx-carcinoma-squamous_cell_carcinoma | 1946 | 17 | 16828 | 49 |
SLC4A4,NPAS3,NRXN1,ITPR2,ERBB4,COL5A3,RYR3,ZNRF3,TNIK,GPM6A,NEBL,RORA,HPSE2,BMPR1B,SOX5,PARD3B,ZBTB20 |
1.907e-05 | -10.87 | larynx | COSMIC cancer mutations | larynx | 1948 | 17 | 16828 | 49 |
BMPR1B,SOX5,HPSE2,PARD3B,ZBTB20,ITPR2,NRXN1,RYR3,COL5A3,ERBB4,NPAS3,SLC4A4,GPM6A,NEBL,RORA,ZNRF3,TNIK |
1.942e-05 | -10.85 | PRNP (prion protein (Kanno blood group)) | protein interactions | 5621 | 1118 | 12 | 19454 | 50 |
SLC1A3,QKI,MSI2,NHSL1,SPARCL1,CLU,AQP4,ATP1A2,LSAMP,GPM6A,CAMK2G,SLC4A4 |
2.260e-05 | -10.70 | soft_tissue-blood_vessel-angiosarcoma | COSMIC cancer mutations | soft_tissue-blood_vessel-angiosarcoma | 2192 | 18 | 16828 | 49 |
GPC5,LSAMP,SOX5,CDH20,HPSE2,CTNND2,FBXL7,SLC1A3,NEBL,GPM6A,ARHGAP24,ERBB4,SLC1A2,COL5A3,RYR3,ITPR2,NKAIN3,PREX2 |
2.260e-05 | -10.70 | angiosarcoma | COSMIC cancer mutations | angiosarcoma | 2192 | 18 | 16828 | 49 |
SOX5,CDH20,FBXL7,HPSE2,CTNND2,LSAMP,GPC5,SLC1A2,COL5A3,RYR3,ERBB4,ITPR2,NKAIN3,PREX2,NEBL,SLC1A3,GPM6A,ARHGAP24 |
2.531e-05 | -10.58 | Ion homeostasis | REACTOME pathways | R-HSA-5578775 | 56 | 4 | 10285 | 32 |
ITPR2,CAMK2G,ATP1A2,RYR3 |
2.544e-05 | -10.58 | blood_vessel | COSMIC cancer mutations | blood_vessel | 2211 | 18 | 16828 | 49 |
ARHGAP24,GPM6A,SLC1A3,NEBL,PREX2,NKAIN3,ITPR2,ERBB4,COL5A3,RYR3,SLC1A2,GPC5,LSAMP,CTNND2,HPSE2,FBXL7,CDH20,SOX5 |
3.622e-05 | -10.23 | haematopoietic_and_lymphoid_tissue-lymphoid_neoplasm-mantle_cell_lymphoma | COSMIC cancer mutations | haematopoietic_and_lymphoid_tissue-lymphoid_neoplasm-mantle_cell_lymphoma | 2737 | 20 | 16828 | 49 |
HPSE2,FBXL7,CTNND2,SFXN5,SOX5,GPC5,PARD3B,LSAMP,PREX2,NKAIN3,ITPR2,LRIG1,ERBB4,RYR3,SLC1A2,ARHGAP24,ZNRF3,GPM6A,SLC1A3,NEBL |
3.634e-05 | -10.22 | prostate-carcinoma | COSMIC cancer mutations | prostate-carcinoma | 9000 | 40 | 16828 | 49 |
FBXL7,CDH20,PON2,CLU,DTNA,PARD3B,LSAMP,PREX2,NKAIN3,NPAS3,NRXN1,ITPR2,MSI2,ERBB4,SLC1A2,COL5A3,ARHGAP24,ZNRF3,SLC1A3,PITPNC1,NEBL,HPSE2,CTNND2,ATP13A4,GLIS3,SFXN5,NHSL1,BMPR1B,SOX5,QKI,GPC5,NTM,ZBTB20,SPARCL1,SLC4A4,LRIG1,RYR3,TNIK,GPM6A,RORA |
3.684e-05 | -10.21 | mouth | COSMIC cancer mutations | mouth | 9004 | 40 | 16828 | 49 |
ZBTB20,GPC5,QKI,NTM,SFXN5,ATP1A2,HPSE2,CTNND2,ATP13A4,WWOX,SOX5,NHSL1,PAMR1,TNIK,CST3,RORA,GPM6A,SLC4A4,RYR3,LRIG1,CLU,CAMK2G,CKB,DTNA,PARD3B,LSAMP,CDH20,FBXL7,ZNRF3,SLC1A3,PITPNC1,NEBL,GLUL,PREX2,NPAS3,ERBB4,COL5A3,SLC1A2,NRXN1,ITPR2 |
4.245e-05 | -10.07 | generation of neurons | biological process | GO:0048699 | 1158 | 12 | 18204 | 49 |
NRXN1,TNIK,BMPR1B,SLC1A3,PREX2,CTNNA2,GPM6A,CTNND2,RORA,ERBB4,SOX5,NTM |
5.002e-05 | -9.90 | LRRC7 (leucine rich repeat containing 7) | protein interactions | 57554 | 28 | 3 | 19454 | 50 |
CAMK2G,CTNND2,ERBB4 |
6.177e-05 | -9.69 | diffuse_large_B_cell_lymphoma | COSMIC cancer mutations | diffuse_large_B_cell_lymphoma | 4151 | 25 | 16828 | 49 |
SPARCL1,RYR3,TNIK,RORA,GPM6A,ATP1A2,ATP13A4,HPSE2,CTNND2,SOX5,GPC5,QKI,PREX2,NKAIN3,SLC1A2,ERBB4,ITPR2,NEBL,SLC1A3,CDH20,FBXL7,CLU,LSAMP,AQP4,DTNA |
6.236e-05 | -9.68 | haematopoietic_and_lymphoid_tissue-lymphoid_neoplasm-diffuse_large_B_cell_lymphoma | COSMIC cancer mutations | haematopoietic_and_lymphoid_tissue-lymphoid_neoplasm-diffuse_large_B_cell_lymphoma | 3608 | 23 | 16828 | 49 |
FBXL7,CDH20,AQP4,LSAMP,CLU,ITPR2,ERBB4,SLC1A2,NKAIN3,PREX2,NEBL,SOX5,HPSE2,CTNND2,ATP13A4,ATP1A2,GPC5,QKI,RYR3,SPARCL1,GPM6A,RORA,TNIK |
6.287e-05 | -9.67 | haematopoietic_and_lymphoid_tissue-lymph_node-lymphoid_neoplasm-mantle_cell_lymphoma | COSMIC cancer mutations | haematopoietic_and_lymphoid_tissue-lymph_node-lymphoid_neoplasm-mantle_cell_lymphoma | 476 | 8 | 16828 | 49 |
SFXN5,ATP13A4,CTNND2,RYR3,ERBB4,LSAMP,GPC5,GPM6A |
6.504e-05 | -9.64 | upper_aerodigestive_tract-mouth-carcinoma-squamous_cell_carcinoma | COSMIC cancer mutations | upper_aerodigestive_tract-mouth-carcinoma-squamous_cell_carcinoma | 6953 | 34 | 16828 | 49 |
NTM,GPC5,QKI,ZBTB20,ATP13A4,CTNND2,ATP1A2,SFXN5,PAMR1,NHSL1,SOX5,WWOX,TNIK,GPM6A,RORA,CST3,SLC4A4,LRIG1,RYR3,CAMK2G,PARD3B,LSAMP,DTNA,FBXL7,CDH20,ZNRF3,GLUL,NEBL,PITPNC1,PREX2,ITPR2,NRXN1,SLC1A2,ERBB4 |
6.856e-05 | -9.59 | high-affinity L-glutamate transmembrane transporter activity | molecular function | GO:0005314 | 5 | 2 | 18094 | 48 |
SLC1A3,SLC1A2 |
6.856e-05 | -9.59 | glutamate:sodium symporter activity | molecular function | GO:0015501 | 5 | 2 | 18094 | 48 |
SLC1A2,SLC1A3 |
7.061e-05 | -9.56 | D-aspartate import across plasma membrane | biological process | GO:0070779 | 5 | 2 | 18204 | 49 |
SLC1A2,SLC1A3 |
7.061e-05 | -9.56 | D-aspartate transmembrane transport | biological process | GO:0070777 | 5 | 2 | 18204 | 49 |
SLC1A2,SLC1A3 |
7.070e-05 | -9.56 | neurotransmitter uptake | biological process | GO:0001504 | 30 | 3 | 18204 | 49 |
SLC1A2,ATP1A2,SLC1A3 |
7.700e-05 | -9.47 | cell body | cellular component | GO:0044297 | 556 | 8 | 19108 | 49 |
SLC1A3,NRXN1,GLUL,BMPR1B,CTNND2,SLC1A2,ATP1A2,GPM6A |
8.255e-05 | -9.40 | NTM (neurotrimin) | protein interactions | 50863 | 33 | 3 | 19454 | 50 |
GPM6A,LSAMP,NTM |
8.305e-05 | -9.40 | cell junction | cellular component | GO:0030054 | 2224 | 16 | 19108 | 49 |
CTNND2,PARD3B,CLU,DTNA,GPM6A,ERBB4,CTNNA2,TNIK,CDH20,NRXN1,QKI,SLC1A3,SPARCL1,ATP1A2,ARHGAP24,SLC1A2 |
8.364e-05 | -9.39 | vascular transport | biological process | GO:0010232 | 86 | 4 | 18204 | 49 |
SLC1A3,SLC4A4,ATP1A2,SLC1A2 |
8.364e-05 | -9.39 | transport across blood-brain barrier | biological process | GO:0150104 | 86 | 4 | 18204 | 49 |
SLC1A3,SLC4A4,ATP1A2,SLC1A2 |
9.447e-05 | -9.27 | response to auditory stimulus | biological process | GO:0010996 | 33 | 3 | 18204 | 49 |
NRXN1,ATP1A2,SLC1A3 |
9.646e-05 | -9.25 | central_nervous_system-cerebellum-primitive_neuroectodermal_tumour-medulloblastoma-SHH_subtype | COSMIC cancer mutations | central_nervous_system-cerebellum-primitive_neuroectodermal_tumour-medulloblastoma-SHH_subtype | 653 | 9 | 16828 | 49 |
NEBL,PARD3B,NPAS3,CTNND2,HPSE2,ERBB4,RYR3,NRXN1,ITPR2 |
9.759e-05 | -9.23 | SHH_subtype | COSMIC cancer mutations | SHH_subtype | 654 | 9 | 16828 | 49 |
PARD3B,NEBL,ITPR2,NRXN1,RYR3,ERBB4,CTNND2,HPSE2,NPAS3 |
1.057e-04 | -9.15 | D-amino acid transport | biological process | GO:0042940 | 6 | 2 | 18204 | 49 |
SLC1A3,SLC1A2 |
1.057e-04 | -9.15 | L-aspartate import across plasma membrane | biological process | GO:0140009 | 6 | 2 | 18204 | 49 |
SLC1A2,SLC1A3 |
1.064e-04 | -9.15 | RIH_assoc-dom | interpro domains | IPR013662 | 6 | 2 | 18521 | 50 |
RYR3,ITPR2 |
1.064e-04 | -9.15 | Ins145_P3_rcpt | interpro domains | IPR014821 | 6 | 2 | 18521 | 50 |
RYR3,ITPR2 |
1.064e-04 | -9.15 | RIH_dom | interpro domains | IPR000699 | 6 | 2 | 18521 | 50 |
RYR3,ITPR2 |
1.064e-04 | -9.15 | Ryanodine_IP3_receptor | interpro domains | IPR015925 | 6 | 2 | 18521 | 50 |
RYR3,ITPR2 |
1.064e-04 | -9.15 | RyR/IP3R_RIH_dom_sf | interpro domains | IPR035910 | 6 | 2 | 18521 | 50 |
ITPR2,RYR3 |
1.112e-04 | -9.10 | neuron differentiation | biological process | GO:0030182 | 1081 | 11 | 18204 | 49 |
PREX2,CTNNA2,CTNND2,GPM6A,TNIK,RORA,ERBB4,NRXN1,SLC1A3,NTM,BMPR1B |
1.152e-04 | -9.07 | Ins145_P3_rec | pfam domains | PF08709 | 6 | 2 | 17795 | 50 |
RYR3,ITPR2 |
1.152e-04 | -9.07 | RYDR_ITPR | pfam domains | PF01365 | 6 | 2 | 17795 | 50 |
RYR3,ITPR2 |
1.152e-04 | -9.07 | RIH_assoc | pfam domains | PF08454 | 6 | 2 | 17795 | 50 |
ITPR2,RYR3 |
1.158e-04 | -9.06 | glial cell projection | cellular component | GO:0097386 | 37 | 3 | 19108 | 49 |
SLC1A2,AQP4,GLUL |
1.173e-04 | -9.05 | adherens junction | cellular component | GO:0005912 | 188 | 5 | 19108 | 49 |
CTNNA2,PARD3B,CDH20,CTNND2,ARHGAP24 |
1.275e-04 | -8.97 | soft_tissue | COSMIC cancer mutations | soft_tissue | 5828 | 30 | 16828 | 49 |
ARHGAP24,ZNRF3,NEBL,SLC1A3,NPAS3,NKAIN3,PREX2,ITPR2,COL5A3,SLC1A2,ERBB4,CAMK2G,PON2,CLU,LSAMP,AQP4,PARD3B,FBXL7,CDH20,GPM6A,RORA,SPARCL1,RYR3,GPC5,HPSE2,CTNND2,GLIS3,PAMR1,NHSL1,SOX5 |
1.345e-04 | -8.91 | Glutamine synthetase/guanido kinase, catalytic domain | gene3d domains | 3.30.590.10 | 6 | 2 | 14470 | 44 |
GLUL,CKB |
1.345e-04 | -8.91 | IP3 receptor type 1 binding core, RIH domain | gene3d domains | 1.25.10.30 | 6 | 2 | 14470 | 44 |
ITPR2,RYR3 |
1.378e-04 | -8.89 | monoatomic ion transmembrane transporter activity | molecular function | GO:0015075 | 752 | 9 | 18094 | 48 |
SLC1A2,ITPR2,SFXN5,SLC4A4,SLC1A3,GPM6A,RYR3,ATP1A2,ATP13A4 |
1.398e-04 | -8.88 | chondroblastoma | COSMIC cancer mutations | chondroblastoma | 534 | 8 | 16828 | 49 |
LSAMP,GPM6A,GPC5,CTNND2,SFXN5,NKAIN3,SOX5,RYR3 |
1.435e-04 | -8.85 | Salivary secretion | KEGG pathways | hsa04970 | 90 | 4 | 7161 | 22 |
RYR3,CST3,ITPR2,ATP1A2 |
1.435e-04 | -8.85 | Salivary secretion | KEGG pathways | ko04970 | 90 | 4 | 7161 | 22 |
ATP1A2,ITPR2,RYR3,CST3 |
1.487e-04 | -8.81 | Na-dicarboxylate_symporter | interpro domains | IPR001991 | 7 | 2 | 18521 | 50 |
SLC1A2,SLC1A3 |
1.487e-04 | -8.81 | Na:dicarbo_symporter_sf | interpro domains | IPR036458 | 7 | 2 | 18521 | 50 |
SLC1A2,SLC1A3 |
1.487e-04 | -8.81 | Na-dicarboxylate_symporter_CS | interpro domains | IPR018107 | 7 | 2 | 18521 | 50 |
SLC1A2,SLC1A3 |
1.522e-04 | -8.79 | central_nervous_system-brain-primitive_neuroectodermal_tumour-medulloblastoma | COSMIC cancer mutations | central_nervous_system-brain-primitive_neuroectodermal_tumour-medulloblastoma | 7205 | 34 | 16828 | 49 |
LSAMP,PARD3B,PON2,FBXL7,PITPNC1,SLC1A3,NEBL,NRXN1,ITPR2,ERBB4,COL5A3,SLC1A2,NKAIN3,PREX2,NPAS3,GPC5,QKI,NTM,ZBTB20,NHSL1,PAMR1,WWOX,SOX5,CTNND2,HPSE2,ATP13A4,SFXN5,GLIS3,GPM6A,RORA,TNIK,LRIG1,RYR3,SLC4A4 |
1.534e-04 | -8.78 | metal ion transmembrane transporter activity | molecular function | GO:0046873 | 442 | 7 | 18094 | 48 |
RYR3,SLC1A2,ITPR2,SLC1A3,SLC4A4,ATP1A2,GPM6A |
1.565e-04 | -8.76 | cellular response to alkaloid | biological process | GO:0071312 | 39 | 3 | 18204 | 49 |
RYR3,SLC1A3,SLC1A2 |
1.610e-04 | -8.73 | SDF | pfam domains | PF00375 | 7 | 2 | 17795 | 50 |
SLC1A3,SLC1A2 |
1.625e-04 | -8.72 | stomach-carcinoma-intestinal_adenocarcinoma | COSMIC cancer mutations | stomach-carcinoma-intestinal_adenocarcinoma | 7225 | 34 | 16828 | 49 |
CLU,AQP4,LSAMP,PARD3B,CKB,FBXL7,CDH20,ARHGAP24,ZNRF3,GLUL,PITPNC1,NEBL,PREX2,NPAS3,NRXN1,ITPR2,ERBB4,SLC1A2,COL5A3,QKI,NTM,ZBTB20,HPSE2,CTNND2,ATP13A4,SFXN5,ATP1A2,NHSL1,SOX5,CST3,RORA,SLC4A4,LRIG1,RYR3 |
1.625e-04 | -8.72 | intestinal_adenocarcinoma | COSMIC cancer mutations | intestinal_adenocarcinoma | 7225 | 34 | 16828 | 49 |
ARHGAP24,ZNRF3,GLUL,NEBL,PITPNC1,NPAS3,PREX2,ITPR2,NRXN1,SLC1A2,COL5A3,ERBB4,CLU,AQP4,LSAMP,PARD3B,CKB,FBXL7,CDH20,RORA,CST3,SLC4A4,LRIG1,RYR3,NTM,QKI,ZBTB20,ATP13A4,CTNND2,HPSE2,SFXN5,ATP1A2,NHSL1,SOX5 |
1.820e-04 | -8.61 | sarcoplasmic reticulum membrane | cellular component | GO:0033017 | 43 | 3 | 19108 | 49 |
CAMK2G,ITPR2,RYR3 |
1.841e-04 | -8.60 | beta-catenin binding | molecular function | GO:0008013 | 107 | 4 | 18094 | 48 |
CTNND2,RORA,CDH20,CTNNA2 |
1.869e-04 | -8.58 | lymphoid_neoplasm | COSMIC cancer mutations | lymphoid_neoplasm | 12233 | 46 | 16828 | 49 |
COL5A3,SLC1A2,NRXN1,NKAIN3,PREX2,PITPNC1,CDH20,FBXL7,LSAMP,AQP4,DTNA,SPARCL1,RORA,GPM6A,TNIK,NHSL1,GLIS3,ATP1A2,ATP13A4,CTNND2,ZBTB20,ERBB4,MSI2,ITPR2,NPAS3,NEBL,SLC1A3,ZNRF3,ARHGAP24,CKB,PARD3B,PON2,CLU,CAMK2G,RYR3,LRIG1,SLC4A4,SOX5,WWOX,PAMR1,BMPR1B,SFXN5,HPSE2,NTM,QKI,GPC5 |
1.874e-04 | -8.58 | bone-tibia-other-chondroblastoma | COSMIC cancer mutations | bone-tibia-other-chondroblastoma | 98 | 4 | 16828 | 49 |
LSAMP,GPM6A,CTNND2,NKAIN3 |
1.879e-04 | -8.58 | Sodium:dicarboxylate symporter | gene3d domains | 1.10.3860.10 | 7 | 2 | 14470 | 44 |
SLC1A2,SLC1A3 |
1.979e-04 | -8.53 | Gln_synth/guanido_kin_cat_dom | interpro domains | IPR014746 | 8 | 2 | 18521 | 50 |
GLUL,CKB |
2.276e-04 | -8.39 | monoatomic cation transmembrane transporter activity | molecular function | GO:0008324 | 630 | 8 | 18094 | 48 |
RYR3,ATP1A2,ATP13A4,ITPR2,SLC1A2,SLC1A3,SLC4A4,GPM6A |
2.304e-04 | -8.38 | NEGR1 (neuronal growth regulator 1) | protein interactions | 257194 | 9 | 2 | 19454 | 50 |
NTM,LSAMP |
2.304e-04 | -8.38 | LSAMP (limbic system associated membrane protein) | protein interactions | 4045 | 9 | 2 | 19454 | 50 |
NTM,LSAMP |
2.409e-04 | -8.33 | NA_DICARBOXYL_SYMP_1 | prosite domains | PS00713 | 7 | 2 | 12186 | 42 |
SLC1A2,SLC1A3 |
2.409e-04 | -8.33 | NA_DICARBOXYL_SYMP_2 | prosite domains | PS00714 | 7 | 2 | 12186 | 42 |
SLC1A3,SLC1A2 |
2.561e-04 | -8.27 | monoatomic ion transmembrane transport | biological process | GO:0034220 | 804 | 9 | 18204 | 49 |
SFXN5,SLC4A4,ATP1A2,SLC1A2,ATP13A4,SLC1A3,ITPR2,RYR3,GPM6A |
2.614e-04 | -8.25 | transporter activity | molecular function | GO:0005215 | 1211 | 11 | 18094 | 48 |
GPM6A,SLC1A3,SLC4A4,SFXN5,AQP4,ITPR2,SLC1A2,ATP13A4,ATP1A2,PITPNC1,RYR3 |
2.655e-04 | -8.23 | synapse | cellular component | GO:0045202 | 1473 | 12 | 19108 | 49 |
SLC1A2,ERBB4,GPM6A,DTNA,ATP1A2,CLU,SPARCL1,SLC1A3,QKI,NRXN1,CTNND2,TNIK |
2.660e-04 | -8.23 | central nervous system development | biological process | GO:0007417 | 995 | 10 | 18204 | 49 |
BMPR1B,SLC1A2,ERBB4,ATP1A2,CLU,RORA,MSI2,CKB,QKI,CTNNA2 |
2.888e-04 | -8.15 | EDTRNSPORT | prints domains | PR00173 | 7 | 2 | 5227 | 20 |
SLC1A2,SLC1A3 |
3.013e-04 | -8.11 | neuron projection morphogenesis | biological process | GO:0048812 | 486 | 7 | 18204 | 49 |
GPM6A,CTNND2,PREX2,CTNNA2,BMPR1B,NRXN1,TNIK |
3.150e-04 | -8.06 | cellular response to cocaine | biological process | GO:0071314 | 10 | 2 | 18204 | 49 |
SLC1A2,SLC1A3 |
3.170e-04 | -8.06 | MIR_motif | interpro domains | IPR016093 | 10 | 2 | 18521 | 50 |
ITPR2,RYR3 |
3.170e-04 | -8.06 | MIR_dom_sf | interpro domains | IPR036300 | 10 | 2 | 18521 | 50 |
RYR3,ITPR2 |
3.205e-04 | -8.05 | plasma membrane bounded cell projection morphogenesis | biological process | GO:0120039 | 491 | 7 | 18204 | 49 |
TNIK,PREX2,CTNNA2,NRXN1,CTNND2,GPM6A,BMPR1B |
3.346e-04 | -8.00 | central_nervous_system-brainstem-glioma-oligoastrocytoma_Grade_III | COSMIC cancer mutations | central_nervous_system-brainstem-glioma-oligoastrocytoma_Grade_III | 114 | 4 | 16828 | 49 |
SOX5,RYR3,SLC1A2,PREX2 |
3.407e-04 | -7.98 | cell projection morphogenesis | biological process | GO:0048858 | 496 | 7 | 18204 | 49 |
BMPR1B,TNIK,NRXN1,GPM6A,CTNND2,PREX2,CTNNA2 |
3.432e-04 | -7.98 | MIR | pfam domains | PF02815 | 10 | 2 | 17795 | 50 |
RYR3,ITPR2 |
3.571e-04 | -7.94 | Glutamatergic synapse | KEGG pathways | ko04724 | 114 | 4 | 7161 | 22 |
ITPR2,SLC1A3,SLC1A2,GLUL |
3.571e-04 | -7.94 | Glutamatergic synapse | KEGG pathways | hsa04724 | 114 | 4 | 7161 | 22 |
ITPR2,SLC1A2,SLC1A3,GLUL |
3.844e-04 | -7.86 | L-glutamate import across plasma membrane | biological process | GO:0098712 | 11 | 2 | 18204 | 49 |
SLC1A3,SLC1A2 |
3.844e-04 | -7.86 | L-aspartate transmembrane transport | biological process | GO:0070778 | 11 | 2 | 18204 | 49 |
SLC1A2,SLC1A3 |
4.169e-04 | -7.78 | neuron development | biological process | GO:0048666 | 859 | 9 | 18204 | 49 |
NTM,SLC1A3,BMPR1B,TNIK,NRXN1,GPM6A,CTNND2,PREX2,CTNNA2 |
4.605e-04 | -7.68 | auditory behavior | biological process | GO:0031223 | 12 | 2 | 18204 | 49 |
SLC1A3,NRXN1 |
4.778e-04 | -7.65 | sarcolemma | cellular component | GO:0042383 | 142 | 4 | 19108 | 49 |
AQP4,DTNA,ATP1A2,RYR3 |
4.829e-04 | -7.64 | STRN3 (striatin 3) | protein interactions | 29966 | 142 | 4 | 19454 | 50 |
TNIK,PON2,ARHGAP24,CAMK2G |
4.928e-04 | -7.62 | NAKATPASE | prints domains | PR00121 | 9 | 2 | 5227 | 20 |
ATP13A4,ATP1A2 |
5.128e-04 | -7.58 | MIR | prosite domains | PS50919 | 10 | 2 | 12186 | 42 |
RYR3,ITPR2 |
5.266e-04 | -7.55 | inorganic molecular entity transmembrane transporter activity | molecular function | GO:0015318 | 714 | 8 | 18094 | 48 |
SLC1A2,ITPR2,AQP4,GPM6A,SLC4A4,SLC1A3,RYR3,ATP1A2 |
5.428e-04 | -7.52 | neurotransmitter transport | biological process | GO:0006836 | 140 | 4 | 18204 | 49 |
ATP1A2,NRXN1,SLC1A2,SLC1A3 |
5.507e-04 | -7.50 | cell development | biological process | GO:0048468 | 2236 | 15 | 18204 | 49 |
NTM,ERBB4,CLU,RORA,SLC1A3,BMPR1B,TNIK,NEBL,NRXN1,GPM6A,CTNND2,MSI2,QKI,PREX2,CTNNA2 |
5.584e-04 | -7.49 | transmembrane transporter activity | molecular function | GO:0022857 | 1110 | 10 | 18094 | 48 |
ATP13A4,ATP1A2,RYR3,GPM6A,SLC4A4,SFXN5,SLC1A3,ITPR2,SLC1A2,AQP4 |
5.776e-04 | -7.46 | PLXNA4 (plexin A4) | protein interactions | 91584 | 14 | 2 | 19454 | 50 |
CLU,GPM6A |
5.776e-04 | -7.46 | DACT2 (dishevelled binding antagonist of beta catenin 2) | protein interactions | 168002 | 14 | 2 | 19454 | 50 |
ZBTB20,CAMK2G |
5.787e-04 | -7.45 | follicular_lymphoma | COSMIC cancer mutations | follicular_lymphoma | 1209 | 11 | 16828 | 49 |
RORA,GPC5,AQP4,LSAMP,TNIK,WWOX,SOX5,ITPR2,NKAIN3,CTNND2,HPSE2 |
5.895e-04 | -7.44 | MIR | smart domains | SM00472 | 10 | 2 | 9717 | 36 |
RYR3,ITPR2 |
6.145e-04 | -7.39 | L-glutamate transmembrane transporter activity | molecular function | GO:0005313 | 14 | 2 | 18094 | 48 |
SLC1A3,SLC1A2 |
6.327e-04 | -7.37 | mechanosensory behavior | biological process | GO:0007638 | 14 | 2 | 18204 | 49 |
SLC1A3,NRXN1 |
6.327e-04 | -7.37 | sodium ion export across plasma membrane | biological process | GO:0036376 | 14 | 2 | 18204 | 49 |
SLC4A4,ATP1A2 |
6.356e-04 | -7.36 | adult behavior | biological process | GO:0030534 | 146 | 4 | 18204 | 49 |
ATP1A2,NRXN1,SLC1A2,PREX2 |
6.803e-04 | -7.29 | dendrite morphogenesis | biological process | GO:0048813 | 64 | 3 | 18204 | 49 |
CTNNA2,PREX2,CTNND2 |
6.865e-04 | -7.28 | cell differentiation | biological process | GO:0030154 | 3645 | 20 | 18204 | 49 |
ERBB4,CLU,RORA,WWOX,CAMK2G,NTM,SOX5,QKI,CTNNA2,PREX2,NHSL1,CTNND2,ARHGAP24,GPM6A,MSI2,NRXN1,TNIK,NEBL,BMPR1B,SLC1A3 |
6.932e-04 | -7.27 | cell projection | cellular component | GO:0042995 | 2398 | 15 | 19108 | 49 |
BMPR1B,GLUL,NRXN1,SLC1A3,ARHGAP24,ATP1A2,WWOX,SLC1A2,CAMK2G,CTNND2,AQP4,CLU,GPM6A,DTNA,CTNNA2 |
6.941e-04 | -7.27 | cellular developmental process | biological process | GO:0048869 | 3648 | 20 | 18204 | 49 |
NRXN1,NEBL,TNIK,BMPR1B,SLC1A3,NHSL1,CTNNA2,PREX2,QKI,MSI2,CTNND2,ARHGAP24,GPM6A,CLU,RORA,ERBB4,WWOX,CAMK2G,SOX5,NTM |
7.516e-04 | -7.19 | Ion transport by P-type ATPases | REACTOME pathways | R-HSA-936837 | 58 | 3 | 10285 | 32 |
CAMK2G,ATP1A2,ATP13A4 |
7.721e-04 | -7.17 | active monoatomic ion transmembrane transporter activity | molecular function | GO:0022853 | 274 | 5 | 18094 | 48 |
SLC1A2,SLC1A3,ATP1A2,SLC4A4,ATP13A4 |
8.077e-04 | -7.12 | sodium ion transmembrane transporter activity | molecular function | GO:0015081 | 158 | 4 | 18094 | 48 |
SLC1A2,SLC1A3,ATP1A2,SLC4A4 |
8.086e-04 | -7.12 | human chr3q13.31 | chromosome location | human chr3q13.31 | 22 | 2 | 26134 | 50 |
LSAMP,ZBTB20 |
8.111e-04 | -7.12 | cell adhesion | biological process | GO:0007155 | 942 | 9 | 18204 | 49 |
PARD3B,NTM,SPARCL1,COL5A3,CDH20,NRXN1,CTNND2,CTNNA2,LSAMP |
8.421e-04 | -7.08 | membrane | cellular component | GO:0016020 | 9220 | 35 | 19108 | 49 |
ITPR2,CAMK2G,LSAMP,CLU,ZNRF3,ERBB4,NTM,TNIK,GLUL,SLC1A3,PON2,WWOX,CST3,HPSE2,SLC1A2,CTNND2,AQP4,PARD3B,PTGDS,ATP13A4,GPM6A,DTNA,PREX2,SFXN5,CTNNA2,LRIG1,CKB,BMPR1B,RYR3,CDH20,NRXN1,GPC5,NKAIN3,ATP1A2,SLC4A4 |
8.632e-04 | -7.05 | inorganic cation transmembrane transporter activity | molecular function | GO:0022890 | 589 | 7 | 18094 | 48 |
SLC1A2,ITPR2,GPM6A,SLC4A4,SLC1A3,RYR3,ATP1A2 |
8.637e-04 | -7.05 | Transmembrane transport of small molecules | REACTOME pathways | R-HSA-382551 | 677 | 8 | 10285 | 32 |
AQP4,RYR3,ATP1A2,CAMK2G,SLC4A4,SLC1A2,ATP13A4,SLC1A3 |
8.727e-04 | -7.04 | intracellular chemical homeostasis | biological process | GO:0055082 | 581 | 7 | 18204 | 49 |
ATP13A4,ZBTB20,SLC1A3,ATP1A2,SLC4A4,AQP4,RYR3 |
8.975e-04 | -7.02 | presynaptic membrane | cellular component | GO:0042734 | 168 | 4 | 19108 | 49 |
NRXN1,SLC1A2,ERBB4,GPM6A |
9.275e-04 | -6.98 | Cardiac conduction | REACTOME pathways | R-HSA-5576891 | 142 | 4 | 10285 | 32 |
RYR3,ATP1A2,CAMK2G,ITPR2 |
9.332e-04 | -6.98 | bone | COSMIC cancer mutations | bone | 8157 | 35 | 16828 | 49 |
LSAMP,PARD3B,DTNA,PON2,PTGDS,CAMK2G,COL5A3,ERBB4,ITPR2,NRXN1,NPAS3,PREX2,NKAIN3,NEBL,SLC1A3,GLUL,SOX5,PAMR1,SFXN5,GLIS3,ATP1A2,ATP13A4,HPSE2,CTNND2,ZBTB20,GPC5,QKI,RYR3,LRIG1,SLC4A4,SPARCL1,RORA,CST3,GPM6A,TNIK |
9.557e-04 | -6.95 | monoatomic ion transport | biological process | GO:0006811 | 964 | 9 | 18204 | 49 |
ITPR2,SLC1A3,ATP13A4,SLC1A2,SFXN5,SLC4A4,ATP1A2,RYR3,GPM6A |
9.592e-04 | -6.95 | humerus | COSMIC cancer mutations | humerus | 546 | 7 | 16828 | 49 |
SOX5,NKAIN3,SFXN5,NEBL,GPC5,GPM6A,PARD3B |
9.767e-04 | -6.93 | sarcoplasmic reticulum | cellular component | GO:0016529 | 76 | 3 | 19108 | 49 |
ITPR2,CAMK2G,RYR3 |
1.022e-03 | -6.89 | Htt (huntingtin) | protein interactions | 15194 | 77 | 3 | 19454 | 50 |
NTM,LSAMP,GPM6A |
1.026e-03 | -6.88 | acidic amino acid transmembrane transporter activity | molecular function | GO:0015172 | 18 | 2 | 18094 | 48 |
SLC1A2,SLC1A3 |
1.026e-03 | -6.88 | intracellularly gated calcium channel activity | molecular function | GO:0015278 | 18 | 2 | 18094 | 48 |
ITPR2,RYR3 |
1.063e-03 | -6.85 | ATPase_P-typ_cation-transptr_N | interpro domains | IPR004014 | 18 | 2 | 18521 | 50 |
ATP13A4,ATP1A2 |
1.071e-03 | -6.84 | astrocyte projection | cellular component | GO:0097449 | 19 | 2 | 19108 | 49 |
SLC1A2,AQP4 |
1.077e-03 | -6.83 | RIT2 (Ras like without CAAX 2) | protein interactions | 6014 | 19 | 2 | 19454 | 50 |
DTNA,ARHGAP24 |
1.150e-03 | -6.77 | Cation_ATPase_N | pfam domains | PF00690 | 18 | 2 | 17795 | 50 |
ATP1A2,ATP13A4 |
1.158e-03 | -6.76 | cell morphogenesis involved in neuron differentiation | biological process | GO:0048667 | 443 | 6 | 18204 | 49 |
PREX2,CTNNA2,NRXN1,SLC1A3,CTNND2,BMPR1B |
1.179e-03 | -6.74 | cartilage condensation | biological process | GO:0001502 | 19 | 2 | 18204 | 49 |
BMPR1B,SOX5 |
1.181e-03 | -6.74 | chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma | COSMIC cancer mutations | chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma | 3511 | 20 | 16828 | 49 |
LSAMP,PARD3B,DTNA,GPC5,CLU,BMPR1B,PAMR1,CTNND2,HPSE2,FBXL7,PITPNC1,SLC1A3,TNIK,ZNRF3,RYR3,ERBB4,MSI2,NPAS3,SLC4A4,PREX2 |
1.181e-03 | -6.74 | haematopoietic_and_lymphoid_tissue-lymphoid_neoplasm-chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma | COSMIC cancer mutations | haematopoietic_and_lymphoid_tissue-lymphoid_neoplasm-chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma | 3511 | 20 | 16828 | 49 |
RYR3,ERBB4,MSI2,NPAS3,SLC4A4,PREX2,SLC1A3,PITPNC1,ZNRF3,TNIK,PAMR1,BMPR1B,CTNND2,HPSE2,FBXL7,LSAMP,PARD3B,GPC5,DTNA,CLU |
1.194e-03 | -6.73 | PON1 (paraoxonase 1) | protein interactions | 5444 | 20 | 2 | 19454 | 50 |
CLU,SFXN5 |
1.209e-03 | -6.72 | serous_carcinoma | COSMIC cancer mutations | serous_carcinoma | 10987 | 42 | 16828 | 49 |
CST3,RORA,TNIK,LRIG1,RYR3,SLC4A4,QKI,GPC5,NTM,ZBTB20,NHSL1,PAMR1,BMPR1B,WWOX,SOX5,HPSE2,CTNND2,ATP13A4,SFXN5,ATP1A2,GLIS3,GLUL,SLC1A3,NEBL,ARHGAP24,ZNRF3,NRXN1,ITPR2,MSI2,ERBB4,COL5A3,SLC1A2,PREX2,NPAS3,DTNA,LSAMP,PARD3B,CAMK2G,PTGDS,CLU,FBXL7,CDH20 |
1.247e-03 | -6.69 | solute:sodium symporter activity | molecular function | GO:0015370 | 80 | 3 | 18094 | 48 |
SLC1A2,SLC1A3,SLC4A4 |
1.257e-03 | -6.68 | Bile secretion | KEGG pathways | ko04976 | 71 | 3 | 7161 | 22 |
SLC4A4,AQP4,ATP1A2 |
1.257e-03 | -6.68 | Bile secretion | KEGG pathways | hsa04976 | 71 | 3 | 7161 | 22 |
ATP1A2,AQP4,SLC4A4 |
1.290e-03 | -6.65 | plasma membrane region | cellular component | GO:0098590 | 1278 | 10 | 19108 | 49 |
GPM6A,ATP1A2,PARD3B,SLC1A2,ERBB4,SLC4A4,TNIK,AQP4,SLC1A3,NRXN1 |
1.307e-03 | -6.64 | aspartate transmembrane transport | biological process | GO:0015810 | 20 | 2 | 18204 | 49 |
SLC1A2,SLC1A3 |
1.307e-03 | -6.64 | positive regulation of chondrocyte differentiation | biological process | GO:0032332 | 20 | 2 | 18204 | 49 |
BMPR1B,SOX5 |
1.318e-03 | -6.63 | HTR2A (5-hydroxytryptamine receptor 2A) | protein interactions | 3356 | 21 | 2 | 19454 | 50 |
PON2,GLUL |
1.384e-03 | -6.58 | extracellular region | cellular component | GO:0005576 | 4350 | 21 | 19108 | 49 |
SPARCL1,COL5A3,ATP1A2,PON2,SLC4A4,CST3,HPSE2,PAMR1,NTM,TNIK,GLUL,NEBL,GPC5,PTGDS,CLU,GPM6A,LRIG1,ERBB4,CKB,LSAMP,AQP4 |
1.443e-03 | -6.54 | positive regulation of purine nucleotide catabolic process | biological process | GO:0033123 | 21 | 2 | 18204 | 49 |
SLC4A4,ZBTB20 |
1.443e-03 | -6.54 | cell aggregation | biological process | GO:0098743 | 21 | 2 | 18204 | 49 |
BMPR1B,SOX5 |
1.443e-03 | -6.54 | positive regulation of glycolytic process | biological process | GO:0045821 | 21 | 2 | 18204 | 49 |
SLC4A4,ZBTB20 |
1.443e-03 | -6.54 | positive regulation of nucleotide catabolic process | biological process | GO:0030813 | 21 | 2 | 18204 | 49 |
ZBTB20,SLC4A4 |
1.444e-03 | -6.54 | CTNNA1 (catenin alpha 1) | protein interactions | 1495 | 325 | 5 | 19454 | 50 |
DTNA,CTNNA2,NEBL,TNIK,NHSL1 |
1.467e-03 | -6.52 | cellular response to organic cyclic compound | biological process | GO:0071407 | 464 | 6 | 18204 | 49 |
ATP1A2,RORA,SLC1A2,RYR3,SLC1A3,ITPR2 |
1.473e-03 | -6.52 | Gastric acid secretion | KEGG pathways | ko04971 | 75 | 3 | 7161 | 22 |
ITPR2,ATP1A2,CAMK2G |
1.473e-03 | -6.52 | Gastric acid secretion | KEGG pathways | hsa04971 | 75 | 3 | 7161 | 22 |
ITPR2,ATP1A2,CAMK2G |
1.474e-03 | -6.52 | monoatomic cation transmembrane transport | biological process | GO:0098655 | 636 | 7 | 18204 | 49 |
SLC1A3,ITPR2,ATP13A4,SLC4A4,ATP1A2,GPM6A,RYR3 |
1.499e-03 | -6.50 | neuronal cell body | cellular component | GO:0043025 | 489 | 6 | 19108 | 49 |
GPM6A,ATP1A2,BMPR1B,CTNND2,NRXN1,SLC1A3 |
1.550e-03 | -6.47 | Cation_ATPase_N | smart domains | SM00831 | 16 | 2 | 9717 | 36 |
ATP1A2,ATP13A4 |
1.582e-03 | -6.45 | Rbm38 (RNA binding motif protein 38) | protein interactions | 56190 | 23 | 2 | 19454 | 50 |
QKI,MSI2 |
1.582e-03 | -6.45 | TIMM10B (translocase of inner mitochondrial membrane 10B) | protein interactions | 26515 | 23 | 2 | 19454 | 50 |
HPSE2,MSI2 |
1.584e-03 | -6.45 | intracellular sodium ion homeostasis | biological process | GO:0006883 | 22 | 2 | 18204 | 49 |
SLC1A3,ATP1A2 |
1.663e-03 | -6.40 | CAMK2D (calcium/calmodulin dependent protein kinase II delta) | protein interactions | 817 | 198 | 4 | 19454 | 50 |
ITPR2,PON2,WWOX,CAMK2G |
1.683e-03 | -6.39 | amino acid:sodium symporter activity | molecular function | GO:0005283 | 23 | 2 | 18094 | 48 |
SLC1A2,SLC1A3 |
1.708e-03 | -6.37 | transmembrane transport | biological process | GO:0055085 | 1264 | 10 | 18204 | 49 |
AQP4,RYR3,GPM6A,ATP13A4,SLC1A3,ITPR2,ATP1A2,SLC4A4,SFXN5,SLC1A2 |
1.751e-03 | -6.35 | neuron projection | cellular component | GO:0043005 | 1331 | 10 | 19108 | 49 |
BMPR1B,CTNND2,CAMK2G,SLC1A3,DTNA,ATP1A2,GPM6A,CLU,CTNNA2,SLC1A2 |
1.757e-03 | -6.34 | TIAM1 (TIAM Rac1 associated GEF 1) | protein interactions | 7074 | 201 | 4 | 19454 | 50 |
CAMK2G,DTNA,RYR3,ATP1A2 |
1.758e-03 | -6.34 | right_lower_lobe | COSMIC cancer mutations | right_lower_lobe | 5692 | 27 | 16828 | 49 |
SLC4A4,LRIG1,RYR3,GPM6A,CST3,CTNND2,HPSE2,ATP13A4,ATP1A2,PAMR1,SOX5,GPC5,NTM,NKAIN3,NPAS3,ITPR2,ERBB4,COL5A3,ZNRF3,SLC1A3,NEBL,FBXL7,CDH20,CLU,DTNA,PARD3B,LSAMP |
1.758e-03 | -6.34 | lung-right_lower_lobe-carcinoma-adenocarcinoma | COSMIC cancer mutations | lung-right_lower_lobe-carcinoma-adenocarcinoma | 5692 | 27 | 16828 | 49 |
CDH20,FBXL7,LSAMP,PARD3B,DTNA,CLU,COL5A3,ERBB4,ITPR2,NPAS3,NKAIN3,NEBL,SLC1A3,ZNRF3,SOX5,PAMR1,ATP1A2,ATP13A4,HPSE2,CTNND2,NTM,GPC5,RYR3,LRIG1,SLC4A4,CST3,GPM6A |
1.774e-03 | -6.33 | bone-humerus-other-chondroblastoma | COSMIC cancer mutations | bone-humerus-other-chondroblastoma | 301 | 5 | 16828 | 49 |
SOX5,GPC5,GPM6A,SFXN5,NKAIN3 |
1.781e-03 | -6.33 | ovary-carcinoma-serous_carcinoma | COSMIC cancer mutations | ovary-carcinoma-serous_carcinoma | 10710 | 41 | 16828 | 49 |
PAMR1,BMPR1B,NHSL1,SOX5,ATP13A4,HPSE2,CTNND2,ATP1A2,GLIS3,SFXN5,NTM,QKI,GPC5,ZBTB20,LRIG1,RYR3,SLC4A4,RORA,CST3,TNIK,FBXL7,CDH20,PARD3B,LSAMP,DTNA,PTGDS,CAMK2G,CLU,ITPR2,NRXN1,COL5A3,SLC1A2,MSI2,ERBB4,NPAS3,PREX2,GLUL,NEBL,SLC1A3,ARHGAP24,ZNRF3 |
1.832e-03 | -6.30 | P-type transmembrane transporter activity | molecular function | GO:0140358 | 24 | 2 | 18094 | 48 |
ATP1A2,ATP13A4 |
1.832e-03 | -6.30 | P-type ion transporter activity | molecular function | GO:0015662 | 24 | 2 | 18094 | 48 |
ATP13A4,ATP1A2 |
1.848e-03 | -6.29 | cell surface | cellular component | GO:0009986 | 896 | 8 | 19108 | 49 |
CLU,ATP1A2,SLC4A4,SLC1A2,NRXN1,GPC5,AQP4,SLC1A3 |
1.866e-03 | -6.28 | haematopoietic_and_lymphoid_tissue-lymphoid_neoplasm-follicular_lymphoma | COSMIC cancer mutations | haematopoietic_and_lymphoid_tissue-lymphoid_neoplasm-follicular_lymphoma | 981 | 9 | 16828 | 49 |
SOX5,WWOX,ITPR2,NKAIN3,CTNND2,HPSE2,RORA,LSAMP,GPC5 |
1.898e-03 | -6.27 | HS-GAG degradation | REACTOME pathways | R-HSA-2024096 | 21 | 2 | 10285 | 32 |
GPC5,HPSE2 |
1.911e-03 | -6.26 | cell-cell junction | cellular component | GO:0005911 | 513 | 6 | 19108 | 49 |
CTNNA2,CTNND2,ARHGAP24,CDH20,ATP1A2,PARD3B |
1.913e-03 | -6.26 | human chr3q26.2-q26.31 | chromosome location | human chr3q26.2-q26.31 | 1 | 1 | 26134 | 50 |
TNIK |
1.913e-03 | -6.26 | human chr4q21.23-q21.3 | chromosome location | human chr4q21.23-q21.3 | 1 | 1 | 26134 | 50 |
ARHGAP24 |
1.913e-03 | -6.26 | human chr15q13.3-q14 | chromosome location | human chr15q13.3-q14 | 1 | 1 | 26134 | 50 |
RYR3 |
1.913e-03 | -6.26 | human chr16q23.1-q23.2 | chromosome location | human chr16q23.1-q23.2 | 1 | 1 | 26134 | 50 |
WWOX |
1.915e-03 | -6.26 | sarcoplasm | cellular component | GO:0016528 | 96 | 3 | 19108 | 49 |
RYR3,ITPR2,CAMK2G |
1.960e-03 | -6.23 | synapse organization | biological process | GO:0050808 | 333 | 5 | 18204 | 49 |
SPARCL1,GPM6A,CTNND2,ERBB4,NRXN1 |
1.987e-03 | -6.22 | BTG3 (BTG anti-proliferation factor 3) | protein interactions | 10950 | 97 | 3 | 19454 | 50 |
CLU,GLUL,SPARCL1 |
2.022e-03 | -6.20 | Calcium signaling pathway | KEGG pathways | hsa04020 | 181 | 4 | 7161 | 22 |
CAMK2G,ITPR2,RYR3,ERBB4 |
2.022e-03 | -6.20 | Calcium signaling pathway | KEGG pathways | ko04020 | 181 | 4 | 7161 | 22 |
CAMK2G,RYR3,ITPR2,ERBB4 |
2.047e-03 | -6.19 | L-glutamate transmembrane transport | biological process | GO:0015813 | 25 | 2 | 18204 | 49 |
SLC1A3,SLC1A2 |
2.135e-03 | -6.15 | carcinoid-endocrine_tumour | COSMIC cancer mutations | carcinoid-endocrine_tumour | 7752 | 33 | 16828 | 49 |
SLC1A3,NEBL,ERBB4,COL5A3,SLC1A2,ITPR2,NKAIN3,PREX2,CKB,LSAMP,PON2,CLU,CAMK2G,CDH20,FBXL7,RORA,GPM6A,TNIK,RYR3,LRIG1,SLC4A4,GPC5,QKI,SOX5,NHSL1,BMPR1B,PAMR1,GLIS3,ATP1A2,SFXN5,CTNND2,HPSE2,ATP13A4 |
2.139e-03 | -6.15 | scalp | COSMIC cancer mutations | scalp | 2110 | 14 | 16828 | 49 |
COL5A3,ERBB4,NRXN1,SLC4A4,PREX2,RORA,NEBL,SOX5,ATP1A2,ATP13A4,LSAMP,NTM,GPC5,CAMK2G |
2.152e-03 | -6.14 | extrinsic component of plasma membrane | cellular component | GO:0019897 | 100 | 3 | 19108 | 49 |
CTNNA2,CDH20,DTNA |
2.181e-03 | -6.13 | HPCAL4 (hippocalcin like 4) | protein interactions | 51440 | 27 | 2 | 19454 | 50 |
AQP4,GPM6A |
2.181e-03 | -6.13 | MBNL2 (muscleblind like splicing regulator 2) | protein interactions | 10150 | 27 | 2 | 19454 | 50 |
MSI2,QKI |
2.192e-03 | -6.12 | Proximal tubule bicarbonate reclamation | KEGG pathways | ko04964 | 23 | 2 | 7161 | 22 |
SLC4A4,ATP1A2 |
2.192e-03 | -6.12 | Proximal tubule bicarbonate reclamation | KEGG pathways | hsa04964 | 23 | 2 | 7161 | 22 |
SLC4A4,ATP1A2 |
2.214e-03 | -6.11 | C4-dicarboxylate transport | biological process | GO:0015740 | 26 | 2 | 18204 | 49 |
SLC1A2,SLC1A3 |
2.222e-03 | -6.11 | upper_aerodigestive_tract-pharynx-carcinoma-nasopharyngeal_carcinoma | COSMIC cancer mutations | upper_aerodigestive_tract-pharynx-carcinoma-nasopharyngeal_carcinoma | 1425 | 11 | 16828 | 49 |
PITPNC1,QKI,CLU,SLC1A2,NHSL1,PREX2,ATP1A2,SFXN5,SLC4A4,CTNND2,ATP13A4 |
2.222e-03 | -6.11 | nasopharyngeal_carcinoma | COSMIC cancer mutations | nasopharyngeal_carcinoma | 1425 | 11 | 16828 | 49 |
SLC1A2,NHSL1,SLC4A4,SFXN5,PREX2,ATP1A2,ATP13A4,CTNND2,PITPNC1,QKI,CLU |
2.324e-03 | -6.06 | cellular homeostasis | biological process | GO:0019725 | 689 | 7 | 18204 | 49 |
RYR3,AQP4,ZBTB20,SLC1A3,ATP13A4,SLC4A4,ATP1A2 |
2.345e-03 | -6.06 | PLAAT4 (phospholipase A and acyltransferase 4) | protein interactions | 5920 | 28 | 2 | 19454 | 50 |
WWOX,PTGDS |
2.401e-03 | -6.03 | neuron projection development | biological process | GO:0031175 | 693 | 7 | 18204 | 49 |
BMPR1B,TNIK,NRXN1,GPM6A,CTNND2,PREX2,CTNNA2 |
2.467e-03 | -6.00 | response to alkaloid | biological process | GO:0043279 | 100 | 3 | 18204 | 49 |
SLC1A3,RYR3,SLC1A2 |
2.480e-03 | -6.00 | Glutamate Neurotransmitter Release Cycle | REACTOME pathways | R-HSA-210500 | 24 | 2 | 10285 | 32 |
SLC1A3,SLC1A2 |
2.564e-03 | -5.97 | perinuclear endoplasmic reticulum lumen | cellular component | GO:0099020 | 1 | 1 | 19108 | 49 |
CLU |
2.570e-03 | -5.96 | ZNF780B (zinc finger protein 780B) | protein interactions | 163131 | 1 | 1 | 19454 | 50 |
ARHGAP24 |
2.570e-03 | -5.96 | 1700006A11Rik (RIKEN cDNA 1700006A11 gene) | protein interactions | 71824 | 1 | 1 | 19454 | 50 |
BMPR1B |
2.570e-03 | -5.96 | Lztr1 (leucine-zipper-like transcriptional regulator, 1) | protein interactions | 66863 | 1 | 1 | 19454 | 50 |
BMPR1B |
2.570e-03 | -5.96 | Agtrap (angiotensin II, type I receptor-associated protein) | protein interactions | 11610 | 1 | 1 | 19454 | 50 |
PITPNC1 |
2.570e-03 | -5.96 | ZNF75D (zinc finger protein 75D) | protein interactions | 7626 | 1 | 1 | 19454 | 50 |
ARHGAP24 |
2.570e-03 | -5.96 | RPS15AP21 (ribosomal protein S15a pseudogene 21) | protein interactions | 100271357 | 1 | 1 | 19454 | 50 |
WWOX |
2.570e-03 | -5.96 | ZNF880 (zinc finger protein 880) | protein interactions | 400713 | 1 | 1 | 19454 | 50 |
ARHGAP24 |
2.570e-03 | -5.96 | Dcaf7 (DDB1 and CUL4 associated factor 7) | protein interactions | 71833 | 1 | 1 | 19454 | 50 |
BMPR1B |
2.570e-03 | -5.96 | ZNF729 (zinc finger protein 729) | protein interactions | 100287226 | 1 | 1 | 19454 | 50 |
ARHGAP24 |
2.570e-03 | -5.96 | Isl1 (ISL1 transcription factor, LIM/homeodomain) | protein interactions | 16392 | 1 | 1 | 19454 | 50 |
GLIS3 |
2.570e-03 | -5.96 | Sytl1 (synaptotagmin-like 1) | protein interactions | 269589 | 1 | 1 | 19454 | 50 |
NRXN1 |
2.570e-03 | -5.96 | ZNF781 (zinc finger protein 781) | protein interactions | 163115 | 1 | 1 | 19454 | 50 |
ARHGAP24 |
2.570e-03 | -5.96 | Hipk3 (homeodomain interacting protein kinase 3) | protein interactions | 15259 | 1 | 1 | 19454 | 50 |
GLIS3 |
2.593e-03 | -5.95 | Calcium-transporting ATPase, transmembrane domain | gene3d domains | 1.20.1110.10 | 25 | 2 | 14470 | 44 |
ATP1A2,ATP13A4 |
2.653e-03 | -5.93 | internal N(7)-methylguanine-containing RNA reader activity | molecular function | GO:0160089 | 1 | 1 | 18094 | 48 |
QKI |
2.673e-03 | -5.92 | amino acid:monoatomic cation symporter activity | molecular function | GO:0005416 | 29 | 2 | 18094 | 48 |
SLC1A2,SLC1A3 |
2.673e-03 | -5.92 | ligand-gated calcium channel activity | molecular function | GO:0099604 | 29 | 2 | 18094 | 48 |
RYR3,ITPR2 |
2.690e-03 | -5.92 | CLNK (cytokine dependent hematopoietic cell linker) | protein interactions | 116449 | 30 | 2 | 19454 | 50 |
GLIS3,WWOX |
2.691e-03 | -5.92 | Nuclear signaling by ERBB4 | REACTOME pathways | R-HSA-1251985 | 25 | 2 | 10285 | 32 |
WWOX,ERBB4 |
2.692e-03 | -5.92 | regulation of neuronal signal transduction | biological process | GO:1902847 | 1 | 1 | 18204 | 49 |
CLU |
2.692e-03 | -5.92 | positive regulation of neurofibrillary tangle assembly | biological process | GO:1902998 | 1 | 1 | 18204 | 49 |
CLU |
2.692e-03 | -5.92 | negative regulation of elastin catabolic process | biological process | GO:0060311 | 1 | 1 | 18204 | 49 |
CST3 |
2.692e-03 | -5.92 | negative regulation of calcium:sodium antiporter activity | biological process | GO:1903280 | 1 | 1 | 18204 | 49 |
ATP1A2 |
2.692e-03 | -5.92 | olfactory cortex development | biological process | GO:0021989 | 1 | 1 | 18204 | 49 |
ATP1A2 |
2.692e-03 | -5.92 | negative regulation of collagen catabolic process | biological process | GO:0010711 | 1 | 1 | 18204 | 49 |
CST3 |
2.692e-03 | -5.92 | oesophagus-carcinoma-squamous_cell_carcinoma | COSMIC cancer mutations | oesophagus-carcinoma-squamous_cell_carcinoma | 6486 | 29 | 16828 | 49 |
GPM6A,TNIK,RYR3,SLC4A4,SPARCL1,ZBTB20,GPC5,WWOX,SOX5,BMPR1B,ATP1A2,GLIS3,SFXN5,HPSE2,CTNND2,ATP13A4,PITPNC1,NEBL,GLUL,ARHGAP24,ERBB4,COL5A3,NRXN1,ITPR2,PREX2,NPAS3,PARD3B,AQP4,FBXL7 |
2.698e-03 | -5.92 | FKBP1A (FKBP prolyl isomerase 1A) | protein interactions | 2280 | 108 | 3 | 19454 | 50 |
ERBB4,MSI2,RYR3 |
2.700e-03 | -5.91 | Clusterin_CS | interpro domains | IPR033986 | 1 | 1 | 18521 | 50 |
CLU |
2.700e-03 | -5.91 | Gln_synth_N_conserv_site | interpro domains | IPR027302 | 1 | 1 | 18521 | 50 |
GLUL |
2.700e-03 | -5.91 | WWOX_SDR_c-like | interpro domains | IPR042732 | 1 | 1 | 18521 | 50 |
WWOX |
2.700e-03 | -5.91 | STAR_dimer | interpro domains | IPR032377 | 1 | 1 | 18521 | 50 |
QKI |
2.700e-03 | -5.91 | Gln_synth_gly_rich_site | interpro domains | IPR027303 | 1 | 1 | 18521 | 50 |
GLUL |
2.700e-03 | -5.91 | Quaking_NLS | interpro domains | IPR032367 | 1 | 1 | 18521 | 50 |
QKI |
2.700e-03 | -5.91 | Nebulette_SH3 | interpro domains | IPR035631 | 1 | 1 | 18521 | 50 |
NEBL |
2.700e-03 | -5.91 | Rex2_DEP_1 | interpro domains | IPR037367 | 1 | 1 | 18521 | 50 |
PREX2 |
2.700e-03 | -5.91 | SPARC-like_p1 | interpro domains | IPR016359 | 1 | 1 | 18521 | 50 |
SPARCL1 |
2.700e-03 | -5.91 | Clusterin | interpro domains | IPR016016 | 1 | 1 | 18521 | 50 |
CLU |
2.700e-03 | -5.91 | ZNRF3_Znf_RING | interpro domains | IPR045903 | 1 | 1 | 18521 | 50 |
ZNRF3 |
2.709e-03 | -5.91 | large_intestine-caecum-carcinoma-adenocarcinoma | COSMIC cancer mutations | large_intestine-caecum-carcinoma-adenocarcinoma | 14236 | 48 | 16828 | 49 |
NHSL1,ATP13A4,CTNND2,GLIS3,ATP1A2,ZBTB20,SPARCL1,GPM6A,RORA,TNIK,FBXL7,CDH20,AQP4,LSAMP,DTNA,NRXN1,SLC1A2,COL5A3,PREX2,NKAIN3,GLUL,PITPNC1,BMPR1B,PAMR1,SOX5,WWOX,HPSE2,SFXN5,NTM,GPC5,QKI,LRIG1,RYR3,SLC4A4,CST3,PARD3B,CKB,PTGDS,CAMK2G,CLU,PON2,ITPR2,ERBB4,NPAS3,NEBL,SLC1A3,ARHGAP24,ZNRF3 |
2.809e-03 | -5.87 | caecum | COSMIC cancer mutations | caecum | 14248 | 48 | 16828 | 49 |
CKB,PARD3B,CLU,PON2,PTGDS,CAMK2G,ERBB4,ITPR2,NPAS3,NEBL,SLC1A3,ZNRF3,ARHGAP24,SOX5,WWOX,BMPR1B,PAMR1,SFXN5,HPSE2,NTM,QKI,GPC5,RYR3,LRIG1,SLC4A4,CST3,CDH20,FBXL7,AQP4,LSAMP,DTNA,COL5A3,SLC1A2,NRXN1,NKAIN3,PREX2,PITPNC1,GLUL,NHSL1,ATP1A2,GLIS3,ATP13A4,CTNND2,ZBTB20,SPARCL1,RORA,GPM6A,TNIK |
2.810e-03 | -5.87 | Quaking_NLS | pfam domains | PF16551 | 1 | 1 | 17795 | 50 |
QKI |
2.810e-03 | -5.87 | Gln-synt_N | pfam domains | PF03951 | 1 | 1 | 17795 | 50 |
GLUL |
2.810e-03 | -5.87 | STAR_dimer | pfam domains | PF16544 | 1 | 1 | 17795 | 50 |
QKI |
2.828e-03 | -5.87 | chemical homeostasis | biological process | GO:0048878 | 914 | 8 | 18204 | 49 |
RYR3,AQP4,ZBTB20,SLC1A3,ATP13A4,ATP1A2,RORA,SLC4A4 |
2.842e-03 | -5.86 | LZTR1 (leucine zipper like post translational regulator 1) | protein interactions | 8216 | 110 | 3 | 19454 | 50 |
CKB,BMPR1B,PARD3B |
2.857e-03 | -5.86 | catenin complex | cellular component | GO:0016342 | 31 | 2 | 19108 | 49 |
CDH20,CTNNA2 |
2.898e-03 | -5.84 | ErbB4 signaling events | Pathway Interaction DB | erbb4_pathway | 32 | 2 | 2226 | 6 |
WWOX,LRIG1 |
2.901e-03 | -5.84 | Pancreatic secretion | KEGG pathways | hsa04972 | 95 | 3 | 7161 | 22 |
SLC4A4,ATP1A2,ITPR2 |
2.901e-03 | -5.84 | Pancreatic secretion | KEGG pathways | ko04972 | 95 | 3 | 7161 | 22 |
ITPR2,ATP1A2,SLC4A4 |
2.916e-03 | -5.84 | cell junction organization | biological process | GO:0034330 | 532 | 6 | 18204 | 49 |
GPM6A,CTNND2,NRXN1,ERBB4,CDH20,SPARCL1 |
2.934e-03 | -5.83 | extracellular matrix | cellular component | GO:0031012 | 559 | 6 | 19108 | 49 |
GPC5,HPSE2,LRIG1,CLU,COL5A3,SPARCL1 |
2.942e-03 | -5.83 | L-glutamate import | biological process | GO:0051938 | 30 | 2 | 18204 | 49 |
SLC1A3,SLC1A2 |
2.952e-03 | -5.83 | cellular response to endogenous stimulus | biological process | GO:0071495 | 1135 | 9 | 18204 | 49 |
RYR3,BMPR1B,SOX5,ITPR2,SLC1A3,ERBB4,ATP1A2,WWOX,SLC1A2 |
2.960e-03 | -5.82 | external encapsulating structure | cellular component | GO:0030312 | 560 | 6 | 19108 | 49 |
SPARCL1,CLU,COL5A3,LRIG1,HPSE2,GPC5 |
3.032e-03 | -5.80 | pharynx | COSMIC cancer mutations | pharynx | 2696 | 16 | 16828 | 49 |
PITPNC1,PREX2,NPAS3,SLC4A4,SLC1A2,RYR3,CLU,GPC5,QKI,DTNA,PARD3B,CTNND2,ATP13A4,ATP1A2,SFXN5,NHSL1 |
3.041e-03 | -5.80 | - | gene3d domains | 1.20.5.4010 | 1 | 1 | 14470 | 44 |
QKI |
3.041e-03 | -5.80 | - | gene3d domains | 6.10.250.880 | 1 | 1 | 14470 | 44 |
ERBB4 |
3.051e-03 | -5.79 | intracellularly ligand-gated monoatomic ion channel activity | molecular function | GO:0005217 | 31 | 2 | 18094 | 48 |
ITPR2,RYR3 |
3.070e-03 | -5.79 | Proteoglycans in cancer | KEGG pathways | ko05205 | 203 | 4 | 7161 | 22 |
HPSE2,ITPR2,CAMK2G,ERBB4 |
3.070e-03 | -5.79 | Proteoglycans in cancer | KEGG pathways | hsa05205 | 203 | 4 | 7161 | 22 |
ERBB4,CAMK2G,HPSE2,ITPR2 |
3.104e-03 | -5.78 | upper_aerodigestive_tract | COSMIC cancer mutations | upper_aerodigestive_tract | 13181 | 46 | 16828 | 49 |
PTGDS,CAMK2G,CLU,PARD3B,CKB,ARHGAP24,ZNRF3,NEBL,SLC1A3,NPAS3,ITPR2,MSI2,ERBB4,NTM,GPC5,QKI,HPSE2,SFXN5,BMPR1B,PAMR1,SOX5,WWOX,CST3,SLC4A4,LRIG1,RYR3,LSAMP,DTNA,FBXL7,CDH20,GLUL,PITPNC1,NKAIN3,PREX2,NRXN1,COL5A3,SLC1A2,ZBTB20,ATP13A4,CTNND2,ATP1A2,GLIS3,NHSL1,TNIK,GPM6A,RORA |
3.188e-03 | -5.75 | CAMK2A (calcium/calmodulin dependent protein kinase II alpha) | protein interactions | 815 | 237 | 4 | 19454 | 50 |
SOX5,GPM6A,CAMK2G,ITPR2 |
3.219e-03 | -5.74 | skin-leg-malignant_melanoma-superficial_spreading | COSMIC cancer mutations | skin-leg-malignant_melanoma-superficial_spreading | 210 | 4 | 16828 | 49 |
ATP13A4,SLC4A4,NTM,COL5A3 |
3.224e-03 | -5.74 | human chr11p13 | chromosome location | human chr11p13 | 44 | 2 | 26134 | 50 |
SLC1A2,PAMR1 |
3.249e-03 | -5.73 | KATNAL1 (katanin catalytic subunit A1 like 1) | protein interactions | 84056 | 33 | 2 | 19454 | 50 |
PITPNC1,ARHGAP24 |
3.326e-03 | -5.71 | L-glutamine biosynthesis I | BIOCYC pathways | META_GLNSYN-PWY | 1 | 1 | 902 | 3 |
GLUL |
3.326e-03 | -5.71 | glutamine biosynthesis | BIOCYC pathways | HUMAN_GLNSYN-PWY | 1 | 1 | 902 | 3 |
GLUL |
3.326e-03 | -5.71 | glutamate dependent acid resistance | BIOCYC pathways | HUMAN_PWY0-1305 | 1 | 1 | 902 | 3 |
GLUL |
3.336e-03 | -5.70 | GJA1 (gap junction protein alpha 1) | protein interactions | 2697 | 572 | 6 | 19454 | 50 |
ERBB4,ITPR2,TNIK,DTNA,CKB,WWOX |
3.344e-03 | -5.70 | positive regulation of ATP metabolic process | biological process | GO:1903580 | 32 | 2 | 18204 | 49 |
SLC4A4,ZBTB20 |
3.344e-03 | -5.70 | positive regulation of cartilage development | biological process | GO:0061036 | 32 | 2 | 18204 | 49 |
SOX5,BMPR1B |
3.344e-03 | -5.70 | transepithelial transport | biological process | GO:0070633 | 32 | 2 | 18204 | 49 |
SLC1A2,SLC1A3 |
3.415e-03 | -5.68 | E1-E2_ATPase | pfam domains | PF00122 | 31 | 2 | 17795 | 50 |
ATP13A4,ATP1A2 |
3.441e-03 | -5.67 | HAX1 (HCLS1 associated protein X-1) | protein interactions | 10456 | 397 | 5 | 19454 | 50 |
ITPR2,NTM,CLU,GPM6A,CKB |
3.447e-03 | -5.67 | GLNA_1 | prosite domains | PS00180 | 1 | 1 | 12186 | 42 |
GLUL |
3.447e-03 | -5.67 | CLUSTERIN_2 | prosite domains | PS00493 | 1 | 1 | 12186 | 42 |
CLU |
3.447e-03 | -5.67 | GLNA_ATP | prosite domains | PS00181 | 1 | 1 | 12186 | 42 |
GLUL |
3.447e-03 | -5.67 | CLUSTERIN_1 | prosite domains | PS00492 | 1 | 1 | 12186 | 42 |
CLU |
3.468e-03 | -5.66 | pancreas-carcinoid-endocrine_tumour | COSMIC cancer mutations | pancreas-carcinoid-endocrine_tumour | 7250 | 31 | 16828 | 49 |
NEBL,SLC1A3,SLC1A2,COL5A3,ERBB4,ITPR2,NKAIN3,PREX2,CKB,LSAMP,CLU,PON2,CDH20,FBXL7,RORA,GPM6A,RYR3,LRIG1,SLC4A4,QKI,GPC5,SOX5,PAMR1,BMPR1B,NHSL1,ATP1A2,GLIS3,SFXN5,ATP13A4,HPSE2,CTNND2 |
3.486e-03 | -5.66 | dendrite development | biological process | GO:0016358 | 113 | 3 | 18204 | 49 |
PREX2,CTNNA2,CTNND2 |
3.497e-03 | -5.66 | Muscle contraction | REACTOME pathways | R-HSA-397014 | 204 | 4 | 10285 | 32 |
RYR3,ATP1A2,CAMK2G,ITPR2 |
3.548e-03 | -5.64 | skin-trunk-malignant_melanoma-nodular | COSMIC cancer mutations | skin-trunk-malignant_melanoma-nodular | 1291 | 10 | 16828 | 49 |
GLIS3,PREX2,ATP1A2,NPAS3,CDH20,CTNND2,SPARCL1,ATP13A4,ERBB4,NEBL |
3.588e-03 | -5.63 | nodular | COSMIC cancer mutations | nodular | 1515 | 11 | 16828 | 49 |
GLIS3,ATP1A2,CDH20,CTNND2,ATP13A4,NEBL,ERBB4,PREX2,SLC4A4,NPAS3,SPARCL1 |
3.637e-03 | -5.62 | Cation_ATPase | pfam domains | PF13246 | 32 | 2 | 17795 | 50 |
ATP13A4,ATP1A2 |
3.649e-03 | -5.61 | TPRA1 (transmembrane protein adipocyte associated 1) | protein interactions | 131601 | 35 | 2 | 19454 | 50 |
ITPR2,BMPR1B |
3.653e-03 | -5.61 | response to endogenous stimulus | biological process | GO:0009719 | 1402 | 10 | 18204 | 49 |
RYR3,ITPR2,SOX5,SLC1A3,BMPR1B,PTGDS,WWOX,SLC1A2,ERBB4,ATP1A2 |
3.688e-03 | -5.60 | calcium channel activity | molecular function | GO:0005262 | 117 | 3 | 18094 | 48 |
GPM6A,ITPR2,RYR3 |
3.688e-03 | -5.60 | solute:monoatomic cation symporter activity | molecular function | GO:0015294 | 117 | 3 | 18094 | 48 |
SLC4A4,SLC1A3,SLC1A2 |
3.814e-03 | -5.57 | Ion channel transport | REACTOME pathways | R-HSA-983712 | 209 | 4 | 10285 | 32 |
CAMK2G,RYR3,ATP1A2,ATP13A4 |
3.826e-03 | -5.57 | AQUAPORIN4 | prints domains | PR02016 | 1 | 1 | 5227 | 20 |
AQP4 |
3.857e-03 | -5.56 | ZNRF1 (zinc and ring finger 1) | protein interactions | 84937 | 36 | 2 | 19454 | 50 |
GLUL,ATP1A2 |
3.857e-03 | -5.56 | SLC5A5 (solute carrier family 5 member 5) | protein interactions | 6528 | 36 | 2 | 19454 | 50 |
CAMK2G,SFXN5 |
3.878e-03 | -5.55 | organic acid:sodium symporter activity | molecular function | GO:0005343 | 35 | 2 | 18094 | 48 |
SLC1A3,SLC1A2 |
3.913e-03 | -5.54 | TGFBR1 (transforming growth factor beta receptor 1) | protein interactions | 7046 | 251 | 4 | 19454 | 50 |
BMPR1B,CLU,WWOX,PREX2 |
3.937e-03 | -5.54 | synapse assembly | biological process | GO:0007416 | 118 | 3 | 18204 | 49 |
NRXN1,ERBB4,GPM6A |
3.979e-03 | -5.53 | glutamatergic synapse | cellular component | GO:0098978 | 412 | 5 | 19108 | 49 |
SLC1A2,ERBB4,SPARCL1,GPM6A,TNIK |
4.007e-03 | -5.52 | haematopoietic_and_lymphoid_tissue-lymphoid_neoplasm | COSMIC cancer mutations | haematopoietic_and_lymphoid_tissue-lymphoid_neoplasm | 7307 | 31 | 16828 | 49 |
GPM6A,RORA,TNIK,LRIG1,RYR3,SPARCL1,QKI,GPC5,NHSL1,PAMR1,BMPR1B,SOX5,HPSE2,CTNND2,ATP13A4,SFXN5,GLIS3,SLC1A3,NEBL,ITPR2,ERBB4,SLC1A2,COL5A3,PREX2,NKAIN3,PARD3B,LSAMP,PON2,CLU,FBXL7,CDH20 |
4.070e-03 | -5.50 | plasma membrane bounded cell projection | cellular component | GO:0120025 | 2285 | 13 | 19108 | 49 |
AQP4,CTNND2,CAMK2G,CTNNA2,DTNA,GPM6A,CLU,SLC1A3,GLUL,BMPR1B,SLC1A2,WWOX,ATP1A2 |
4.071e-03 | -5.50 | TRNAU1AP (tRNA selenocysteine 1 associated protein 1) | protein interactions | 54952 | 37 | 2 | 19454 | 50 |
ZBTB20,QKI |
4.071e-03 | -5.50 | PRRG4 (proline rich and Gla domain 4) | protein interactions | 79056 | 37 | 2 | 19454 | 50 |
NEBL,ERBB4 |
4.071e-03 | -5.50 | MAGI2 (membrane associated guanylate kinase, WW and PDZ domain containing 2) | protein interactions | 9863 | 37 | 2 | 19454 | 50 |
CTNND2,ERBB4 |
4.071e-03 | -5.50 | TFAP2C (transcription factor AP-2 gamma) | protein interactions | 7022 | 37 | 2 | 19454 | 50 |
WWOX,ERBB4 |
4.071e-03 | -5.50 | HPCA (hippocalcin) | protein interactions | 3208 | 37 | 2 | 19454 | 50 |
CST3,GPM6A |
4.099e-03 | -5.50 | proteoglycan binding | molecular function | GO:0043394 | 36 | 2 | 18094 | 48 |
COL5A3,HPSE2 |
4.127e-03 | -5.49 | striated muscle contraction | biological process | GO:0006941 | 120 | 3 | 18204 | 49 |
RYR3,DTNA,ATP1A2 |
4.138e-03 | -5.49 | Neuronal System | REACTOME pathways | R-HSA-112316 | 349 | 5 | 10285 | 32 |
SLC1A2,NRXN1,SLC1A3,CAMK2G,GLUL |
4.183e-03 | -5.48 | monoatomic cation transport | biological process | GO:0006812 | 766 | 7 | 18204 | 49 |
GPM6A,RYR3,SLC1A3,ITPR2,ATP13A4,SLC4A4,ATP1A2 |
4.244e-03 | -5.46 | P_typ_ATPase | interpro domains | IPR001757 | 36 | 2 | 18521 | 50 |
ATP13A4,ATP1A2 |
4.244e-03 | -5.46 | ATPase_P-typ_cyto_dom_N | interpro domains | IPR023299 | 36 | 2 | 18521 | 50 |
ATP1A2,ATP13A4 |
4.244e-03 | -5.46 | ATPase_P-typ_P_site | interpro domains | IPR018303 | 36 | 2 | 18521 | 50 |
ATP13A4,ATP1A2 |
4.244e-03 | -5.46 | ATPase_P-typ_transduc_dom_A_sf | interpro domains | IPR008250 | 36 | 2 | 18521 | 50 |
ATP1A2,ATP13A4 |
4.244e-03 | -5.46 | P_typ_ATPase_HD_dom | interpro domains | IPR044492 | 36 | 2 | 18521 | 50 |
ATP13A4,ATP1A2 |
4.258e-03 | -5.46 | PAX9 (paired box 9) | protein interactions | 5083 | 127 | 3 | 19454 | 50 |
ARHGAP24,QKI,WWOX |
4.290e-03 | -5.45 | Pcbp1 (poly(rC) binding protein 1) | protein interactions | 23983 | 38 | 2 | 19454 | 50 |
QKI,MSI2 |
4.361e-03 | -5.44 | Transport of inorganic cations/anions and amino acids/oligopeptides | REACTOME pathways | R-HSA-425393 | 107 | 3 | 10285 | 32 |
SLC1A2,SLC1A3,SLC4A4 |
4.361e-03 | -5.44 | Transmission across Chemical Synapses | REACTOME pathways | R-HSA-112315 | 217 | 4 | 10285 | 32 |
GLUL,CAMK2G,SLC1A3,SLC1A2 |
4.451e-03 | -5.41 | positive regulation of purine nucleotide metabolic process | biological process | GO:1900544 | 37 | 2 | 18204 | 49 |
ZBTB20,SLC4A4 |
4.451e-03 | -5.41 | positive regulation of nucleotide metabolic process | biological process | GO:0045981 | 37 | 2 | 18204 | 49 |
ZBTB20,SLC4A4 |
4.478e-03 | -5.41 | ATPase_P-typ_TM_dom_sf | interpro domains | IPR023298 | 37 | 2 | 18521 | 50 |
ATP13A4,ATP1A2 |
4.691e-03 | -5.36 | amino acid import across plasma membrane | biological process | GO:0089718 | 38 | 2 | 18204 | 49 |
SLC1A2,SLC1A3 |
4.753e-03 | -5.35 | endoplasmic reticulum | cellular component | GO:0005783 | 2051 | 12 | 19108 | 49 |
CAMK2G,ITPR2,GLUL,RYR3,NRXN1,SPARCL1,PTGDS,COL5A3,CLU,ATP1A2,ATP13A4,CST3 |
4.936e-03 | -5.31 | olfactory lobe development | biological process | GO:0021988 | 39 | 2 | 18204 | 49 |
ATP1A2,ERBB4 |
4.936e-03 | -5.31 | sodium ion homeostasis | biological process | GO:0055078 | 39 | 2 | 18204 | 49 |
ATP1A2,SLC1A3 |
4.980e-03 | -5.30 | SRGAP3 (SLIT-ROBO Rho GTPase activating protein 3) | protein interactions | 9901 | 41 | 2 | 19454 | 50 |
TNIK,ARHGAP24 |
5.134e-03 | -5.27 | Bcr (BCR activator of RhoGEF and GTPase) | protein interactions | 110279 | 2 | 1 | 19454 | 50 |
BMPR1B |
5.134e-03 | -5.27 | Irf7 (interferon regulatory factor 7) | protein interactions | 54123 | 2 | 1 | 19454 | 50 |
BMPR1B |
5.134e-03 | -5.27 | Ppp3cc (protein phosphatase 3, catalytic subunit, gamma isoform) | protein interactions | 19057 | 2 | 1 | 19454 | 50 |
BMPR1B |
5.134e-03 | -5.27 | Kdm4c (lysine (K)-specific demethylase 4C) | protein interactions | 76804 | 2 | 1 | 19454 | 50 |
GLIS3 |
5.134e-03 | -5.27 | ZNF680 (zinc finger protein 680) | protein interactions | 340252 | 2 | 1 | 19454 | 50 |
ARHGAP24 |
5.134e-03 | -5.27 | Mknk2 (MAP kinase-interacting serine/threonine kinase 2) | protein interactions | 17347 | 2 | 1 | 19454 | 50 |
BMPR1B |
5.134e-03 | -5.27 | Fkbp1b (FK506 binding protein 1b) | protein interactions | 14226 | 2 | 1 | 19454 | 50 |
BMPR1B |
5.134e-03 | -5.27 | cdh11.S (cadherin 11 S homeolog) | protein interactions | 100337621 | 2 | 1 | 19454 | 50 |
ERBB4 |
5.134e-03 | -5.27 | Klhl1 (kelch-like 1) | protein interactions | 93688 | 2 | 1 | 19454 | 50 |
BMPR1B |
5.134e-03 | -5.27 | Fbxo34 (F-box protein 34) | protein interactions | 78938 | 2 | 1 | 19454 | 50 |
BMPR1B |
5.134e-03 | -5.27 | Bmpr2 (bone morphogenetic protein receptor type 2) | protein interactions | 12168 | 2 | 1 | 19454 | 50 |
BMPR1B |
5.134e-03 | -5.27 | ZNF658B (zinc finger protein 658B (pseudogene)) | protein interactions | 401509 | 2 | 1 | 19454 | 50 |
ARHGAP24 |
5.134e-03 | -5.27 | Sh3kbp1 (SH3-domain kinase binding protein 1) | protein interactions | 58194 | 2 | 1 | 19454 | 50 |
BMPR1B |
5.134e-03 | -5.27 | Zmym2 (zinc finger, MYM-type 2) | protein interactions | 76007 | 2 | 1 | 19454 | 50 |
GLIS3 |
5.134e-03 | -5.27 | Fkbp1a (FK506 binding protein 1a) | protein interactions | 14225 | 2 | 1 | 19454 | 50 |
BMPR1B |
5.299e-03 | -5.24 | heparanase activity | molecular function | GO:0030305 | 2 | 1 | 18094 | 48 |
HPSE2 |
5.299e-03 | -5.24 | ammonia ligase activity | molecular function | GO:0016211 | 2 | 1 | 18094 | 48 |
GLUL |
5.299e-03 | -5.24 | glutamine synthetase activity | molecular function | GO:0004356 | 2 | 1 | 18094 | 48 |
GLUL |
5.329e-03 | -5.23 | TRIM67 (tripartite motif containing 67) | protein interactions | 440730 | 4804 | 21 | 19454 | 50 |
ATP1A2,CTNND2,LSAMP,GLUL,LRIG1,GPM6A,CAMK2G,ITPR2,SLC4A4,NTM,TNIK,CST3,SLC1A3,QKI,MSI2,PON2,DTNA,CLU,CKB,PITPNC1,CTNNA2 |
5.330e-03 | -5.23 | CUL1 (cullin 1) | protein interactions | 8454 | 838 | 7 | 19454 | 50 |
MSI2,FBXL7,ARHGAP24,RYR3,CLU,CKB,ZNRF3 |
5.331e-03 | -5.23 | Calcium-transporting ATPase, cytoplasmic domain N | gene3d domains | 3.40.1110.10 | 36 | 2 | 14470 | 44 |
ATP13A4,ATP1A2 |
5.331e-03 | -5.23 | Calcium-transporting ATPase, cytoplasmic transduction domain A | gene3d domains | 2.70.150.10 | 36 | 2 | 14470 | 44 |
ATP1A2,ATP13A4 |
5.376e-03 | -5.23 | Wnt receptor catabolic process | biological process | GO:0038018 | 2 | 1 | 18204 | 49 |
ZNRF3 |
5.376e-03 | -5.23 | myofibroblast contraction | biological process | GO:1990764 | 2 | 1 | 18204 | 49 |
QKI |
5.376e-03 | -5.23 | negative regulation of 3'-UTR-mediated mRNA stabilization | biological process | GO:1905869 | 2 | 1 | 18204 | 49 |
QKI |
5.376e-03 | -5.23 | regulation of neurofibrillary tangle assembly | biological process | GO:1902996 | 2 | 1 | 18204 | 49 |
CLU |
5.376e-03 | -5.23 | regulation of elastin catabolic process | biological process | GO:0060310 | 2 | 1 | 18204 | 49 |
CST3 |
5.376e-03 | -5.23 | glutamine biosynthetic process | biological process | GO:0006542 | 2 | 1 | 18204 | 49 |
GLUL |
5.376e-03 | -5.23 | futile creatine cycle | biological process | GO:0140651 | 2 | 1 | 18204 | 49 |
CKB |
5.376e-03 | -5.23 | negative regulation of blood vessel remodeling | biological process | GO:0060313 | 2 | 1 | 18204 | 49 |
CST3 |
5.376e-03 | -5.23 | establishment of planar polarity involved in nephron morphogenesis | biological process | GO:0072046 | 2 | 1 | 18204 | 49 |
ERBB4 |
5.377e-03 | -5.23 | somatodendritic compartment | cellular component | GO:0036477 | 842 | 7 | 19108 | 49 |
CTNND2,BMPR1B,NRXN1,SLC1A3,CLU,GPM6A,ATP1A2 |
5.383e-03 | -5.22 | amino acid transport | biological process | GO:0006865 | 132 | 3 | 18204 | 49 |
SLC1A3,SLC1A2,SFXN5 |
5.392e-03 | -5.22 | Osteonectin_CS | interpro domains | IPR001999 | 2 | 1 | 18521 | 50 |
SPARCL1 |
5.392e-03 | -5.22 | ZNRF-3_ecto | interpro domains | IPR040700 | 2 | 1 | 18521 | 50 |
ZNRF3 |
5.392e-03 | -5.22 | Par3/HAL_N | interpro domains | IPR021922 | 2 | 1 | 18521 | 50 |
PARD3B |
5.392e-03 | -5.22 | MSI_RRM2 | interpro domains | IPR034126 | 2 | 1 | 18521 | 50 |
MSI2 |
5.392e-03 | -5.22 | Clusterin-like | interpro domains | IPR000753 | 2 | 1 | 18521 | 50 |
CLU |
5.392e-03 | -5.22 | Glyco_hydro_79 | interpro domains | IPR005199 | 2 | 1 | 18521 | 50 |
HPSE2 |
5.392e-03 | -5.22 | Gln_synt_N_sf | interpro domains | IPR036651 | 2 | 1 | 18521 | 50 |
GLUL |
5.392e-03 | -5.22 | Gln_synt_N | interpro domains | IPR008147 | 2 | 1 | 18521 | 50 |
GLUL |
5.392e-03 | -5.22 | Gln_synth_cat_dom | interpro domains | IPR008146 | 2 | 1 | 18521 | 50 |
GLUL |
5.392e-03 | -5.22 | Distrobrevin | interpro domains | IPR017432 | 2 | 1 | 18521 | 50 |
DTNA |
5.392e-03 | -5.22 | Paraoxonase2 | interpro domains | IPR008364 | 2 | 1 | 18521 | 50 |
PON2 |
5.392e-03 | -5.22 | Clusterin_N | interpro domains | IPR016014 | 2 | 1 | 18521 | 50 |
CLU |
5.392e-03 | -5.22 | Clusterin_C | interpro domains | IPR016015 | 2 | 1 | 18521 | 50 |
CLU |
5.432e-03 | -5.22 | Ig_I-set | interpro domains | IPR013098 | 132 | 3 | 18521 | 50 |
LSAMP,NTM,LRIG1 |
5.492e-03 | -5.20 | organic anion transmembrane transporter activity | molecular function | GO:0008514 | 268 | 4 | 18094 | 48 |
SLC1A2,SLC1A3,SFXN5,SLC4A4 |
5.497e-03 | -5.20 | regulation of sequestering of calcium ion | biological process | GO:0051282 | 133 | 3 | 18204 | 49 |
ATP1A2,RYR3,ITPR2 |
5.545e-03 | -5.19 | neutral L-amino acid transmembrane transporter activity | molecular function | GO:0015175 | 42 | 2 | 18094 | 48 |
SLC1A2,SLC1A3 |
5.612e-03 | -5.18 | ZNRF_3_ecto | pfam domains | PF18212 | 2 | 1 | 17795 | 50 |
ZNRF3 |
5.612e-03 | -5.18 | Gln-synt_C | pfam domains | PF00120 | 2 | 1 | 17795 | 50 |
GLUL |
5.612e-03 | -5.18 | Glyco_hydro_79n | pfam domains | PF03662 | 2 | 1 | 17795 | 50 |
HPSE2 |
5.612e-03 | -5.18 | Clusterin | pfam domains | PF01093 | 2 | 1 | 17795 | 50 |
CLU |
5.612e-03 | -5.18 | Par3_HAL_N_term | pfam domains | PF12053 | 2 | 1 | 17795 | 50 |
PARD3B |
5.612e-03 | -5.18 | calcium ion transmembrane transporter activity | molecular function | GO:0015085 | 136 | 3 | 18094 | 48 |
GPM6A,ITPR2,RYR3 |
5.706e-03 | -5.17 | cellular modified amino acid biosynthetic process | biological process | GO:0042398 | 42 | 2 | 18204 | 49 |
CKB,SLC1A2 |
5.717e-03 | -5.16 | SH2D1A (SH2 domain containing 1A) | protein interactions | 4068 | 44 | 2 | 19454 | 50 |
CAMK2G,ERBB4 |
5.721e-03 | -5.16 | intracellular monoatomic cation homeostasis | biological process | GO:0030003 | 428 | 5 | 18204 | 49 |
SLC1A3,RYR3,ATP13A4,SLC4A4,ATP1A2 |
5.802e-03 | -5.15 | mast_cell_neoplasm | COSMIC cancer mutations | mast_cell_neoplasm | 248 | 4 | 16828 | 49 |
HPSE2,NPAS3,GPC5,ERBB4 |
5.802e-03 | -5.15 | haematopoietic_and_lymphoid_tissue-haematopoietic_neoplasm-mast_cell_neoplasm | COSMIC cancer mutations | haematopoietic_and_lymphoid_tissue-haematopoietic_neoplasm-mast_cell_neoplasm | 248 | 4 | 16828 | 49 |
ERBB4,GPC5,NPAS3,HPSE2 |
6.018e-03 | -5.11 | carboxylic acid biosynthetic process | biological process | GO:0046394 | 271 | 4 | 18204 | 49 |
QKI,PTGDS,GLUL,SLC1A3 |
6.044e-03 | -5.11 | inorganic cation transmembrane transport | biological process | GO:0098662 | 618 | 6 | 18204 | 49 |
SLC4A4,ATP1A2,ITPR2,SLC1A3,GPM6A,RYR3 |
6.064e-03 | -5.11 | I-set | pfam domains | PF07679 | 132 | 3 | 17795 | 50 |
LRIG1,NTM,LSAMP |
6.073e-03 | -5.10 | Vinculin, Vh2 four-helix bundle | gene3d domains | 1.20.120.810 | 2 | 1 | 14470 | 44 |
CTNNA2 |
6.073e-03 | -5.10 | - | gene3d domains | 6.20.350.10 | 2 | 1 | 14470 | 44 |
RYR3 |
6.073e-03 | -5.10 | Glutamine synthetase, N-terminal domain | gene3d domains | 3.10.20.70 | 2 | 1 | 14470 | 44 |
GLUL |
6.084e-03 | -5.10 | autonomic_ganglia | COSMIC cancer mutations | autonomic_ganglia | 4005 | 20 | 16828 | 49 |
ERBB4,SLC1A2,COL5A3,RYR3,PREX2,SLC4A4,NPAS3,GPM6A,PITPNC1,NEBL,ZNRF3,TNIK,NHSL1,CTNND2,FBXL7,ATP1A2,GLIS3,AQP4,PARD3B,CAMK2G |
6.174e-03 | -5.09 | vascular process in circulatory system | biological process | GO:0003018 | 273 | 4 | 18204 | 49 |
ATP1A2,SLC4A4,SLC1A2,SLC1A3 |
6.238e-03 | -5.08 | intracellular monoatomic ion homeostasis | biological process | GO:0006873 | 437 | 5 | 18204 | 49 |
SLC1A3,RYR3,ATP13A4,SLC4A4,ATP1A2 |
6.254e-03 | -5.07 | organic acid biosynthetic process | biological process | GO:0016053 | 274 | 4 | 18204 | 49 |
GLUL,QKI,PTGDS,SLC1A3 |
6.257e-03 | -5.07 | active transmembrane transporter activity | molecular function | GO:0022804 | 444 | 5 | 18094 | 48 |
SLC1A2,SLC4A4,ATP1A2,SLC1A3,ATP13A4 |
6.288e-03 | -5.07 | basal plasma membrane | cellular component | GO:0009925 | 288 | 4 | 19108 | 49 |
AQP4,SLC1A3,ERBB4,SLC4A4 |
6.500e-03 | -5.04 | LRIG3 (leucine rich repeats and immunoglobulin like domains 3) | protein interactions | 121227 | 47 | 2 | 19454 | 50 |
LRIG1,ERBB4 |
6.527e-03 | -5.03 | acidic amino acid transport | biological process | GO:0015800 | 45 | 2 | 18204 | 49 |
SLC1A2,SLC1A3 |
6.588e-03 | -5.02 | monoatomic anion transmembrane transport | biological process | GO:0098656 | 142 | 3 | 18204 | 49 |
SLC1A3,SLC1A2,SLC4A4 |
6.624e-03 | -5.02 | metal ion transport | biological process | GO:0030001 | 630 | 6 | 18204 | 49 |
SLC4A4,ATP1A2,ITPR2,SLC1A3,GPM6A,RYR3 |
6.645e-03 | -5.01 | L-glutamate and L-glutamine biosynthesis | BIOCYC pathways | META_PWY-5505 | 2 | 1 | 902 | 3 |
GLUL |
6.757e-03 | -5.00 | CPVL (carboxypeptidase vitellogenic like) | protein interactions | 54504 | 150 | 3 | 19454 | 50 |
TNIK,WWOX,SOX5 |
6.783e-03 | -4.99 | ATPASE_E1_E2 | prosite domains | PS00154 | 36 | 2 | 12186 | 42 |
ATP1A2,ATP13A4 |
6.882e-03 | -4.98 | GS_CATALYTIC | prosite domains | PS51987 | 2 | 1 | 12186 | 42 |
GLUL |
6.882e-03 | -4.98 | OSTEONECTIN_1 | prosite domains | PS00612 | 2 | 1 | 12186 | 42 |
SPARCL1 |
6.882e-03 | -4.98 | GS_BETA_GRASP | prosite domains | PS51986 | 2 | 1 | 12186 | 42 |
GLUL |
6.882e-03 | -4.98 | OSTEONECTIN_2 | prosite domains | PS00613 | 2 | 1 | 12186 | 42 |
SPARCL1 |
6.997e-03 | -4.96 | Wnt signaling pathway | biological process | GO:0016055 | 283 | 4 | 18204 | 49 |
ZNRF3,TNIK,WWOX,CTNND2 |
7.007e-03 | -4.96 | CAMK2B (calcium/calmodulin dependent protein kinase II beta) | protein interactions | 816 | 152 | 3 | 19454 | 50 |
CAMK2G,GPM6A,ITPR2 |
7.009e-03 | -4.96 | response to organic cyclic compound | biological process | GO:0014070 | 843 | 7 | 18204 | 49 |
RYR3,ITPR2,SLC1A3,ATP1A2,RORA,PTGDS,SLC1A2 |
7.087e-03 | -4.95 | symporter activity | molecular function | GO:0015293 | 148 | 3 | 18094 | 48 |
SLC1A2,SLC4A4,SLC1A3 |
7.119e-03 | -4.94 | oligoastrocytoma_Grade_III | COSMIC cancer mutations | oligoastrocytoma_Grade_III | 263 | 4 | 16828 | 49 |
PREX2,SLC1A2,SOX5,RYR3 |
7.170e-03 | -4.94 | cell junction assembly | biological process | GO:0034329 | 285 | 4 | 18204 | 49 |
GPM6A,CDH20,NRXN1,ERBB4 |
7.253e-03 | -4.93 | central_nervous_system-brainstem-glioma-astrocytoma_Grade_II | COSMIC cancer mutations | central_nervous_system-brainstem-glioma-astrocytoma_Grade_II | 136 | 3 | 16828 | 49 |
PREX2,WWOX,ERBB4 |
7.272e-03 | -4.92 | Ig_3 | pfam domains | PF13927 | 141 | 3 | 17795 | 50 |
LSAMP,NTM,LRIG1 |
7.396e-03 | -4.91 | CLa | smart domains | SM00035 | 2 | 1 | 9717 | 36 |
CLU |
7.396e-03 | -4.91 | CLb | smart domains | SM00030 | 2 | 1 | 9717 | 36 |
CLU |
7.396e-03 | -4.91 | Gln-synt_C | smart domains | SM01230 | 2 | 1 | 9717 | 36 |
GLUL |
7.423e-03 | -4.90 | IGF2BP1 (insulin like growth factor 2 mRNA binding protein 1) | protein interactions | 10642 | 477 | 5 | 19454 | 50 |
QKI,MSI2,ARHGAP24,WWOX,SOX5 |
7.519e-03 | -4.89 | neuromuscular process | biological process | GO:0050905 | 149 | 3 | 18204 | 49 |
SLC1A3,CTNNA2,NRXN1 |
7.617e-03 | -4.88 | LINGO1 (leucine rich repeat and Ig domain containing 1) | protein interactions | 84894 | 51 | 2 | 19454 | 50 |
NTM,PON2 |
7.639e-03 | -4.87 | PARAOXONASE2 | prints domains | PR01787 | 2 | 1 | 5227 | 20 |
PON2 |
7.657e-03 | -4.87 | CARM1 (coactivator associated arginine methyltransferase 1) | protein interactions | 10498 | 304 | 4 | 19454 | 50 |
QKI,RORA,DTNA,CAMK2G |
7.674e-03 | -4.87 | CATATPASE | prints domains | PR00119 | 35 | 2 | 5227 | 20 |
ATP1A2,ATP13A4 |
7.691e-03 | -4.87 | ZNF716 (zinc finger protein 716) | protein interactions | 441234 | 3 | 1 | 19454 | 50 |
ARHGAP24 |
7.691e-03 | -4.87 | Fbxw5 (F-box and WD-40 domain protein 5) | protein interactions | 30839 | 3 | 1 | 19454 | 50 |
BMPR1B |
7.691e-03 | -4.87 | Lrrc7 (leucine rich repeat containing 7) | protein interactions | 117284 | 3 | 1 | 19454 | 50 |
CAMK2G |
7.691e-03 | -4.87 | Atg16l1 (autophagy related 16 like 1) | protein interactions | 77040 | 3 | 1 | 19454 | 50 |
BMPR1B |
7.691e-03 | -4.87 | Usp45 (ubiquitin specific petidase 45) | protein interactions | 77593 | 3 | 1 | 19454 | 50 |
BMPR1B |
7.691e-03 | -4.87 | ZNF257 (zinc finger protein 257) | protein interactions | 113835 | 3 | 1 | 19454 | 50 |
ARHGAP24 |
7.691e-03 | -4.87 | Stk35 (serine/threonine kinase 35) | protein interactions | 67333 | 3 | 1 | 19454 | 50 |
BMPR1B |
7.691e-03 | -4.87 | Spop (speckle-type BTB/POZ protein) | protein interactions | 20747 | 3 | 1 | 19454 | 50 |
GLIS3 |
7.691e-03 | -4.87 | TULP1 (TUB like protein 1) | protein interactions | 7287 | 3 | 1 | 19454 | 50 |
NRXN1 |
7.691e-03 | -4.87 | NRG3 (neuregulin 3) | protein interactions | 10718 | 3 | 1 | 19454 | 50 |
ERBB4 |
7.691e-03 | -4.87 | Lep (leptin) | protein interactions | 16846 | 3 | 1 | 19454 | 50 |
CLU |
7.691e-03 | -4.87 | ZNF506 (zinc finger protein 506) | protein interactions | 440515 | 3 | 1 | 19454 | 50 |
ARHGAP24 |
7.691e-03 | -4.87 | Rap2a (RAS related protein 2a) | protein interactions | 76108 | 3 | 1 | 19454 | 50 |
BMPR1B |
7.691e-03 | -4.87 | Hk2 (hexokinase 2) | protein interactions | 25059 | 3 | 1 | 19454 | 50 |
PTGDS |
7.691e-03 | -4.87 | ZNF682 (zinc finger protein 682) | protein interactions | 91120 | 3 | 1 | 19454 | 50 |
ARHGAP24 |
7.691e-03 | -4.87 | Plekhb1 (pleckstrin homology domain containing, family B (evectins) member 1) | protein interactions | 27276 | 3 | 1 | 19454 | 50 |
BMPR1B |
7.691e-03 | -4.87 | Chn1 (chimerin 1) | protein interactions | 108699 | 3 | 1 | 19454 | 50 |
BMPR1B |
7.691e-03 | -4.87 | Smad6 (SMAD family member 6) | protein interactions | 17130 | 3 | 1 | 19454 | 50 |
BMPR1B |
7.691e-03 | -4.87 | ZNF540 (zinc finger protein 540) | protein interactions | 163255 | 3 | 1 | 19454 | 50 |
ARHGAP24 |
7.691e-03 | -4.87 | QRFPR (pyroglutamylated RFamide peptide receptor) | protein interactions | 84109 | 3 | 1 | 19454 | 50 |
NTM |
7.792e-03 | -4.85 | NPEPPS (aminopeptidase puromycin sensitive) | protein interactions | 9520 | 158 | 3 | 19454 | 50 |
CKB,WWOX,ARHGAP24 |
7.821e-03 | -4.85 | Signaling by ERBB4 | REACTOME pathways | R-HSA-1236394 | 43 | 2 | 10285 | 32 |
WWOX,ERBB4 |
7.847e-03 | -4.85 | basal part of cell | cellular component | GO:0045178 | 307 | 4 | 19108 | 49 |
SLC1A3,AQP4,ERBB4,SLC4A4 |
7.909e-03 | -4.84 | SNAP91 (synaptosome associated protein 91) | protein interactions | 9892 | 52 | 2 | 19454 | 50 |
ERBB4,GPM6A |
7.938e-03 | -4.84 | acyl-L-homoserine-lactone lactonohydrolase activity | molecular function | GO:0102007 | 3 | 1 | 18094 | 48 |
PON2 |
7.938e-03 | -4.84 | prostaglandin-D synthase activity | molecular function | GO:0004667 | 3 | 1 | 18094 | 48 |
PTGDS |
7.938e-03 | -4.84 | epidermal growth factor receptor activity | molecular function | GO:0005006 | 3 | 1 | 18094 | 48 |
ERBB4 |
7.938e-03 | -4.84 | inositol 1,4,5-trisphosphate-gated calcium channel activity | molecular function | GO:0005220 | 3 | 1 | 18094 | 48 |
ITPR2 |
7.938e-03 | -4.84 | cysteine transmembrane transporter activity | molecular function | GO:0033229 | 3 | 1 | 18094 | 48 |
SLC1A2 |
7.938e-03 | -4.84 | lactonohydrolase activity | molecular function | GO:0046573 | 3 | 1 | 18094 | 48 |
PON2 |
7.938e-03 | -4.84 | neuregulin receptor activity | molecular function | GO:0038131 | 3 | 1 | 18094 | 48 |
ERBB4 |
7.938e-03 | -4.84 | acid-ammonia (or amide) ligase activity | molecular function | GO:0016880 | 3 | 1 | 18094 | 48 |
GLUL |
8.054e-03 | -4.82 | neuroligin clustering involved in postsynaptic membrane assembly | biological process | GO:0097118 | 3 | 1 | 18204 | 49 |
NRXN1 |
8.054e-03 | -4.82 | immune complex clearance | biological process | GO:0002434 | 3 | 1 | 18204 | 49 |
CLU |
8.054e-03 | -4.82 | protein targeting to lysosome involved in chaperone-mediated autophagy | biological process | GO:0061740 | 3 | 1 | 18204 | 49 |
CLU |
8.054e-03 | -4.82 | cysteine transmembrane transport | biological process | GO:1903712 | 3 | 1 | 18204 | 49 |
SLC1A2 |
8.054e-03 | -4.82 | regulation of calcium:sodium antiporter activity | biological process | GO:1903279 | 3 | 1 | 18204 | 49 |
ATP1A2 |
8.054e-03 | -4.82 | cardiac muscle thin filament assembly | biological process | GO:0071691 | 3 | 1 | 18204 | 49 |
NEBL |
8.054e-03 | -4.82 | cysteine transport | biological process | GO:0042883 | 3 | 1 | 18204 | 49 |
SLC1A2 |
8.054e-03 | -4.82 | radial glia guided migration of Purkinje cell | biological process | GO:0021942 | 3 | 1 | 18204 | 49 |
CTNNA2 |
8.054e-03 | -4.82 | central nervous system morphogenesis | biological process | GO:0021551 | 3 | 1 | 18204 | 49 |
ERBB4 |
8.078e-03 | -4.82 | RYDR_Jsol | interpro domains | IPR048581 | 3 | 1 | 18521 | 50 |
RYR3 |
8.078e-03 | -4.82 | Ryan_recept | interpro domains | IPR013333 | 3 | 1 | 18521 | 50 |
RYR3 |
8.078e-03 | -4.82 | ROR_rcpt | interpro domains | IPR003079 | 3 | 1 | 18521 | 50 |
RORA |
8.078e-03 | -4.82 | SPRY3_RyR | interpro domains | IPR035762 | 3 | 1 | 18521 | 50 |
RYR3 |
8.078e-03 | -4.82 | Vinculin_CS | interpro domains | IPR000633 | 3 | 1 | 18521 | 50 |
CTNNA2 |
8.078e-03 | -4.82 | NR_DBD_ROR | interpro domains | IPR044101 | 3 | 1 | 18521 | 50 |
RORA |
8.078e-03 | -4.82 | SPRY1_RyR | interpro domains | IPR035761 | 3 | 1 | 18521 | 50 |
RYR3 |
8.078e-03 | -4.82 | TM_ErbB1 | interpro domains | IPR049328 | 3 | 1 | 18521 | 50 |
ERBB4 |
8.078e-03 | -4.82 | InsP3_rcpt | interpro domains | IPR000493 | 3 | 1 | 18521 | 50 |
ITPR2 |
8.078e-03 | -4.82 | Ryanodine_rcpt | interpro domains | IPR003032 | 3 | 1 | 18521 | 50 |
RYR3 |
8.078e-03 | -4.82 | Arylesterase | interpro domains | IPR002640 | 3 | 1 | 18521 | 50 |
PON2 |
8.078e-03 | -4.82 | Myelin_PLP_CS | interpro domains | IPR018237 | 3 | 1 | 18521 | 50 |
GPM6A |
8.078e-03 | -4.82 | SPRY2_RyR | interpro domains | IPR035764 | 3 | 1 | 18521 | 50 |
RYR3 |
8.078e-03 | -4.82 | Myelin_PLP | interpro domains | IPR001614 | 3 | 1 | 18521 | 50 |
GPM6A |
8.078e-03 | -4.82 | Ryanrecept_TM4-6 | interpro domains | IPR009460 | 3 | 1 | 18521 | 50 |
RYR3 |
8.100e-03 | -4.82 | ITCH (itchy E3 ubiquitin protein ligase) | protein interactions | 83737 | 309 | 4 | 19454 | 50 |
WWOX,RORA,GLIS3,ERBB4 |
8.157e-03 | -4.81 | oesophagus-middle_third-carcinoma-squamous_cell_carcinoma | COSMIC cancer mutations | oesophagus-middle_third-carcinoma-squamous_cell_carcinoma | 3531 | 18 | 16828 | 49 |
NHSL1,PAMR1,SOX5,CTNND2,HPSE2,ATP1A2,GPC5,ZBTB20,PON2,LRIG1,COL5A3,RYR3,SPARCL1,PREX2,SLC4A4,GPM6A,NEBL,TNIK |
8.206e-03 | -4.80 | middle_third | COSMIC cancer mutations | middle_third | 3533 | 18 | 16828 | 49 |
SPARCL1,PREX2,SLC4A4,LRIG1,RYR3,COL5A3,TNIK,GPM6A,NEBL,HPSE2,CTNND2,ATP1A2,NHSL1,PAMR1,SOX5,PON2,GPC5,ZBTB20 |
8.230e-03 | -4.80 | calcium-mediated signaling | biological process | GO:0019722 | 154 | 3 | 18204 | 49 |
ATP1A2,RYR3,ITPR2 |
8.295e-03 | -4.79 | endoplasmic reticulum lumen | cellular component | GO:0005788 | 312 | 4 | 19108 | 49 |
SPARCL1,COL5A3,CLU,CST3 |
8.320e-03 | -4.79 | neuromuscular process controlling balance | biological process | GO:0050885 | 51 | 2 | 18204 | 49 |
SLC1A3,NRXN1 |
8.320e-03 | -4.79 | positive regulation of extrinsic apoptotic signaling pathway | biological process | GO:2001238 | 51 | 2 | 18204 | 49 |
WWOX,BMPR1B |
8.343e-03 | -4.79 | KLRC1 (killer cell lectin like receptor C1) | protein interactions | 3821 | 162 | 3 | 19454 | 50 |
SFXN5,PON2,LRIG1 |
8.373e-03 | -4.78 | ACTN1 (actinin alpha 1) | protein interactions | 87 | 312 | 4 | 19454 | 50 |
CLU,CKB,NEBL,ARHGAP24 |
8.406e-03 | -4.78 | Arylesterase | pfam domains | PF01731 | 3 | 1 | 17795 | 50 |
PON2 |
8.406e-03 | -4.78 | Myelin_PLP | pfam domains | PF01275 | 3 | 1 | 17795 | 50 |
GPM6A |
8.406e-03 | -4.78 | TM_ErbB1 | pfam domains | PF21314 | 3 | 1 | 17795 | 50 |
ERBB4 |
8.406e-03 | -4.78 | RYDR_Jsol | pfam domains | PF21119 | 3 | 1 | 17795 | 50 |
RYR3 |
8.406e-03 | -4.78 | RR_TM4-6 | pfam domains | PF06459 | 3 | 1 | 17795 | 50 |
RYR3 |
8.406e-03 | -4.78 | RyR | pfam domains | PF02026 | 3 | 1 | 17795 | 50 |
RYR3 |
8.436e-03 | -4.78 | protein binding | molecular function | GO:0005515 | 13983 | 44 | 18094 | 48 |
FBXL7,DTNA,ITPR2,SLC1A2,WWOX,LRIG1,ERBB4,CDH20,SFXN5,CAMK2G,GPC5,ATP1A2,ZNRF3,SLC1A3,PITPNC1,BMPR1B,NRXN1,PARD3B,SOX5,GPM6A,RYR3,HPSE2,ARHGAP24,NTM,CKB,NEBL,TNIK,CTNND2,SPARCL1,SLC4A4,CTNNA2,COL5A3,PON2,CLU,PTGDS,LSAMP,QKI,RORA,NPAS3,GLUL,AQP4,GLIS3,MSI2,CST3 |
8.507e-03 | -4.77 | SYNM (synemin) | protein interactions | 23336 | 54 | 2 | 19454 | 50 |
DTNA,ERBB4 |
8.638e-03 | -4.75 | regulation of nucleotide catabolic process | biological process | GO:0030811 | 52 | 2 | 18204 | 49 |
SLC4A4,ZBTB20 |
8.638e-03 | -4.75 | regulation of glycolytic process | biological process | GO:0006110 | 52 | 2 | 18204 | 49 |
SLC4A4,ZBTB20 |
8.638e-03 | -4.75 | regulation of purine nucleotide catabolic process | biological process | GO:0033121 | 52 | 2 | 18204 | 49 |
ZBTB20,SLC4A4 |
8.712e-03 | -4.74 | ATPase-coupled monoatomic cation transmembrane transporter activity | molecular function | GO:0019829 | 53 | 2 | 18094 | 48 |
ATP13A4,ATP1A2 |
8.814e-03 | -4.73 | SYN1 (synapsin I) | protein interactions | 6853 | 55 | 2 | 19454 | 50 |
GPM6A,CAMK2G |
8.814e-03 | -4.73 | AMPH (amphiphysin) | protein interactions | 273 | 55 | 2 | 19454 | 50 |
GLUL,GPM6A |
8.836e-03 | -4.73 | skin-back-malignant_melanoma | COSMIC cancer mutations | skin-back-malignant_melanoma | 280 | 4 | 16828 | 49 |
ERBB4,ATP1A2,PREX2,TNIK |
8.962e-03 | -4.71 | neutral amino acid transport | biological process | GO:0015804 | 53 | 2 | 18204 | 49 |
SLC1A2,SLC1A3 |
8.962e-03 | -4.71 | regulation of chondrocyte differentiation | biological process | GO:0032330 | 53 | 2 | 18204 | 49 |
BMPR1B,SOX5 |
8.979e-03 | -4.71 | monoatomic anion transport | biological process | GO:0006820 | 159 | 3 | 18204 | 49 |
SLC4A4,SLC1A2,SLC1A3 |
9.072e-03 | -4.70 | TARDBP (TAR DNA binding protein) | protein interactions | 23435 | 501 | 5 | 19454 | 50 |
MSI2,GLUL,CKB,WWOX,GPM6A |
9.095e-03 | -4.70 | - | gene3d domains | 6.10.250.2510 | 3 | 1 | 14470 | 44 |
CTNNA2 |
9.095e-03 | -4.70 | - | gene3d domains | 1.10.490.160 | 3 | 1 | 14470 | 44 |
RYR3 |
9.142e-03 | -4.69 | cervix-carcinoma-squamous_cell_carcinoma | COSMIC cancer mutations | cervix-carcinoma-squamous_cell_carcinoma | 11789 | 42 | 16828 | 49 |
GLUL,NEBL,PITPNC1,SLC1A3,ARHGAP24,ZNRF3,ITPR2,NRXN1,SLC1A2,COL5A3,ERBB4,NPAS3,PREX2,LSAMP,PARD3B,DTNA,CKB,PON2,FBXL7,CDH20,GPM6A,RORA,CST3,TNIK,LRIG1,RYR3,SPARCL1,SLC4A4,NTM,GPC5,QKI,ZBTB20,BMPR1B,PAMR1,NHSL1,SOX5,ATP13A4,HPSE2,CTNND2,SFXN5,ATP1A2,GLIS3 |
9.212e-03 | -4.69 | POU2F1 (POU class 2 homeobox 1) | protein interactions | 5451 | 168 | 3 | 19454 | 50 |
GPC5,SOX5,ARHGAP24 |
9.227e-03 | -4.69 | cervix | COSMIC cancer mutations | cervix | 11793 | 42 | 16828 | 49 |
CDH20,FBXL7,PON2,CKB,PARD3B,LSAMP,DTNA,NPAS3,PREX2,COL5A3,SLC1A2,ERBB4,ITPR2,NRXN1,ZNRF3,ARHGAP24,NEBL,PITPNC1,SLC1A3,GLUL,GLIS3,SFXN5,ATP1A2,ATP13A4,CTNND2,HPSE2,SOX5,BMPR1B,PAMR1,NHSL1,ZBTB20,NTM,GPC5,QKI,SLC4A4,SPARCL1,RYR3,LRIG1,TNIK,RORA,CST3,GPM6A |
9.442e-03 | -4.66 | NXPH3 (neurexophilin 3) | protein interactions | 11248 | 57 | 2 | 19454 | 50 |
NRXN1,CTNNA2 |
9.513e-03 | -4.66 | SH2D3C (SH2 domain containing 3C) | protein interactions | 10044 | 170 | 3 | 19454 | 50 |
CKB,PON2,ERBB4 |
9.565e-03 | -4.65 | export from cell | biological process | GO:0140352 | 485 | 5 | 18204 | 49 |
CAMK2G,ATP1A2,NRXN1,SLC4A4,PTGDS |
9.613e-03 | -4.64 | Amyotrophic lateral sclerosis (ALS) | WikiPathways | WP2447 | 38 | 2 | 5310 | 21 |
SLC1A2,CST3 |
9.625e-03 | -4.64 | response to cocaine | biological process | GO:0042220 | 55 | 2 | 18204 | 49 |
SLC1A3,SLC1A2 |
9.634e-03 | -4.64 | biliary_tract | COSMIC cancer mutations | biliary_tract | 15309 | 49 | 16828 | 49 |
ATP13A4,CTNND2,ATP1A2,GLIS3,NHSL1,ZBTB20,SPARCL1,TNIK,GPM6A,RORA,FBXL7,CDH20,LSAMP,AQP4,DTNA,PREX2,NKAIN3,NRXN1,SLC1A2,COL5A3,GLUL,PITPNC1,HPSE2,SFXN5,BMPR1B,PAMR1,SOX5,WWOX,NTM,GPC5,QKI,SLC4A4,LRIG1,RYR3,CST3,PTGDS,CAMK2G,PON2,CLU,PARD3B,CKB,NPAS3,ITPR2,ERBB4,MSI2,ARHGAP24,ZNRF3,NEBL,SLC1A3 |
9.763e-03 | -4.63 | CILK1 (ciliogenesis associated kinase 1) | protein interactions | 22858 | 58 | 2 | 19454 | 50 |
CAMK2G,MSI2 |
9.763e-03 | -4.63 | LRIG1 (leucine rich repeats and immunoglobulin like domains 1) | protein interactions | 26018 | 58 | 2 | 19454 | 50 |
ERBB4,PON2 |
9.763e-03 | -4.63 | ZMAT5 (zinc finger matrin-type 5) | protein interactions | 55954 | 58 | 2 | 19454 | 50 |
WWOX,QKI |
9.814e-03 | -4.62 | establishment of localization | biological process | GO:0051234 | 3887 | 18 | 18204 | 49 |
GPM6A,QKI,PITPNC1,SLC1A3,PARD3B,NRXN1,SLC4A4,SLC1A2,AQP4,RYR3,ATP13A4,CAMK2G,ITPR2,ERBB4,ATP1A2,SFXN5,CLU,PTGDS |
9.818e-03 | -4.62 | haematopoietic_and_lymphoid_tissue-lymphoid_neoplasm-plasma_cell_myeloma | COSMIC cancer mutations | haematopoietic_and_lymphoid_tissue-lymphoid_neoplasm-plasma_cell_myeloma | 1263 | 9 | 16828 | 49 |
NEBL,NTM,GPM6A,TNIK,RYR3,PAMR1,ATP13A4,HPSE2,CTNND2 |
9.818e-03 | -4.62 | plasma_cell_myeloma | COSMIC cancer mutations | plasma_cell_myeloma | 1263 | 9 | 16828 | 49 |
HPSE2,CTNND2,ATP13A4,RYR3,PAMR1,TNIK,NEBL,GPM6A,NTM |
9.929e-03 | -4.61 | import across plasma membrane | biological process | GO:0098739 | 165 | 3 | 18204 | 49 |
SLC1A3,ATP1A2,SLC1A2 |
9.956e-03 | -4.61 | GABA shunt | BIOCYC pathways | HUMAN_GLUDEG-I-PWY | 3 | 1 | 902 | 3 |
GLUL |
9.964e-03 | -4.61 | release of sequestered calcium ion into cytosol | biological process | GO:0051209 | 56 | 2 | 18204 | 49 |
RYR3,ITPR2 |
1.009e-02 | -4.60 | ADAM17 (ADAM metallopeptidase domain 17) | protein interactions | 6868 | 59 | 2 | 19454 | 50 |
ERBB4,CAMK2G |
1.009e-02 | -4.60 | HBA1 (hemoglobin subunit alpha 1) | protein interactions | 3039 | 59 | 2 | 19454 | 50 |
ARHGAP24,CLU |
1.012e-02 | -4.59 | tibia | COSMIC cancer mutations | tibia | 836 | 7 | 16828 | 49 |
CTNND2,NKAIN3,PREX2,TNIK,GPM6A,QKI,LSAMP |
1.013e-02 | -4.59 | DUSP14 (dual specificity phosphatase 14) | protein interactions | 11072 | 174 | 3 | 19454 | 50 |
ERBB4,QKI,SPARCL1 |
1.013e-02 | -4.59 | NME2 (NME/NM23 nucleoside diphosphate kinase 2) | protein interactions | 4831 | 174 | 3 | 19454 | 50 |
WWOX,RORA,ARHGAP24 |
1.022e-02 | -4.58 | extrinsic component of membrane | cellular component | GO:0019898 | 175 | 3 | 19108 | 49 |
CTNNA2,DTNA,CDH20 |
1.022e-02 | -4.58 | collagen type V trimer | cellular component | GO:0005588 | 4 | 1 | 19108 | 49 |
COL5A3 |
1.024e-02 | -4.58 | Ilkap (integrin-linked kinase-associated serine/threonine phosphatase 2C) | protein interactions | 67444 | 4 | 1 | 19454 | 50 |
BMPR1B |
1.024e-02 | -4.58 | Nme2 (NME/NM23 nucleoside diphosphate kinase 2) | protein interactions | 18103 | 4 | 1 | 19454 | 50 |
RORA |
1.024e-02 | -4.58 | Arhgef6 (Rac/Cdc42 guanine nucleotide exchange factor 6) | protein interactions | 73341 | 4 | 1 | 19454 | 50 |
BMPR1B |
1.024e-02 | -4.58 | ZNF749 (zinc finger protein 749) | protein interactions | 388567 | 4 | 1 | 19454 | 50 |
ARHGAP24 |
1.024e-02 | -4.58 | CALML4 (calmodulin like 4) | protein interactions | 91860 | 4 | 1 | 19454 | 50 |
CAMK2G |
1.024e-02 | -4.58 | ZNF879 (zinc finger protein 879) | protein interactions | 345462 | 4 | 1 | 19454 | 50 |
ARHGAP24 |
1.024e-02 | -4.58 | Naa20 (N(alpha)-acetyltransferase 20, NatB catalytic subunit) | protein interactions | 67877 | 4 | 1 | 19454 | 50 |
BMPR1B |
1.024e-02 | -4.58 | Srgap1 (SLIT-ROBO Rho GTPase activating protein 1) | protein interactions | 117600 | 4 | 1 | 19454 | 50 |
BMPR1B |
1.024e-02 | -4.58 | CCDC126 (coiled-coil domain containing 126) | protein interactions | 90693 | 4 | 1 | 19454 | 50 |
GPM6A |
1.024e-02 | -4.58 | ZNF615 (zinc finger protein 615) | protein interactions | 284370 | 4 | 1 | 19454 | 50 |
ARHGAP24 |
1.024e-02 | -4.58 | Nkiras1 (NFKB inhibitor interacting Ras-like protein 1) | protein interactions | 69721 | 4 | 1 | 19454 | 50 |
BMPR1B |
1.024e-02 | -4.58 | Cdk14 (cyclin dependent kinase 14) | protein interactions | 18647 | 4 | 1 | 19454 | 50 |
BMPR1B |
1.024e-02 | -4.58 | Dnaja1 (DnaJ heat shock protein family (Hsp40) member A1) | protein interactions | 15502 | 4 | 1 | 19454 | 50 |
GLIS3 |
1.024e-02 | -4.58 | MYH16 (myosin heavy chain 16 (pseudogene)) | protein interactions | 84176 | 4 | 1 | 19454 | 50 |
WWOX |
1.024e-02 | -4.58 | Rhebl1 (Ras homolog enriched in brain like 1) | protein interactions | 69159 | 4 | 1 | 19454 | 50 |
BMPR1B |
1.026e-02 | -4.58 | papillary_renal_cell_carcinoma | COSMIC cancer mutations | papillary_renal_cell_carcinoma | 6364 | 27 | 16828 | 49 |
ZBTB20,GPC5,NTM,ATP1A2,CTNND2,HPSE2,ATP13A4,SOX5,PAMR1,BMPR1B,TNIK,RORA,SLC4A4,RYR3,LRIG1,PON2,CLU,CAMK2G,CKB,ZNRF3,ARHGAP24,PITPNC1,GLUL,PREX2,ERBB4,NRXN1,ITPR2 |
1.026e-02 | -4.58 | kidney-carcinoma-papillary_renal_cell_carcinoma | COSMIC cancer mutations | kidney-carcinoma-papillary_renal_cell_carcinoma | 6364 | 27 | 16828 | 49 |
TNIK,RORA,SLC4A4,RYR3,LRIG1,ZBTB20,NTM,GPC5,ATP1A2,ATP13A4,HPSE2,CTNND2,SOX5,PAMR1,BMPR1B,ZNRF3,ARHGAP24,PITPNC1,GLUL,PREX2,ERBB4,ITPR2,NRXN1,CLU,PON2,CAMK2G,CKB |
1.030e-02 | -4.58 | MYELIN_PLP_2 | prosite domains | PS01004 | 3 | 1 | 12186 | 42 |
GPM6A |
1.030e-02 | -4.58 | VINCULIN_1 | prosite domains | PS00663 | 3 | 1 | 12186 | 42 |
CTNNA2 |
1.030e-02 | -4.58 | MYELIN_PLP_1 | prosite domains | PS00575 | 3 | 1 | 12186 | 42 |
GPM6A |
1.031e-02 | -4.57 | visual behavior | biological process | GO:0007632 | 57 | 2 | 18204 | 49 |
SLC1A2,ATP1A2 |
1.031e-02 | -4.57 | negative regulation of sequestering of calcium ion | biological process | GO:0051283 | 57 | 2 | 18204 | 49 |
ITPR2,RYR3 |
1.042e-02 | -4.56 | LRIG2 (leucine rich repeats and immunoglobulin like domains 2) | protein interactions | 9860 | 60 | 2 | 19454 | 50 |
LRIG1,PON2 |
1.042e-02 | -4.56 | ITGA8 (integrin subunit alpha 8) | protein interactions | 8516 | 60 | 2 | 19454 | 50 |
CLU,ZNRF3 |
1.054e-02 | -4.55 | haematopoietic_and_lymphoid_tissue-lymph_node-lymphoid_neoplasm-acute_lymphoblastic_leukaemia | COSMIC cancer mutations | haematopoietic_and_lymphoid_tissue-lymph_node-lymphoid_neoplasm-acute_lymphoblastic_leukaemia | 156 | 3 | 16828 | 49 |
ARHGAP24,WWOX,PARD3B |
1.057e-02 | -4.55 | citrate transmembrane transporter activity | molecular function | GO:0015137 | 4 | 1 | 18094 | 48 |
SFXN5 |
1.057e-02 | -4.55 | tricarboxylic acid transmembrane transporter activity | molecular function | GO:0015142 | 4 | 1 | 18094 | 48 |
SFXN5 |
1.057e-02 | -4.55 | ryanodine-sensitive calcium-release channel activity | molecular function | GO:0005219 | 4 | 1 | 18094 | 48 |
RYR3 |
1.072e-02 | -4.54 | ovarian cumulus expansion | biological process | GO:0001550 | 4 | 1 | 18204 | 49 |
BMPR1B |
1.072e-02 | -4.54 | response to glycoside | biological process | GO:1903416 | 4 | 1 | 18204 | 49 |
ATP1A2 |
1.072e-02 | -4.54 | regulation of glutamate uptake involved in transmission of nerve impulse | biological process | GO:0051946 | 4 | 1 | 18204 | 49 |
ATP1A2 |
1.072e-02 | -4.54 | negative regulation of male germ cell proliferation | biological process | GO:2000255 | 4 | 1 | 18204 | 49 |
PTGDS |
1.072e-02 | -4.54 | regulation of collagen catabolic process | biological process | GO:0010710 | 4 | 1 | 18204 | 49 |
CST3 |
1.072e-02 | -4.54 | negative regulation of germ cell proliferation | biological process | GO:1905937 | 4 | 1 | 18204 | 49 |
PTGDS |
1.072e-02 | -4.54 | regulation of amino acid uptake involved in synaptic transmission | biological process | GO:0051941 | 4 | 1 | 18204 | 49 |
ATP1A2 |
1.072e-02 | -4.54 | cardiac muscle tissue regeneration | biological process | GO:0061026 | 4 | 1 | 18204 | 49 |
ERBB4 |
1.072e-02 | -4.54 | positive regulation of inclusion body assembly | biological process | GO:0090261 | 4 | 1 | 18204 | 49 |
CLU |
1.072e-02 | -4.54 | positive regulation of mesenchymal stem cell differentiation | biological process | GO:2000741 | 4 | 1 | 18204 | 49 |
SOX5 |
1.074e-02 | -4.53 | Oxytocin signaling pathway | KEGG pathways | ko04921 | 152 | 3 | 7161 | 22 |
RYR3,ITPR2,CAMK2G |
1.074e-02 | -4.53 | Oxytocin signaling pathway | KEGG pathways | hsa04921 | 152 | 3 | 7161 | 22 |
ITPR2,RYR3,CAMK2G |
1.076e-02 | -4.53 | Nebulin_repeat | interpro domains | IPR000900 | 4 | 1 | 18521 | 50 |
NEBL |
1.076e-02 | -4.53 | NHS-like | interpro domains | IPR024845 | 4 | 1 | 18521 | 50 |
NHSL1 |
1.076e-02 | -4.53 | P5B-type_ATPase | interpro domains | IPR047821 | 4 | 1 | 18521 | 50 |
ATP13A4 |
1.076e-02 | -4.53 | ATP-guanido_PTrfase_N | interpro domains | IPR022413 | 4 | 1 | 18521 | 50 |
CKB |
1.076e-02 | -4.53 | ATP-guanido_PTrfase_N_sf | interpro domains | IPR036802 | 4 | 1 | 18521 | 50 |
CKB |
1.076e-02 | -4.53 | Tyr_kinase_EGF/ERB/XmrK_rcpt | interpro domains | IPR016245 | 4 | 1 | 18521 | 50 |
ERBB4 |
1.076e-02 | -4.53 | P5A-ATPase_N | interpro domains | IPR047819 | 4 | 1 | 18521 | 50 |
ATP13A4 |
1.076e-02 | -4.53 | Ca/CaM-dep_prot_kinase-assoc | interpro domains | IPR013543 | 4 | 1 | 18521 | 50 |
CAMK2G |
1.076e-02 | -4.53 | Na/K-Atpase_Interacting | interpro domains | IPR008516 | 4 | 1 | 18521 | 50 |
NKAIN3 |
1.076e-02 | -4.53 | Alpha_catenin | interpro domains | IPR001033 | 4 | 1 | 18521 | 50 |
CTNNA2 |
1.076e-02 | -4.53 | ATP-guanido_PTrfase_AS | interpro domains | IPR022415 | 4 | 1 | 18521 | 50 |
CKB |
1.076e-02 | -4.53 | ATP-guanido_PTrfase | interpro domains | IPR000749 | 4 | 1 | 18521 | 50 |
CKB |
1.076e-02 | -4.53 | ATP-guanido_PTrfase_cat | interpro domains | IPR022414 | 4 | 1 | 18521 | 50 |
CKB |
1.076e-02 | -4.53 | CABP2 (calcium binding protein 2) | protein interactions | 51475 | 61 | 2 | 19454 | 50 |
CAMK2G,ITPR2 |
1.077e-02 | -4.53 | ERBB4 (erb-b2 receptor tyrosine kinase 4) | protein interactions | 2066 | 178 | 3 | 19454 | 50 |
LRIG1,WWOX,ERBB4 |
1.077e-02 | -4.53 | transport | biological process | GO:0006810 | 3615 | 17 | 18204 | 49 |
AQP4,RYR3,ATP13A4,CAMK2G,ITPR2,ATP1A2,ERBB4,CLU,SFXN5,PTGDS,GPM6A,QKI,PITPNC1,SLC1A3,NRXN1,SLC4A4,SLC1A2 |
1.087e-02 | -4.52 | Neurotransmitter Release Cycle | REACTOME pathways | R-HSA-112310 | 51 | 2 | 10285 | 32 |
SLC1A3,SLC1A2 |
1.098e-02 | -4.51 | primitive_neuroectodermal_tumour-medulloblastoma | COSMIC cancer mutations | primitive_neuroectodermal_tumour-medulloblastoma | 15350 | 49 | 16828 | 49 |
NKAIN3,PREX2,SLC1A2,COL5A3,NRXN1,PITPNC1,GLUL,CDH20,FBXL7,AQP4,LSAMP,DTNA,SPARCL1,TNIK,RORA,GPM6A,ATP1A2,GLIS3,ATP13A4,CTNND2,NHSL1,ZBTB20,NPAS3,ERBB4,MSI2,ITPR2,ZNRF3,ARHGAP24,NEBL,SLC1A3,CLU,PON2,PTGDS,CAMK2G,CKB,PARD3B,SLC4A4,RYR3,LRIG1,CST3,SFXN5,HPSE2,SOX5,WWOX,PAMR1,BMPR1B,NTM,GPC5,QKI |
1.101e-02 | -4.51 | protein localization to synapse | biological process | GO:0035418 | 59 | 2 | 18204 | 49 |
ERBB4,NRXN1 |
1.104e-02 | -4.51 | EZR (ezrin) | protein interactions | 7430 | 526 | 5 | 19454 | 50 |
DTNA,WWOX,ARHGAP24,NEBL,TNIK |
1.107e-02 | -4.50 | PLP | smart domains | SM00002 | 3 | 1 | 9717 | 36 |
GPM6A |
1.119e-02 | -4.49 | CaMKII_AD | pfam domains | PF08332 | 4 | 1 | 17795 | 50 |
CAMK2G |
1.119e-02 | -4.49 | P5-ATPase | pfam domains | PF12409 | 4 | 1 | 17795 | 50 |
ATP13A4 |
1.119e-02 | -4.49 | NKAIN | pfam domains | PF05640 | 4 | 1 | 17795 | 50 |
NKAIN3 |
1.119e-02 | -4.49 | ATP-gua_Ptrans | pfam domains | PF00217 | 4 | 1 | 17795 | 50 |
CKB |
1.119e-02 | -4.49 | Nebulin | pfam domains | PF00880 | 4 | 1 | 17795 | 50 |
NEBL |
1.119e-02 | -4.49 | NHS | pfam domains | PF15273 | 4 | 1 | 17795 | 50 |
NHSL1 |
1.119e-02 | -4.49 | ATP-gua_PtransN | pfam domains | PF02807 | 4 | 1 | 17795 | 50 |
CKB |
1.126e-02 | -4.49 | monoatomic cation homeostasis | biological process | GO:0055080 | 505 | 5 | 18204 | 49 |
ATP1A2,SLC4A4,RYR3,SLC1A3,ATP13A4 |
1.137e-02 | -4.48 | protein homotetramerization | biological process | GO:0051289 | 60 | 2 | 18204 | 49 |
AQP4,RYR3 |
1.137e-02 | -4.48 | export across plasma membrane | biological process | GO:0140115 | 60 | 2 | 18204 | 49 |
SLC4A4,ATP1A2 |
1.143e-02 | -4.47 | human chr4q34.2 | chromosome location | human chr4q34.2 | 6 | 1 | 26134 | 50 |
GPM6A |
1.143e-02 | -4.47 | human chr14q13.1 | chromosome location | human chr14q13.1 | 6 | 1 | 26134 | 50 |
NPAS3 |
1.144e-02 | -4.47 | RYANODINER | prints domains | PR00795 | 3 | 1 | 5227 | 20 |
RYR3 |
1.144e-02 | -4.47 | INSP3RECEPTR | prints domains | PR00779 | 3 | 1 | 5227 | 20 |
ITPR2 |
1.144e-02 | -4.47 | PARAOXONASE | prints domains | PR01785 | 3 | 1 | 5227 | 20 |
PON2 |
1.144e-02 | -4.47 | MYELINPLP | prints domains | PR00214 | 3 | 1 | 5227 | 20 |
GPM6A |
1.144e-02 | -4.47 | RORNUCRECPTR | prints domains | PR01293 | 3 | 1 | 5227 | 20 |
RORA |
1.144e-02 | -4.47 | PGNDSYNTHASE | prints domains | PR01254 | 3 | 1 | 5227 | 20 |
PTGDS |
1.144e-02 | -4.47 | NAXD (NAD(P)HX dehydratase) | protein interactions | 55739 | 63 | 2 | 19454 | 50 |
PON2,NEBL |
1.144e-02 | -4.47 | NLGN2 (neuroligin 2) | protein interactions | 57555 | 63 | 2 | 19454 | 50 |
CLU,NRXN1 |
1.144e-02 | -4.47 | INTS13 (integrator complex subunit 13) | protein interactions | 55726 | 63 | 2 | 19454 | 50 |
TNIK,ARHGAP24 |
1.160e-02 | -4.46 | skin-lower_leg-malignant_melanoma-nodular | COSMIC cancer mutations | skin-lower_leg-malignant_melanoma-nodular | 4 | 1 | 16828 | 49 |
PREX2 |
1.160e-02 | -4.46 | skin-face-malignant_melanoma-superficial_spreading | COSMIC cancer mutations | skin-face-malignant_melanoma-superficial_spreading | 4 | 1 | 16828 | 49 |
PREX2 |
1.161e-02 | -4.46 | GSN (gelsolin) | protein interactions | 2934 | 183 | 3 | 19454 | 50 |
TNIK,ARHGAP24,DTNA |
1.179e-02 | -4.44 | COL1A2 (collagen type I alpha 2 chain) | protein interactions | 1278 | 64 | 2 | 19454 | 50 |
ARHGAP24,COL5A3 |
1.190e-02 | -4.43 | biliary_tract-gallbladder-carcinoma-adenocarcinoma | COSMIC cancer mutations | biliary_tract-gallbladder-carcinoma-adenocarcinoma | 2821 | 15 | 16828 | 49 |
CLU,CTNND2,NHSL1,ZNRF3,TNIK,PITPNC1,SPARCL1,NKAIN3,PREX2,SLC4A4,ITPR2,LRIG1,ERBB4,COL5A3,RYR3 |
1.190e-02 | -4.43 | gallbladder | COSMIC cancer mutations | gallbladder | 2821 | 15 | 16828 | 49 |
PITPNC1,ZNRF3,TNIK,RYR3,COL5A3,ERBB4,LRIG1,ITPR2,SLC4A4,NKAIN3,PREX2,SPARCL1,CLU,NHSL1,CTNND2 |
1.195e-02 | -4.43 | inorganic ion transmembrane transport | biological process | GO:0098660 | 715 | 6 | 18204 | 49 |
SLC4A4,ATP1A2,ITPR2,SLC1A3,RYR3,GPM6A |
1.205e-02 | -4.42 | Ewings_sarcoma-peripheral_primitive_neuroectodermal_tumour | COSMIC cancer mutations | Ewings_sarcoma-peripheral_primitive_neuroectodermal_tumour | 7434 | 30 | 16828 | 49 |
ZBTB20,QKI,ATP1A2,GLIS3,CTNND2,ATP13A4,SOX5,PAMR1,TNIK,CST3,RORA,SLC4A4,SPARCL1,RYR3,LRIG1,PON2,CAMK2G,PTGDS,DTNA,PARD3B,SLC1A3,NEBL,GLUL,PREX2,NKAIN3,NPAS3,ERBB4,COL5A3,NRXN1,ITPR2 |
1.211e-02 | -4.41 | ATP:guanido phosphotransferase, N-terminal domain | gene3d domains | 1.10.135.10 | 4 | 1 | 14470 | 44 |
CKB |
1.211e-02 | -4.41 | regulation of carbohydrate catabolic process | biological process | GO:0043470 | 62 | 2 | 18204 | 49 |
ZBTB20,SLC4A4 |
1.212e-02 | -4.41 | skin-face-carcinoma-squamous_cell_carcinoma | COSMIC cancer mutations | skin-face-carcinoma-squamous_cell_carcinoma | 2036 | 12 | 16828 | 49 |
MSI2,ERBB4,ITPR2,PREX2,RORA,NEBL,GPM6A,ZNRF3,ARHGAP24,GPC5,AQP4,LSAMP |
1.213e-02 | -4.41 | Heparan sulfate/heparin (HS-GAG) metabolism | REACTOME pathways | R-HSA-1638091 | 54 | 2 | 10285 | 32 |
HPSE2,GPC5 |
1.218e-02 | -4.41 | monoatomic ion homeostasis | biological process | GO:0050801 | 515 | 5 | 18204 | 49 |
SLC1A3,RYR3,ATP13A4,SLC4A4,ATP1A2 |
1.249e-02 | -4.38 | back | COSMIC cancer mutations | back | 310 | 4 | 16828 | 49 |
ERBB4,ATP1A2,PREX2,TNIK |
1.250e-02 | -4.38 | KATNA1 (katanin catalytic subunit A1) | protein interactions | 11104 | 66 | 2 | 19454 | 50 |
ARHGAP24,CLU |
1.250e-02 | -4.38 | ORM1 (orosomucoid 1) | protein interactions | 5004 | 66 | 2 | 19454 | 50 |
PTGDS,CLU |
1.250e-02 | -4.38 | PPM1F (protein phosphatase, Mg2+/Mn2+ dependent 1F) | protein interactions | 9647 | 66 | 2 | 19454 | 50 |
ERBB4,WWOX |
1.250e-02 | -4.38 | MICB (MHC class I polypeptide-related sequence B) | protein interactions | 4277 | 66 | 2 | 19454 | 50 |
CLU,SFXN5 |
1.254e-02 | -4.38 | autonomic_ganglia-neuroblastoma | COSMIC cancer mutations | autonomic_ganglia-neuroblastoma | 3970 | 19 | 16828 | 49 |
PARD3B,AQP4,CAMK2G,GLIS3,ATP1A2,FBXL7,CTNND2,NEBL,PITPNC1,GPM6A,TNIK,ZNRF3,SLC1A2,COL5A3,RYR3,ERBB4,SLC4A4,NPAS3,PREX2 |
1.258e-02 | -4.38 | neuroblastoma | COSMIC cancer mutations | neuroblastoma | 3971 | 19 | 16828 | 49 |
CAMK2G,PARD3B,AQP4,CTNND2,FBXL7,ATP1A2,GLIS3,ZNRF3,TNIK,GPM6A,PITPNC1,NEBL,PREX2,NPAS3,SLC4A4,ERBB4,RYR3,SLC1A2,COL5A3 |
1.262e-02 | -4.37 | bone-pelvis-chondrosarcoma | COSMIC cancer mutations | bone-pelvis-chondrosarcoma | 311 | 4 | 16828 | 49 |
PARD3B,LSAMP,ERBB4,COL5A3 |
1.265e-02 | -4.37 | brain development | biological process | GO:0007420 | 724 | 6 | 18204 | 49 |
CKB,SLC1A2,CTNNA2,ERBB4,ATP1A2,RORA |
1.268e-02 | -4.37 | oesophagus-carcinoma | COSMIC cancer mutations | oesophagus-carcinoma | 4269 | 20 | 16828 | 49 |
GPM6A,TNIK,ITPR2,LRIG1,RYR3,COL5A3,PREX2,SLC4A4,PARD3B,NTM,CKB,ZBTB20,PTGDS,NHSL1,SOX5,CTNND2,HPSE2,FBXL7,ATP13A4,CDH20 |
1.276e-02 | -4.36 | calcium- and calmodulin-dependent protein kinase complex | cellular component | GO:0005954 | 5 | 1 | 19108 | 49 |
CAMK2G |
1.276e-02 | -4.36 | neurofibrillary tangle | cellular component | GO:0097418 | 5 | 1 | 19108 | 49 |
CLU |
1.279e-02 | -4.36 | ZNF836 (zinc finger protein 836) | protein interactions | 162962 | 5 | 1 | 19454 | 50 |
ARHGAP24 |
1.279e-02 | -4.36 | Wwp2 (WW domain containing E3 ubiquitin protein ligase 2) | protein interactions | 66894 | 5 | 1 | 19454 | 50 |
GLIS3 |
1.279e-02 | -4.36 | PTGER2 (prostaglandin E receptor 2) | protein interactions | 5732 | 5 | 1 | 19454 | 50 |
PTGDS |
1.279e-02 | -4.36 | Hk3 (hexokinase 3) | protein interactions | 25060 | 5 | 1 | 19454 | 50 |
PTGDS |
1.279e-02 | -4.36 | CAMK2N2 (calcium/calmodulin dependent protein kinase II inhibitor 2) | protein interactions | 94032 | 5 | 1 | 19454 | 50 |
CAMK2G |
1.279e-02 | -4.36 | NRG2 (neuregulin 2) | protein interactions | 9542 | 5 | 1 | 19454 | 50 |
ERBB4 |
1.279e-02 | -4.36 | TRPM6 (transient receptor potential cation channel subfamily M member 6) | protein interactions | 140803 | 5 | 1 | 19454 | 50 |
ARHGAP24 |
1.279e-02 | -4.36 | Cdk4 (cyclin dependent kinase 4) | protein interactions | 12567 | 5 | 1 | 19454 | 50 |
BMPR1B |
1.279e-02 | -4.36 | SYT13 (synaptotagmin 13) | protein interactions | 57586 | 5 | 1 | 19454 | 50 |
NRXN1 |
1.279e-02 | -4.36 | ZNF93 (zinc finger protein 93) | protein interactions | 81931 | 5 | 1 | 19454 | 50 |
ARHGAP24 |
1.279e-02 | -4.36 | POU2F3 (POU class 2 homeobox 3) | protein interactions | 25833 | 5 | 1 | 19454 | 50 |
ARHGAP24 |
1.279e-02 | -4.36 | Rras2 (related RAS viral (r-ras) oncogene 2) | protein interactions | 66922 | 5 | 1 | 19454 | 50 |
BMPR1B |
1.279e-02 | -4.36 | ZNF571 (zinc finger protein 571) | protein interactions | 51276 | 5 | 1 | 19454 | 50 |
ARHGAP24 |
1.279e-02 | -4.36 | Rhobtb1 (Rho-related BTB domain containing 1) | protein interactions | 69288 | 5 | 1 | 19454 | 50 |
BMPR1B |
1.279e-02 | -4.36 | Rhoj (ras homolog family member J) | protein interactions | 80837 | 5 | 1 | 19454 | 50 |
BMPR1B |
1.279e-02 | -4.36 | ADCYAP1R1 (ADCYAP receptor type I) | protein interactions | 117 | 5 | 1 | 19454 | 50 |
CLU |
1.279e-02 | -4.36 | EPPIN (epididymal peptidase inhibitor) | protein interactions | 57119 | 5 | 1 | 19454 | 50 |
CLU |
1.279e-02 | -4.36 | ORF17 (ORF17) | protein interactions | 4961478 | 5 | 1 | 19454 | 50 |
WWOX |
1.279e-02 | -4.36 | Rab6b (RAB6B, member RAS oncogene family) | protein interactions | 270192 | 5 | 1 | 19454 | 50 |
BMPR1B |
1.279e-02 | -4.36 | Rab38 (RAB38, member RAS oncogene family) | protein interactions | 72433 | 5 | 1 | 19454 | 50 |
BMPR1B |
1.281e-02 | -4.36 | cell population proliferation | biological process | GO:0008283 | 726 | 6 | 18204 | 49 |
SOX5,HPSE2,GLUL,ZNRF3,RORA,CLU |
1.287e-02 | -4.35 | SHC3 (SHC adaptor protein 3) | protein interactions | 53358 | 67 | 2 | 19454 | 50 |
ERBB4,WWOX |
1.293e-02 | -4.35 | stem cell differentiation | biological process | GO:0048863 | 182 | 3 | 18204 | 49 |
ERBB4,MSI2,GPM6A |
1.296e-02 | -4.35 | regulation of Wnt signaling pathway | biological process | GO:0030111 | 339 | 4 | 18204 | 49 |
ZNRF3,WWOX,GPC5,CTNND2 |
1.312e-02 | -4.33 | regulation of carbohydrate metabolic process | biological process | GO:0006109 | 183 | 3 | 18204 | 49 |
RORA,SLC4A4,ZBTB20 |
1.317e-02 | -4.33 | carboxylic acid transmembrane transporter activity | molecular function | GO:0046943 | 186 | 3 | 18094 | 48 |
SFXN5,SLC1A3,SLC1A2 |
1.320e-02 | -4.33 | neuroligin family protein binding | molecular function | GO:0097109 | 5 | 1 | 18094 | 48 |
NRXN1 |
1.320e-02 | -4.33 | transforming growth factor beta receptor activity, type I | molecular function | GO:0005025 | 5 | 1 | 18094 | 48 |
BMPR1B |
1.325e-02 | -4.32 | apoptotic mitochondrial changes | biological process | GO:0008637 | 65 | 2 | 18204 | 49 |
ERBB4,CLU |
1.326e-02 | -4.32 | creatine-phosphate biosynthesis | BIOCYC pathways | META_PWY-6158 | 4 | 1 | 902 | 3 |
CKB |
1.327e-02 | -4.32 | L-amino acid transmembrane transporter activity | molecular function | GO:0015179 | 66 | 2 | 18094 | 48 |
SLC1A3,SLC1A2 |
1.328e-02 | -4.32 | positive regulation of multicellular organismal process | biological process | GO:0051240 | 1691 | 10 | 18204 | 49 |
BMPR1B,ZBTB20,SOX5,NRXN1,ERBB4,ATP1A2,SFXN5,RORA,CLU,QKI |
1.332e-02 | -4.32 | human chr8q13.2 | chromosome location | human chr8q13.2 | 7 | 1 | 26134 | 50 |
PREX2 |
1.336e-02 | -4.32 | organic acid transmembrane transporter activity | molecular function | GO:0005342 | 187 | 3 | 18094 | 48 |
SFXN5,SLC1A3,SLC1A2 |
1.339e-02 | -4.31 | citrate transport | biological process | GO:0015746 | 5 | 1 | 18204 | 49 |
SFXN5 |
1.339e-02 | -4.31 | otolith morphogenesis | biological process | GO:0032474 | 5 | 1 | 18204 | 49 |
LRIG1 |
1.339e-02 | -4.31 | ERBB2-ERBB4 signaling pathway | biological process | GO:0038135 | 5 | 1 | 18204 | 49 |
ERBB4 |
1.339e-02 | -4.31 | central nervous system myelin maintenance | biological process | GO:0032286 | 5 | 1 | 18204 | 49 |
CLU |
1.339e-02 | -4.31 | tricarboxylic acid transport | biological process | GO:0006842 | 5 | 1 | 18204 | 49 |
SFXN5 |
1.339e-02 | -4.31 | gephyrin clustering involved in postsynaptic density assembly | biological process | GO:0097116 | 5 | 1 | 18204 | 49 |
NRXN1 |
1.339e-02 | -4.31 | phosphocreatine metabolic process | biological process | GO:0006603 | 5 | 1 | 18204 | 49 |
CKB |
1.339e-02 | -4.31 | phosphagen metabolic process | biological process | GO:0006599 | 5 | 1 | 18204 | 49 |
CKB |
1.339e-02 | -4.31 | phosphocreatine biosynthetic process | biological process | GO:0046314 | 5 | 1 | 18204 | 49 |
CKB |
1.339e-02 | -4.31 | amygdala development | biological process | GO:0021764 | 5 | 1 | 18204 | 49 |
ATP1A2 |
1.339e-02 | -4.31 | positive regulation of amyloid fibril formation | biological process | GO:1905908 | 5 | 1 | 18204 | 49 |
CLU |
1.339e-02 | -4.31 | phosphagen biosynthetic process | biological process | GO:0042396 | 5 | 1 | 18204 | 49 |
CKB |
1.339e-02 | -4.31 | negative regulation of Rac protein signal transduction | biological process | GO:0035021 | 5 | 1 | 18204 | 49 |
ARHGAP24 |
1.339e-02 | -4.31 | negative regulation of chondrocyte proliferation | biological process | GO:1902731 | 5 | 1 | 18204 | 49 |
BMPR1B |
1.343e-02 | -4.31 | BBP-like | interpro domains | IPR045071 | 5 | 1 | 18521 | 50 |
QKI |
1.343e-02 | -4.31 | Mtc | interpro domains | IPR004686 | 5 | 1 | 18521 | 50 |
SFXN5 |
1.343e-02 | -4.31 | Vinculin/catenin | interpro domains | IPR006077 | 5 | 1 | 18521 | 50 |
CTNNA2 |
1.343e-02 | -4.31 | P-type_TPase_V | interpro domains | IPR006544 | 5 | 1 | 18521 | 50 |
ATP13A4 |
1.343e-02 | -4.31 | Na/HCO3_transpt | interpro domains | IPR003024 | 5 | 1 | 18521 | 50 |
SLC4A4 |
1.343e-02 | -4.31 | Follistatin/Osteonectin_EGF | interpro domains | IPR015369 | 5 | 1 | 18521 | 50 |
SPARCL1 |
1.343e-02 | -4.31 | PI_transfer | interpro domains | IPR001666 | 5 | 1 | 18521 | 50 |
PITPNC1 |
1.357e-02 | -4.30 | CNPY3 (canopy FGF signaling regulator 3) | protein interactions | 10695 | 194 | 3 | 19454 | 50 |
CAMK2G,LRIG1,ITPR2 |
1.361e-02 | -4.30 | PABPC3 (poly(A) binding protein cytoplasmic 3) | protein interactions | 5042 | 69 | 2 | 19454 | 50 |
ARHGAP24,WWOX |
1.364e-02 | -4.29 | L-alpha-amino acid transmembrane transport | biological process | GO:1902475 | 66 | 2 | 18204 | 49 |
SLC1A3,SLC1A2 |
1.372e-02 | -4.29 | NEBULIN | prosite domains | PS51216 | 4 | 1 | 12186 | 42 |
NEBL |
1.372e-02 | -4.29 | PHOSPHAGEN_KINASE | prosite domains | PS00112 | 4 | 1 | 12186 | 42 |
CKB |
1.372e-02 | -4.29 | PHOSPHAGEN_KINASE_N | prosite domains | PS51509 | 4 | 1 | 12186 | 42 |
CKB |
1.372e-02 | -4.29 | PHOSPHAGEN_KINASE_C | prosite domains | PS51510 | 4 | 1 | 12186 | 42 |
CKB |
1.375e-02 | -4.29 | right_upper_lobe | COSMIC cancer mutations | right_upper_lobe | 10376 | 38 | 16828 | 49 |
ZBTB20,GPC5,NTM,SFXN5,GLIS3,ATP1A2,HPSE2,CTNND2,ATP13A4,SOX5,PAMR1,BMPR1B,TNIK,RORA,GPM6A,SLC4A4,RYR3,LRIG1,PON2,DTNA,PARD3B,LSAMP,CDH20,FBXL7,ZNRF3,ARHGAP24,SLC1A3,PITPNC1,NEBL,GLUL,PREX2,NKAIN3,NPAS3,ERBB4,SLC1A2,COL5A3,NRXN1,ITPR2 |
1.375e-02 | -4.29 | lung-right_upper_lobe-carcinoma-adenocarcinoma | COSMIC cancer mutations | lung-right_upper_lobe-carcinoma-adenocarcinoma | 10376 | 38 | 16828 | 49 |
ARHGAP24,ZNRF3,GLUL,SLC1A3,PITPNC1,NEBL,NKAIN3,PREX2,NPAS3,NRXN1,ITPR2,ERBB4,COL5A3,SLC1A2,PON2,DTNA,LSAMP,PARD3B,FBXL7,CDH20,TNIK,GPM6A,RORA,SLC4A4,LRIG1,RYR3,GPC5,NTM,ZBTB20,HPSE2,CTNND2,ATP13A4,SFXN5,GLIS3,ATP1A2,PAMR1,BMPR1B,SOX5 |
1.397e-02 | -4.27 | IP_trans | pfam domains | PF02121 | 5 | 1 | 17795 | 50 |
PITPNC1 |
1.397e-02 | -4.27 | FOLN | pfam domains | PF09289 | 5 | 1 | 17795 | 50 |
SPARCL1 |
1.397e-02 | -4.27 | SFXNs | pfam domains | PF03820 | 5 | 1 | 17795 | 50 |
SFXN5 |
1.397e-02 | -4.27 | Vinculin | pfam domains | PF01044 | 5 | 1 | 17795 | 50 |
CTNNA2 |
1.399e-02 | -4.27 | MTMR9 (myotubularin related protein 9) | protein interactions | 66036 | 70 | 2 | 19454 | 50 |
CLU,ERBB4 |
1.399e-02 | -4.27 | PCDH20 (protocadherin 20) | protein interactions | 64881 | 70 | 2 | 19454 | 50 |
CTNNA2,PON2 |
1.404e-02 | -4.27 | collagen binding | molecular function | GO:0005518 | 68 | 2 | 18094 | 48 |
COL5A3,SPARCL1 |
1.412e-02 | -4.26 | YES1 (YES proto-oncogene 1, Src family tyrosine kinase) | protein interactions | 7525 | 364 | 4 | 19454 | 50 |
CAMK2G,GLUL,ERBB4,MSI2 |
1.437e-02 | -4.24 | Arachidonic acid metabolism | REACTOME pathways | R-HSA-2142753 | 59 | 2 | 10285 | 32 |
PTGDS,PON2 |
1.437e-02 | -4.24 | ANK2 (ankyrin 2) | protein interactions | 287 | 71 | 2 | 19454 | 50 |
GPM6A,TNIK |
1.448e-02 | -4.24 | skin-lower_leg-malignant_melanoma-superficial_spreading | COSMIC cancer mutations | skin-lower_leg-malignant_melanoma-superficial_spreading | 5 | 1 | 16828 | 49 |
PREX2 |
1.457e-02 | -4.23 | central_nervous_system-brain-primitive_neuroectodermal_tumour-medulloblastoma-large_cell | COSMIC cancer mutations | central_nervous_system-brain-primitive_neuroectodermal_tumour-medulloblastoma-large_cell | 1117 | 8 | 16828 | 49 |
GPC5,QKI,ATP13A4,CDH20,ERBB4,SOX5,SLC1A2,RYR3 |
1.474e-02 | -4.22 | NEBU | smart domains | SM00227 | 4 | 1 | 9717 | 36 |
NEBL |
1.476e-02 | -4.22 | PPP3CC (protein phosphatase 3 catalytic subunit gamma) | protein interactions | 5533 | 72 | 2 | 19454 | 50 |
BMPR1B,PARD3B |
1.476e-02 | -4.22 | DPYSL3 (dihydropyrimidinase like 3) | protein interactions | 1809 | 72 | 2 | 19454 | 50 |
GPM6A,TNIK |
1.480e-02 | -4.21 | EGF | pfam domains | PF00008 | 66 | 2 | 17795 | 50 |
NRXN1,PAMR1 |
1.493e-02 | -4.20 | presynapse | cellular component | GO:0098793 | 569 | 5 | 19108 | 49 |
GPM6A,TNIK,NRXN1,SLC1A2,ERBB4 |
1.511e-02 | -4.19 | - | gene3d domains | 6.10.140.620 | 5 | 1 | 14470 | 44 |
CAMK2G |
1.520e-02 | -4.19 | ORF3a (ORF3a protein) | protein interactions | 43740569 | 789 | 6 | 19454 | 50 |
ZNRF3,CKB,CLU,PARD3B,BMPR1B,SLC4A4 |
1.522e-02 | -4.19 | ALPHACATENIN | prints domains | PR00805 | 4 | 1 | 5227 | 20 |
CTNNA2 |
1.532e-02 | -4.18 | SLC12A5 (solute carrier family 12 member 5) | protein interactions | 57468 | 6 | 1 | 19454 | 50 |
GPM6A |
1.532e-02 | -4.18 | Fancl (Fanconi anemia, complementation group L) | protein interactions | 67030 | 6 | 1 | 19454 | 50 |
BMPR1B |
1.532e-02 | -4.18 | TAT (tyrosine aminotransferase) | protein interactions | 6898 | 6 | 1 | 19454 | 50 |
GLUL |
1.532e-02 | -4.18 | Map2k3 (mitogen-activated protein kinase kinase 3) | protein interactions | 26397 | 6 | 1 | 19454 | 50 |
BMPR1B |
1.532e-02 | -4.18 | RSPO3 (R-spondin 3) | protein interactions | 84870 | 6 | 1 | 19454 | 50 |
ZNRF3 |
1.532e-02 | -4.18 | Taok2 (TAO kinase 2) | protein interactions | 381921 | 6 | 1 | 19454 | 50 |
CLU |
1.532e-02 | -4.18 | SOX1 (SRY-box transcription factor 1) | protein interactions | 6656 | 6 | 1 | 19454 | 50 |
SOX5 |
1.532e-02 | -4.18 | DAZ4 (deleted in azoospermia 4) | protein interactions | 57135 | 6 | 1 | 19454 | 50 |
QKI |
1.532e-02 | -4.18 | PBP2 (Pbp2p) | protein interactions | 852533 | 6 | 1 | 19454 | 50 |
QKI |
1.532e-02 | -4.18 | DRP2 (dystrophin related protein 2) | protein interactions | 1821 | 6 | 1 | 19454 | 50 |
DTNA |
1.532e-02 | -4.18 | NRG4 (neuregulin 4) | protein interactions | 145957 | 6 | 1 | 19454 | 50 |
ERBB4 |
1.532e-02 | -4.18 | ZNF311 (zinc finger protein 311) | protein interactions | 282890 | 6 | 1 | 19454 | 50 |
ARHGAP24 |
1.532e-02 | -4.18 | Rhod (ras homolog family member D) | protein interactions | 11854 | 6 | 1 | 19454 | 50 |
BMPR1B |
1.532e-02 | -4.18 | CIBAR2 (CBY1 interacting BAR domain containing 2) | protein interactions | 339145 | 6 | 1 | 19454 | 50 |
CAMK2G |
1.532e-02 | -4.18 | CYP39A1 (cytochrome P450 family 39 subfamily A member 1) | protein interactions | 51302 | 6 | 1 | 19454 | 50 |
GLUL |
1.532e-02 | -4.18 | Tiam2 (T cell lymphoma invasion and metastasis 2) | protein interactions | 24001 | 6 | 1 | 19454 | 50 |
DTNA |
1.532e-02 | -4.18 | CYRIA (CYFIP related Rac1 interactor A) | protein interactions | 81553 | 6 | 1 | 19454 | 50 |
GPM6A |
1.532e-02 | -4.18 | GDF6 (growth differentiation factor 6) | protein interactions | 392255 | 6 | 1 | 19454 | 50 |
BMPR1B |
1.532e-02 | -4.18 | SYTL3 (synaptotagmin like 3) | protein interactions | 94120 | 6 | 1 | 19454 | 50 |
NRXN1 |
1.532e-02 | -4.18 | SOX11 (SRY-box transcription factor 11) | protein interactions | 6664 | 6 | 1 | 19454 | 50 |
SOX5 |
1.532e-02 | -4.18 | Itch (itchy, E3 ubiquitin protein ligase) | protein interactions | 16396 | 6 | 1 | 19454 | 50 |
GLIS3 |
1.532e-02 | -4.18 | SMR3A (submaxillary gland androgen regulated protein 3A) | protein interactions | 26952 | 6 | 1 | 19454 | 50 |
WWOX |
1.533e-02 | -4.18 | protein homooligomerization | biological process | GO:0051260 | 194 | 3 | 18204 | 49 |
SLC1A2,RYR3,AQP4 |
1.535e-02 | -4.18 | cell-cell adhesion | biological process | GO:0098609 | 546 | 5 | 18204 | 49 |
CTNNA2,CDH20,NRXN1,CTNND2,SPARCL1 |
1.552e-02 | -4.17 | CASK (calcium/calmodulin dependent serine protein kinase) | protein interactions | 8573 | 204 | 3 | 19454 | 50 |
DTNA,PARD3B,NRXN1 |
1.554e-02 | -4.16 | CACNA2D1 (calcium voltage-gated channel auxiliary subunit alpha2delta 1) | protein interactions | 781 | 74 | 2 | 19454 | 50 |
GPM6A,PON2 |
1.554e-02 | -4.16 | TEC (tec protein tyrosine kinase) | protein interactions | 7006 | 74 | 2 | 19454 | 50 |
ERBB4,MSI2 |
1.581e-02 | -4.15 | arylesterase activity | molecular function | GO:0004064 | 6 | 1 | 18094 | 48 |
PON2 |
1.581e-02 | -4.15 | steroid hormone binding | molecular function | GO:1990239 | 6 | 1 | 18094 | 48 |
ATP1A2 |
1.581e-02 | -4.15 | sodium:bicarbonate symporter activity | molecular function | GO:0008510 | 6 | 1 | 18094 | 48 |
SLC4A4 |
1.581e-02 | -4.15 | calcium-induced calcium release activity | molecular function | GO:0048763 | 6 | 1 | 18094 | 48 |
RYR3 |
1.581e-02 | -4.15 | creatine kinase activity | molecular function | GO:0004111 | 6 | 1 | 18094 | 48 |
CKB |
1.600e-02 | -4.13 | lung-middle_lobe-carcinoma-adenocarcinoma | COSMIC cancer mutations | lung-middle_lobe-carcinoma-adenocarcinoma | 1368 | 9 | 16828 | 49 |
ATP13A4,HPSE2,CTNND2,ATP1A2,ITPR2,RYR3,ERBB4,PARD3B,CKB |
1.600e-02 | -4.13 | PDGFRA (platelet derived growth factor receptor alpha) | protein interactions | 5156 | 378 | 4 | 19454 | 50 |
LRIG1,CLU,DTNA,WWOX |
1.604e-02 | -4.13 | imitative learning | biological process | GO:0098596 | 6 | 1 | 18204 | 49 |
NRXN1 |
1.604e-02 | -4.13 | gamma-aminobutyric acid biosynthetic process | biological process | GO:0009449 | 6 | 1 | 18204 | 49 |
SLC1A3 |
1.604e-02 | -4.13 | protein targeting to vacuole involved in autophagy | biological process | GO:0071211 | 6 | 1 | 18204 | 49 |
CLU |
1.604e-02 | -4.13 | postsynaptic density protein 95 clustering | biological process | GO:0097119 | 6 | 1 | 18204 | 49 |
NRXN1 |
1.604e-02 | -4.13 | asymmetric neuroblast division | biological process | GO:0055059 | 6 | 1 | 18204 | 49 |
SOX5 |
1.604e-02 | -4.13 | intracellular water homeostasis | biological process | GO:0009992 | 6 | 1 | 18204 | 49 |
AQP4 |
1.604e-02 | -4.13 | vocal learning | biological process | GO:0042297 | 6 | 1 | 18204 | 49 |
NRXN1 |
1.604e-02 | -4.13 | negative regulation of extracellular matrix disassembly | biological process | GO:0010716 | 6 | 1 | 18204 | 49 |
CST3 |
1.604e-02 | -4.13 | ERBB4-ERBB4 signaling pathway | biological process | GO:0038138 | 6 | 1 | 18204 | 49 |
ERBB4 |
1.604e-02 | -4.13 | fused antrum stage | biological process | GO:0048165 | 6 | 1 | 18204 | 49 |
BMPR1B |
1.609e-02 | -4.13 | P-type_ATPase_IIC | interpro domains | IPR005775 | 6 | 1 | 18521 | 50 |
ATP1A2 |
1.609e-02 | -4.13 | Glypican | interpro domains | IPR001863 | 6 | 1 | 18521 | 50 |
GPC5 |
1.609e-02 | -4.13 | GLI-like | interpro domains | IPR043359 | 6 | 1 | 18521 | 50 |
GLIS3 |
1.609e-02 | -4.13 | EF-hand_dom_typ1 | interpro domains | IPR015153 | 6 | 1 | 18521 | 50 |
DTNA |
1.609e-02 | -4.13 | GF_recep_IV | interpro domains | IPR032778 | 6 | 1 | 18521 | 50 |
ERBB4 |
1.609e-02 | -4.13 | Glypican_CS | interpro domains | IPR019803 | 6 | 1 | 18521 | 50 |
GPC5 |
1.609e-02 | -4.13 | EF-hand_dom_typ2 | interpro domains | IPR015154 | 6 | 1 | 18521 | 50 |
DTNA |
1.609e-02 | -4.13 | Syndecan/Neurexin_dom | interpro domains | IPR027789 | 6 | 1 | 18521 | 50 |
NRXN1 |
1.609e-02 | -4.13 | regulation of ATP metabolic process | biological process | GO:1903578 | 72 | 2 | 18204 | 49 |
SLC4A4,ZBTB20 |
1.613e-02 | -4.13 | MAGEA9 (MAGE family member A9) | protein interactions | 4108 | 207 | 3 | 19454 | 50 |
CAMK2G,ITPR2,NHSL1 |
1.635e-02 | -4.11 | PGM3 (phosphoglucomutase 3) | protein interactions | 5238 | 76 | 2 | 19454 | 50 |
ARHGAP24,GLUL |
1.635e-02 | -4.11 | MIR200A (microRNA 200a) | protein interactions | 406983 | 76 | 2 | 19454 | 50 |
QKI,MSI2 |
1.652e-02 | -4.10 | regulation of cartilage development | biological process | GO:0061035 | 73 | 2 | 18204 | 49 |
BMPR1B,SOX5 |
1.674e-02 | -4.09 | EF-hand_2 | pfam domains | PF09068 | 6 | 1 | 17795 | 50 |
DTNA |
1.674e-02 | -4.09 | Glypican | pfam domains | PF01153 | 6 | 1 | 17795 | 50 |
GPC5 |
1.674e-02 | -4.09 | GF_recep_IV | pfam domains | PF14843 | 6 | 1 | 17795 | 50 |
ERBB4 |
1.674e-02 | -4.09 | Syndecan | pfam domains | PF01034 | 6 | 1 | 17795 | 50 |
NRXN1 |
1.674e-02 | -4.09 | EF-hand_3 | pfam domains | PF09069 | 6 | 1 | 17795 | 50 |
DTNA |
1.701e-02 | -4.07 | middle_lobe | COSMIC cancer mutations | middle_lobe | 1382 | 9 | 16828 | 49 |
CTNND2,HPSE2,ATP13A4,ATP1A2,ITPR2,ERBB4,RYR3,PARD3B,CKB |
1.705e-02 | -4.07 | HAD_sf | interpro domains | IPR023214 | 74 | 2 | 18521 | 50 |
ATP13A4,ATP1A2 |
1.709e-02 | -4.07 | human chr4q22.3 | chromosome location | human chr4q22.3 | 9 | 1 | 26134 | 50 |
BMPR1B |
1.710e-02 | -4.07 | head development | biological process | GO:0060322 | 774 | 6 | 18204 | 49 |
ERBB4,ATP1A2,RORA,SLC1A2,CTNNA2,CKB |
1.717e-02 | -4.06 | MIR34C (microRNA 34c) | protein interactions | 407042 | 78 | 2 | 19454 | 50 |
QKI,MSI2 |
1.717e-02 | -4.06 | ANKRD40 (ankyrin repeat domain 40) | protein interactions | 91369 | 78 | 2 | 19454 | 50 |
MSI2,SOX5 |
1.735e-02 | -4.05 | autonomic_ganglia-paraganglioma-benign | COSMIC cancer mutations | autonomic_ganglia-paraganglioma-benign | 6 | 1 | 16828 | 49 |
NHSL1 |
1.735e-02 | -4.05 | skin-forearm-malignant_melanoma-superficial_spreading | COSMIC cancer mutations | skin-forearm-malignant_melanoma-superficial_spreading | 6 | 1 | 16828 | 49 |
PREX2 |
1.735e-02 | -4.05 | skin-head_neck-malignant_melanoma | COSMIC cancer mutations | skin-head_neck-malignant_melanoma | 6 | 1 | 16828 | 49 |
PREX2 |
1.738e-02 | -4.05 | amino acid biosynthetic process | biological process | GO:0008652 | 75 | 2 | 18204 | 49 |
GLUL,SLC1A3 |
1.751e-02 | -4.05 | face | COSMIC cancer mutations | face | 2139 | 12 | 16828 | 49 |
LSAMP,AQP4,GPC5,ARHGAP24,ZNRF3,GPM6A,NEBL,RORA,PREX2,ITPR2,MSI2,ERBB4 |
1.754e-02 | -4.04 | Synaptic Vesicle Pathway | WikiPathways | WP2267 | 52 | 2 | 5310 | 21 |
ATP1A2,SLC1A3 |
1.759e-02 | -4.04 | NUCB2 (nucleobindin 2) | protein interactions | 4925 | 79 | 2 | 19454 | 50 |
CLU,GLUL |
1.761e-02 | -4.04 | NCK1 (NCK adaptor protein 1) | protein interactions | 4690 | 214 | 3 | 19454 | 50 |
TNIK,NHSL1,ERBB4 |
1.766e-02 | -4.04 | Long-term potentiation | KEGG pathways | ko04720 | 67 | 2 | 7161 | 22 |
ITPR2,CAMK2G |
1.766e-02 | -4.04 | Long-term potentiation | KEGG pathways | hsa04720 | 67 | 2 | 7161 | 22 |
CAMK2G,ITPR2 |
1.768e-02 | -4.04 | ovary-carcinoma | COSMIC cancer mutations | ovary-carcinoma | 933 | 7 | 16828 | 49 |
ATP1A2,PREX2,ERBB4,ITPR2,BMPR1B,TNIK,CAMK2G |
1.774e-02 | -4.03 | calcium ion transmembrane transport | biological process | GO:0070588 | 205 | 3 | 18204 | 49 |
ITPR2,GPM6A,RYR3 |
1.786e-02 | -4.03 | CYP4F8 (cytochrome P450 family 4 subfamily F member 8) | protein interactions | 11283 | 7 | 1 | 19454 | 50 |
CLU |
1.786e-02 | -4.03 | C7 (complement C7) | protein interactions | 730 | 7 | 1 | 19454 | 50 |
CLU |
1.786e-02 | -4.03 | SASH3 (SAM and SH3 domain containing 3) | protein interactions | 54440 | 7 | 1 | 19454 | 50 |
BMPR1B |
1.786e-02 | -4.03 | CYYR1 (cysteine and tyrosine rich 1) | protein interactions | 116159 | 7 | 1 | 19454 | 50 |
WWOX |
1.786e-02 | -4.03 | C8B (complement C8 beta chain) | protein interactions | 732 | 7 | 1 | 19454 | 50 |
CLU |
1.786e-02 | -4.03 | Fbxo3 (F-box protein 3) | protein interactions | 57443 | 7 | 1 | 19454 | 50 |
BMPR1B |
1.786e-02 | -4.03 | SOAT2 (sterol O-acyltransferase 2) | protein interactions | 8435 | 7 | 1 | 19454 | 50 |
CLU |
1.786e-02 | -4.03 | ZBTB45 (zinc finger and BTB domain containing 45) | protein interactions | 84878 | 7 | 1 | 19454 | 50 |
ZBTB20 |
1.786e-02 | -4.03 | ABCC12 (ATP binding cassette subfamily C member 12) | protein interactions | 94160 | 7 | 1 | 19454 | 50 |
NPAS3 |
1.786e-02 | -4.03 | Uhmk1 (U2AF homology motif (UHM) kinase 1) | protein interactions | 16589 | 7 | 1 | 19454 | 50 |
BMPR1B |
1.786e-02 | -4.03 | Pum2 (pumilio RNA-binding family member 2) | protein interactions | 80913 | 7 | 1 | 19454 | 50 |
QKI |
1.786e-02 | -4.03 | Smad7 (SMAD family member 7) | protein interactions | 17131 | 7 | 1 | 19454 | 50 |
BMPR1B |
1.786e-02 | -4.03 | RGMB (repulsive guidance molecule BMP co-receptor b) | protein interactions | 285704 | 7 | 1 | 19454 | 50 |
BMPR1B |
1.786e-02 | -4.03 | Smurf1 (SMAD specific E3 ubiquitin protein ligase 1) | protein interactions | 75788 | 7 | 1 | 19454 | 50 |
GLIS3 |
1.786e-02 | -4.03 | ZNF701 (zinc finger protein 701) | protein interactions | 55762 | 7 | 1 | 19454 | 50 |
ARHGAP24 |
1.786e-02 | -4.03 | ZNF501 (zinc finger protein 501) | protein interactions | 115560 | 7 | 1 | 19454 | 50 |
ARHGAP24 |
1.801e-02 | -4.02 | PIAS3 (protein inhibitor of activated STAT 3) | protein interactions | 10401 | 80 | 2 | 19454 | 50 |
GLUL,ERBB4 |
1.804e-02 | -4.01 | CAMK2G (calcium/calmodulin dependent protein kinase II gamma) | protein interactions | 818 | 216 | 3 | 19454 | 50 |
PON2,ITPR2,CAMK2G |
1.827e-02 | -4.00 | regulation of synaptic transmission, glutamatergic | biological process | GO:0051966 | 77 | 2 | 18204 | 49 |
NRXN1,ATP1A2 |
1.843e-02 | -3.99 | phosphotransferase activity, nitrogenous group as acceptor | molecular function | GO:0016775 | 7 | 1 | 18094 | 48 |
CKB |
1.843e-02 | -3.99 | P-type sodium:potassium-exchanging transporter activity | molecular function | GO:0005391 | 7 | 1 | 18094 | 48 |
ATP1A2 |
1.843e-02 | -3.99 | P-type sodium transporter activity | molecular function | GO:0008554 | 7 | 1 | 18094 | 48 |
ATP1A2 |
1.843e-02 | -3.99 | phosphatidic acid transfer activity | molecular function | GO:1990050 | 7 | 1 | 18094 | 48 |
PITPNC1 |
1.843e-02 | -3.99 | calcium-dependent protein serine/threonine phosphatase activity | molecular function | GO:0004723 | 7 | 1 | 18094 | 48 |
CAMK2G |
1.865e-02 | -3.98 | Protein_kinase_ATP_BS | interpro domains | IPR017441 | 377 | 4 | 18521 | 50 |
ERBB4,TNIK,BMPR1B,CAMK2G |
1.869e-02 | -3.98 | regulation of 3'-UTR-mediated mRNA stabilization | biological process | GO:1905868 | 7 | 1 | 18204 | 49 |
QKI |
1.869e-02 | -3.98 | cellular response to magnesium ion | biological process | GO:0071286 | 7 | 1 | 18204 | 49 |
RYR3 |
1.869e-02 | -3.98 | negative regulation of ruffle assembly | biological process | GO:1900028 | 7 | 1 | 18204 | 49 |
ARHGAP24 |
1.869e-02 | -3.98 | observational learning | biological process | GO:0098597 | 7 | 1 | 18204 | 49 |
NRXN1 |
1.869e-02 | -3.98 | regulation of male germ cell proliferation | biological process | GO:2000254 | 7 | 1 | 18204 | 49 |
PTGDS |
1.869e-02 | -3.98 | chaperone-mediated autophagy | biological process | GO:0061684 | 7 | 1 | 18204 | 49 |
CLU |
1.869e-02 | -3.98 | negative regulation of non-canonical Wnt signaling pathway | biological process | GO:2000051 | 7 | 1 | 18204 | 49 |
ZNRF3 |
1.869e-02 | -3.98 | negative regulation of Arp2/3 complex-mediated actin nucleation | biological process | GO:0034316 | 7 | 1 | 18204 | 49 |
CTNNA2 |
1.872e-02 | -3.98 | positive regulation of carbohydrate metabolic process | biological process | GO:0045913 | 78 | 2 | 18204 | 49 |
ZBTB20,SLC4A4 |
1.872e-02 | -3.98 | dicarboxylic acid transport | biological process | GO:0006835 | 78 | 2 | 18204 | 49 |
SLC1A2,SLC1A3 |
1.875e-02 | -3.98 | Plakophilin/d_Catenin | interpro domains | IPR028435 | 7 | 1 | 18521 | 50 |
CTNND2 |
1.875e-02 | -3.98 | Rcpt_L-dom | interpro domains | IPR000494 | 7 | 1 | 18521 | 50 |
ERBB4 |
1.875e-02 | -3.98 | Alpha-catenin/vinculin-like_sf | interpro domains | IPR036723 | 7 | 1 | 18521 | 50 |
CTNNA2 |
1.875e-02 | -3.98 | Rcpt_L-dom_sf | interpro domains | IPR036941 | 7 | 1 | 18521 | 50 |
ERBB4 |
1.875e-02 | -3.98 | Aquaporin_transptr | interpro domains | IPR034294 | 7 | 1 | 18521 | 50 |
AQP4 |
1.875e-02 | -3.98 | GS_dom | interpro domains | IPR003605 | 7 | 1 | 18521 | 50 |
BMPR1B |
1.875e-02 | -3.98 | Furin-like_Cys-rich_dom | interpro domains | IPR006211 | 7 | 1 | 18521 | 50 |
ERBB4 |
1.875e-02 | -3.98 | SPARC/Testican_Ca-bd-dom | interpro domains | IPR019577 | 7 | 1 | 18521 | 50 |
SPARCL1 |
1.882e-02 | -3.97 | HAD-like_sf | interpro domains | IPR036412 | 78 | 2 | 18521 | 50 |
ATP13A4,ATP1A2 |
1.886e-02 | -3.97 | HYAL2 (hyaluronidase 2) | protein interactions | 8692 | 82 | 2 | 19454 | 50 |
WWOX,PON2 |
1.897e-02 | -3.96 | human chr12p11.23 | chromosome location | human chr12p11.23 | 10 | 1 | 26134 | 50 |
ITPR2 |
1.897e-02 | -3.96 | human chr9p24.2 | chromosome location | human chr9p24.2 | 10 | 1 | 26134 | 50 |
GLIS3 |
1.899e-02 | -3.96 | NAHCO3TRSPRT | prints domains | PR01232 | 5 | 1 | 5227 | 20 |
SLC4A4 |
1.899e-02 | -3.96 | PITRANSFER | prints domains | PR00391 | 5 | 1 | 5227 | 20 |
PITPNC1 |
1.911e-02 | -3.96 | synaptic membrane | cellular component | GO:0097060 | 400 | 4 | 19108 | 49 |
NRXN1,SLC1A2,ERBB4,GPM6A |
1.929e-02 | -3.95 | localization | biological process | GO:0051179 | 4474 | 19 | 18204 | 49 |
PTGDS,ERBB4,ATP1A2,SFXN5,CLU,ITPR2,ATP13A4,CAMK2G,RYR3,AQP4,TNIK,SLC1A2,NRXN1,SLC4A4,PARD3B,SLC1A3,QKI,PITPNC1,GPM6A |
1.930e-02 | -3.95 | SYT1 (synaptotagmin 1) | protein interactions | 6857 | 83 | 2 | 19454 | 50 |
GPM6A,NRXN1 |
1.951e-02 | -3.94 | Furin-like | pfam domains | PF00757 | 7 | 1 | 17795 | 50 |
ERBB4 |
1.951e-02 | -3.94 | TGF_beta_GS | pfam domains | PF08515 | 7 | 1 | 17795 | 50 |
BMPR1B |
1.951e-02 | -3.94 | Recep_L_domain | pfam domains | PF01030 | 7 | 1 | 17795 | 50 |
ERBB4 |
1.951e-02 | -3.94 | SPARC_Ca_bdg | pfam domains | PF10591 | 7 | 1 | 17795 | 50 |
SPARCL1 |
1.954e-02 | -3.94 | transmembrane receptor protein kinase activity | molecular function | GO:0019199 | 81 | 2 | 18094 | 48 |
BMPR1B,ERBB4 |
1.962e-02 | -3.93 | KIF2A (kinesin family member 2A) | protein interactions | 3796 | 223 | 3 | 19454 | 50 |
ARHGAP24,WWOX,GPM6A |
1.974e-02 | -3.93 | ST8SIA4 (ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 4) | protein interactions | 7903 | 84 | 2 | 19454 | 50 |
PON2,LRIG1 |
2.009e-02 | -3.91 | adult locomotory behavior | biological process | GO:0008344 | 81 | 2 | 18204 | 49 |
PREX2,ATP1A2 |
2.018e-02 | -3.90 | CCND3 (cyclin D3) | protein interactions | 896 | 85 | 2 | 19454 | 50 |
CLU,QKI |
2.020e-02 | -3.90 | SOX2 (SRY-box transcription factor 2) | protein interactions | 6657 | 1342 | 8 | 19454 | 50 |
LSAMP,GLIS3,QKI,MSI2,ITPR2,CKB,CLU,SOX5 |
2.021e-02 | -3.90 | skin-face-malignant_melanoma-nodular | COSMIC cancer mutations | skin-face-malignant_melanoma-nodular | 7 | 1 | 16828 | 49 |
PREX2 |
2.021e-02 | -3.90 | skin-upper_leg-malignant_melanoma-nodular | COSMIC cancer mutations | skin-upper_leg-malignant_melanoma-nodular | 7 | 1 | 16828 | 49 |
PREX2 |
2.034e-02 | -3.90 | HFE-transferrin receptor complex | cellular component | GO:1990712 | 8 | 1 | 19108 | 49 |
BMPR1B |
2.034e-02 | -3.90 | spherical high-density lipoprotein particle | cellular component | GO:0034366 | 8 | 1 | 19108 | 49 |
CLU |
2.038e-02 | -3.89 | Rps27a (ribosomal protein S27A) | protein interactions | 78294 | 8 | 1 | 19454 | 50 |
BMPR1B |
2.038e-02 | -3.89 | PTGER1 (prostaglandin E receptor 1) | protein interactions | 5731 | 8 | 1 | 19454 | 50 |
PTGDS |
2.038e-02 | -3.89 | DEPP1 (DEPP autophagy regulator 1) | protein interactions | 11067 | 8 | 1 | 19454 | 50 |
QKI |
2.038e-02 | -3.89 | ZNF568 (zinc finger protein 568) | protein interactions | 374900 | 8 | 1 | 19454 | 50 |
ARHGAP24 |
2.038e-02 | -3.89 | BMP15 (bone morphogenetic protein 15) | protein interactions | 9210 | 8 | 1 | 19454 | 50 |
BMPR1B |
2.038e-02 | -3.89 | LHB (luteinizing hormone subunit beta) | protein interactions | 3972 | 8 | 1 | 19454 | 50 |
NTM |
2.038e-02 | -3.89 | ZNF236 (zinc finger protein 236) | protein interactions | 7776 | 8 | 1 | 19454 | 50 |
ARHGAP24 |
2.038e-02 | -3.89 | Chmp2a (charged multivesicular body protein 2A) | protein interactions | 68953 | 8 | 1 | 19454 | 50 |
CLU |
2.038e-02 | -3.89 | Rasd2 (RASD family, member 2) | protein interactions | 75141 | 8 | 1 | 19454 | 50 |
BMPR1B |
2.038e-02 | -3.89 | CATSPERE (catsper channel auxiliary subunit epsilon) | protein interactions | 257044 | 8 | 1 | 19454 | 50 |
WWOX |
2.038e-02 | -3.89 | ZNF28 (zinc finger protein 28) | protein interactions | 7576 | 8 | 1 | 19454 | 50 |
ARHGAP24 |
2.051e-02 | -3.89 | GLYPICAN | prosite domains | PS01207 | 6 | 1 | 12186 | 42 |
GPC5 |
2.059e-02 | -3.88 | Calcium Regulation in the Cardiac Cell | WikiPathways | WP536 | 151 | 3 | 5310 | 21 |
RYR3,ITPR2,CAMK2G |
2.079e-02 | -3.87 | haematopoietic_and_lymphoid_tissue-lymph_node-lymphoid_neoplasm-diffuse_large_B_cell_lymphoma | COSMIC cancer mutations | haematopoietic_and_lymphoid_tissue-lymph_node-lymphoid_neoplasm-diffuse_large_B_cell_lymphoma | 748 | 6 | 16828 | 49 |
SLC1A3,NEBL,DTNA,CTNND2,SOX5,ITPR2 |
2.084e-02 | -3.87 | dendrite | cellular component | GO:0030425 | 620 | 5 | 19108 | 49 |
CLU,GPM6A,CTNND2,BMPR1B,ATP1A2 |
2.090e-02 | -3.87 | PDIA3 (protein disulfide isomerase family A member 3) | protein interactions | 2923 | 410 | 4 | 19454 | 50 |
WWOX,CKB,CLU,DTNA |
2.103e-02 | -3.86 | glutamate binding | molecular function | GO:0016595 | 8 | 1 | 18094 | 48 |
SLC1A3 |
2.103e-02 | -3.86 | sodium ion binding | molecular function | GO:0031402 | 8 | 1 | 18094 | 48 |
ATP1A2 |
2.103e-02 | -3.86 | P-type potassium transmembrane transporter activity | molecular function | GO:0008556 | 8 | 1 | 18094 | 48 |
ATP1A2 |
2.103e-02 | -3.86 | BMP receptor activity | molecular function | GO:0098821 | 8 | 1 | 18094 | 48 |
BMPR1B |
2.108e-02 | -3.86 | MIR141 (microRNA 141) | protein interactions | 406933 | 87 | 2 | 19454 | 50 |
QKI,MSI2 |
2.110e-02 | -3.86 | Receptor L-domain | gene3d domains | 3.80.20.20 | 7 | 1 | 14470 | 44 |
ERBB4 |
2.110e-02 | -3.86 | dendritic tree | cellular component | GO:0097447 | 622 | 5 | 19108 | 49 |
ATP1A2,BMPR1B,CTNND2,GPM6A,CLU |
2.111e-02 | -3.86 | anion binding | molecular function | GO:0043168 | 2412 | 12 | 18094 | 48 |
BMPR1B,PITPNC1,PTGDS,ATP13A4,GLUL,ERBB4,CAMK2G,TNIK,CKB,ATP1A2,ITPR2,SLC1A3 |
2.120e-02 | -3.85 | urinary_tract-bladder-carcinoma-transitional_cell_carcinoma | COSMIC cancer mutations | urinary_tract-bladder-carcinoma-transitional_cell_carcinoma | 6040 | 25 | 16828 | 49 |
ERBB4,COL5A3,NRXN1,ITPR2,PREX2,SLC1A3,NEBL,CDH20,CKB,DTNA,PARD3B,CLU,PON2,CAMK2G,LRIG1,SLC4A4,SPARCL1,GPM6A,ATP1A2,SFXN5,GLIS3,HPSE2,ATP13A4,ZBTB20,GPC5 |
2.125e-02 | -3.85 | HAD superfamily/HAD-like | gene3d domains | 3.40.50.1000 | 74 | 2 | 14470 | 44 |
ATP1A2,ATP13A4 |
2.125e-02 | -3.85 | acute_lymphoblastic_leukaemia | COSMIC cancer mutations | acute_lymphoblastic_leukaemia | 2197 | 12 | 16828 | 49 |
DTNA,PARD3B,CAMK2G,BMPR1B,WWOX,SOX5,ATP1A2,ARHGAP24,TNIK,ERBB4,PREX2,SLC4A4 |
2.127e-02 | -3.85 | ConA-like_dom_sf | interpro domains | IPR013320 | 219 | 3 | 18521 | 50 |
RYR3,COL5A3,NRXN1 |
2.129e-02 | -3.85 | transitional_cell_carcinoma | COSMIC cancer mutations | transitional_cell_carcinoma | 6042 | 25 | 16828 | 49 |
LRIG1,SLC4A4,SPARCL1,GPM6A,GLIS3,ATP1A2,SFXN5,HPSE2,ATP13A4,ZBTB20,GPC5,ERBB4,COL5A3,NRXN1,ITPR2,PREX2,SLC1A3,NEBL,CDH20,CKB,DTNA,PARD3B,PON2,CLU,CAMK2G |
2.129e-02 | -3.85 | Thyroid hormone synthesis | KEGG pathways | hsa04918 | 74 | 2 | 7161 | 22 |
ITPR2,ATP1A2 |
2.129e-02 | -3.85 | Thyroid hormone synthesis | KEGG pathways | ko04918 | 74 | 2 | 7161 | 22 |
ITPR2,ATP1A2 |
2.132e-02 | -3.85 | Creatine pathway | KEGG pathways | M00047 | 7 | 1 | 7161 | 22 |
CKB |
2.132e-02 | -3.85 | Creatine pathway | KEGG pathways | hsa_M00047 | 7 | 1 | 7161 | 22 |
CKB |
2.134e-02 | -3.85 | regulation of germ cell proliferation | biological process | GO:1905936 | 8 | 1 | 18204 | 49 |
PTGDS |
2.134e-02 | -3.85 | regulation of synapse structural plasticity | biological process | GO:0051823 | 8 | 1 | 18204 | 49 |
CTNNA2 |
2.134e-02 | -3.85 | cell proliferation in external granule layer | biological process | GO:0021924 | 8 | 1 | 18204 | 49 |
RORA |
2.134e-02 | -3.85 | glutamate catabolic process | biological process | GO:0006538 | 8 | 1 | 18204 | 49 |
GLUL |
2.134e-02 | -3.85 | protein import | biological process | GO:0017038 | 8 | 1 | 18204 | 49 |
CLU |
2.134e-02 | -3.85 | regulation of L-glutamate import across plasma membrane | biological process | GO:0002036 | 8 | 1 | 18204 | 49 |
ATP1A2 |
2.134e-02 | -3.85 | gamma-aminobutyric acid metabolic process | biological process | GO:0009448 | 8 | 1 | 18204 | 49 |
SLC1A3 |
2.134e-02 | -3.85 | cell proliferation in hindbrain | biological process | GO:0021534 | 8 | 1 | 18204 | 49 |
RORA |
2.134e-02 | -3.85 | ERBB4 signaling pathway | biological process | GO:0038130 | 8 | 1 | 18204 | 49 |
ERBB4 |
2.134e-02 | -3.85 | cerebellar granule cell precursor proliferation | biological process | GO:0021930 | 8 | 1 | 18204 | 49 |
RORA |
2.134e-02 | -3.85 | response to mechanical stimulus | biological process | GO:0009612 | 220 | 3 | 18204 | 49 |
SLC1A3,NRXN1,ATP1A2 |
2.151e-02 | -3.84 | L-amino acid transport | biological process | GO:0015807 | 84 | 2 | 18204 | 49 |
SLC1A2,SLC1A3 |
2.151e-02 | -3.84 | regulation of sodium ion transport | biological process | GO:0002028 | 84 | 2 | 18204 | 49 |
ATP1A2,NKAIN3 |
2.151e-02 | -3.84 | stem cell development | biological process | GO:0048864 | 84 | 2 | 18204 | 49 |
MSI2,ERBB4 |
2.151e-02 | -3.84 | SLC15A3 (solute carrier family 15 member 3) | protein interactions | 51296 | 231 | 3 | 19454 | 50 |
PON2,ITPR2,CKB |
2.153e-02 | -3.84 | RAP2A (RAP2A, member of RAS oncogene family) | protein interactions | 5911 | 88 | 2 | 19454 | 50 |
BMPR1B,TNIK |
2.175e-02 | -3.83 | SEC23A (SEC23 homolog A, COPII coat complex component) | protein interactions | 10484 | 232 | 3 | 19454 | 50 |
WWOX,DTNA,ARHGAP24 |
2.186e-02 | -3.82 | skin-upper_arm-malignant_melanoma | COSMIC cancer mutations | skin-upper_arm-malignant_melanoma | 553 | 5 | 16828 | 49 |
ERBB4,PARD3B,ITPR2,PREX2,SLC4A4 |
2.199e-02 | -3.82 | chondrocyte differentiation | biological process | GO:0002062 | 85 | 2 | 18204 | 49 |
BMPR1B,SOX5 |
2.200e-02 | -3.82 | TNS2 (tensin 2) | protein interactions | 23371 | 233 | 3 | 19454 | 50 |
ERBB4,DTNA,GLUL |
2.201e-02 | -3.82 | organic anion transport | biological process | GO:0015711 | 398 | 4 | 18204 | 49 |
SLC1A2,SLC4A4,SFXN5,SLC1A3 |
2.232e-02 | -3.80 | lung-left_upper_lobe-carcinoma-adenocarcinoma | COSMIC cancer mutations | lung-left_upper_lobe-carcinoma-adenocarcinoma | 556 | 5 | 16828 | 49 |
SLC4A4,FBXL7,CTNND2,ERBB4,RYR3 |
2.246e-02 | -3.80 | TXNDC11 (thioredoxin domain containing 11) | protein interactions | 51061 | 90 | 2 | 19454 | 50 |
CLU,WWOX |
2.246e-02 | -3.80 | MED25 (mediator complex subunit 25) | protein interactions | 81857 | 90 | 2 | 19454 | 50 |
WWOX,QKI |
2.246e-02 | -3.80 | FGFR1OP2 (FGFR1 oncogene partner 2) | protein interactions | 26127 | 90 | 2 | 19454 | 50 |
TNIK,CAMK2G |
2.247e-02 | -3.80 | protein localization to cell junction | biological process | GO:1902414 | 86 | 2 | 18204 | 49 |
NRXN1,ERBB4 |
2.262e-02 | -3.79 | left_upper_lobe | COSMIC cancer mutations | left_upper_lobe | 558 | 5 | 16828 | 49 |
RYR3,ERBB4,SLC4A4,FBXL7,CTNND2 |
2.267e-02 | -3.79 | PPP2R1A (protein phosphatase 2 scaffold subunit Aalpha) | protein interactions | 5518 | 632 | 5 | 19454 | 50 |
NHSL1,ARHGAP24,CKB,CTNNA2,CAMK2G |
2.272e-02 | -3.78 | human chr6q26 | chromosome location | human chr6q26 | 12 | 1 | 26134 | 50 |
QKI |
2.274e-02 | -3.78 | CTSL (cathepsin L) | protein interactions | 1514 | 236 | 3 | 19454 | 50 |
CST3,PON2,CLU |
2.275e-02 | -3.78 | ACTIVIN2R | prints domains | PR00653 | 6 | 1 | 5227 | 20 |
BMPR1B |
2.285e-02 | -3.78 | platelet dense tubular network membrane | cellular component | GO:0031095 | 9 | 1 | 19108 | 49 |
ITPR2 |
2.285e-02 | -3.78 | astrocyte end-foot | cellular component | GO:0097450 | 9 | 1 | 19108 | 49 |
AQP4 |
2.290e-02 | -3.78 | MUC4 (mucin 4, cell surface associated) | protein interactions | 4585 | 9 | 1 | 19454 | 50 |
ERBB4 |
2.290e-02 | -3.78 | ZNF766 (zinc finger protein 766) | protein interactions | 90321 | 9 | 1 | 19454 | 50 |
ARHGAP24 |
2.290e-02 | -3.78 | CAMK2N1 (calcium/calmodulin dependent protein kinase II inhibitor 1) | protein interactions | 55450 | 9 | 1 | 19454 | 50 |
CAMK2G |
2.290e-02 | -3.78 | KLB (klotho beta) | protein interactions | 152831 | 9 | 1 | 19454 | 50 |
ARHGAP24 |
2.290e-02 | -3.78 | VEPH1 (ventricular zone expressed PH domain containing 1) | protein interactions | 79674 | 9 | 1 | 19454 | 50 |
BMPR1B |
2.290e-02 | -3.78 | Tyw3 (tRNA-yW synthesizing protein 3 homolog (S. cerevisiae)) | protein interactions | 209584 | 9 | 1 | 19454 | 50 |
CTNNA2 |
2.290e-02 | -3.78 | Ywhag (tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, gamma polypeptide) | protein interactions | 22628 | 9 | 1 | 19454 | 50 |
QKI |
2.292e-02 | -3.78 | DGUOK (deoxyguanosine kinase) | protein interactions | 1716 | 91 | 2 | 19454 | 50 |
NTM,GPM6A |
2.306e-02 | -3.77 | central_nervous_system-chiasm-glioma-astrocytoma_Grade_I | COSMIC cancer mutations | central_nervous_system-chiasm-glioma-astrocytoma_Grade_I | 8 | 1 | 16828 | 49 |
QKI |
2.306e-02 | -3.77 | skin-chest-malignant_melanoma-nodular | COSMIC cancer mutations | skin-chest-malignant_melanoma-nodular | 8 | 1 | 16828 | 49 |
PREX2 |
2.309e-02 | -3.77 | salivary_gland-parotid-carcinoma-adenoid_cystic_carcinoma | COSMIC cancer mutations | salivary_gland-parotid-carcinoma-adenoid_cystic_carcinoma | 561 | 5 | 16828 | 49 |
CKB,ERBB4,RYR3,TNIK,CAMK2G |
2.313e-02 | -3.77 | C20 prostanoid biosynthesis | BIOCYC pathways | HUMAN_PWY66-374 | 7 | 1 | 902 | 3 |
PTGDS |
2.313e-02 | -3.77 | C20 prostanoid biosynthesis | BIOCYC pathways | META_PWY66-374 | 7 | 1 | 902 | 3 |
PTGDS |
2.320e-02 | -3.76 | Myometrial Relaxation and Contraction Pathways | WikiPathways | WP289 | 158 | 3 | 5310 | 21 |
RYR3,ITPR2,CAMK2G |
2.324e-02 | -3.76 | LCOR (ligand dependent nuclear receptor corepressor) | protein interactions | 84458 | 238 | 3 | 19454 | 50 |
CLU,GLUL,SPARCL1 |
2.325e-02 | -3.76 | forearm | COSMIC cancer mutations | forearm | 81 | 2 | 16828 | 49 |
ERBB4,PREX2 |
2.331e-02 | -3.76 | amyloid-beta binding | molecular function | GO:0001540 | 89 | 2 | 18094 | 48 |
CST3,CLU |
2.339e-02 | -3.76 | RLN1 (relaxin 1) | protein interactions | 6013 | 92 | 2 | 19454 | 50 |
PON2,LRIG1 |
2.341e-02 | -3.75 | skeletal system morphogenesis | biological process | GO:0048705 | 228 | 3 | 18204 | 49 |
SOX5,BMPR1B,WWOX |
2.381e-02 | -3.74 | collagen-containing extracellular matrix | cellular component | GO:0062023 | 428 | 4 | 19108 | 49 |
CLU,COL5A3,SPARCL1,GPC5 |
2.387e-02 | -3.74 | TEX11 (testis expressed 11) | protein interactions | 56159 | 93 | 2 | 19454 | 50 |
QKI,SOX5 |
2.387e-02 | -3.74 | DMRTB1 (DMRT like family B with proline rich C-terminal 1) | protein interactions | 63948 | 93 | 2 | 19454 | 50 |
QKI,MSI2 |
2.387e-02 | -3.74 | ODR4 (odr-4 GPCR localization factor homolog) | protein interactions | 54953 | 93 | 2 | 19454 | 50 |
LRIG1,GPM6A |
2.387e-02 | -3.74 | FKBP15 (FKBP prolyl isomerase family member 15) | protein interactions | 23307 | 93 | 2 | 19454 | 50 |
TNIK,WWOX |
2.387e-02 | -3.74 | MIR19B2 (microRNA 19b-2) | protein interactions | 406981 | 93 | 2 | 19454 | 50 |
MSI2,QKI |
2.388e-02 | -3.73 | GS | prosite domains | PS51256 | 7 | 1 | 12186 | 42 |
BMPR1B |
2.397e-02 | -3.73 | hindbrain radial glia guided cell migration | biological process | GO:0021932 | 9 | 1 | 18204 | 49 |
CTNNA2 |
2.397e-02 | -3.73 | negative regulation of striated muscle contraction | biological process | GO:0045988 | 9 | 1 | 18204 | 49 |
ATP1A2 |
2.397e-02 | -3.73 | macrophage proliferation | biological process | GO:0061517 | 9 | 1 | 18204 | 49 |
CLU |
2.397e-02 | -3.73 | negative regulation of actin nucleation | biological process | GO:0051126 | 9 | 1 | 18204 | 49 |
CTNNA2 |
2.397e-02 | -3.73 | regulation of protein localization to nucleolus | biological process | GO:1904749 | 9 | 1 | 18204 | 49 |
GLUL |
2.397e-02 | -3.73 | release of sequestered calcium ion into cytosol by sarcoplasmic reticulum | biological process | GO:0014808 | 9 | 1 | 18204 | 49 |
RYR3 |
2.397e-02 | -3.73 | cyclooxygenase pathway | biological process | GO:0019371 | 9 | 1 | 18204 | 49 |
PTGDS |
2.397e-02 | -3.73 | polyamine transmembrane transport | biological process | GO:1902047 | 9 | 1 | 18204 | 49 |
ATP13A4 |
2.397e-02 | -3.73 | positive regulation of synapse maturation | biological process | GO:0090129 | 9 | 1 | 18204 | 49 |
NRXN1 |
2.397e-02 | -3.73 | microglial cell proliferation | biological process | GO:0061518 | 9 | 1 | 18204 | 49 |
CLU |
2.401e-02 | -3.73 | - | gene3d domains | 2.80.10.50 | 79 | 2 | 14470 | 44 |
RYR3,ITPR2 |
2.404e-02 | -3.73 | Band3_cytoplasmic_dom | interpro domains | IPR013769 | 9 | 1 | 18521 | 50 |
SLC4A4 |
2.404e-02 | -3.73 | Fol_N | interpro domains | IPR003645 | 9 | 1 | 18521 | 50 |
SPARCL1 |
2.404e-02 | -3.73 | Prot_inh_cystat_CS | interpro domains | IPR018073 | 9 | 1 | 18521 | 50 |
CST3 |
2.404e-02 | -3.73 | Activin_recp | interpro domains | IPR000472 | 9 | 1 | 18521 | 50 |
BMPR1B |
2.408e-02 | -3.73 | ion binding | molecular function | GO:0043167 | 6007 | 23 | 18094 | 48 |
SLC1A3,ZNRF3,ATP1A2,GLIS3,GLUL,NRXN1,RORA,BMPR1B,PITPNC1,ITPR2,SLC1A2,SPARCL1,DTNA,TNIK,CKB,PAMR1,RYR3,CAMK2G,ERBB4,PTGDS,ATP13A4,ZBTB20,PON2 |
2.435e-02 | -3.72 | TTR (transthyretin) | protein interactions | 7276 | 94 | 2 | 19454 | 50 |
CTNND2,CLU |
2.438e-02 | -3.71 | postsynapse | cellular component | GO:0098794 | 646 | 5 | 19108 | 49 |
ERBB4,CTNND2,GPM6A,TNIK,ATP1A2 |
2.446e-02 | -3.71 | regulation of purine nucleotide metabolic process | biological process | GO:1900542 | 90 | 2 | 18204 | 49 |
ZBTB20,SLC4A4 |
2.451e-02 | -3.71 | lung-carcinoma-small_cell_carcinoma | COSMIC cancer mutations | lung-carcinoma-small_cell_carcinoma | 9908 | 36 | 16828 | 49 |
ATP13A4,HPSE2,CTNND2,ATP1A2,PAMR1,BMPR1B,SOX5,NTM,QKI,GPC5,SPARCL1,SLC4A4,LRIG1,RYR3,TNIK,GPM6A,RORA,CST3,FBXL7,CDH20,CAMK2G,CLU,PARD3B,DTNA,NPAS3,PREX2,NKAIN3,ITPR2,NRXN1,COL5A3,MSI2,ERBB4,ARHGAP24,ZNRF3,NEBL,PITPNC1 |
2.459e-02 | -3.71 | human chr5p15.1 | chromosome location | human chr5p15.1 | 13 | 1 | 26134 | 50 |
FBXL7 |
2.463e-02 | -3.70 | Downregulation of ERBB4 signaling | REACTOME pathways | R-HSA-1253288 | 8 | 1 | 10285 | 32 |
ERBB4 |
2.463e-02 | -3.70 | Release of Hh-Np from the secreting cell | REACTOME pathways | R-HSA-5362798 | 8 | 1 | 10285 | 32 |
GPC5 |
2.468e-02 | -3.70 | bronchioloalveolar_adenocarcinoma | COSMIC cancer mutations | bronchioloalveolar_adenocarcinoma | 778 | 6 | 16828 | 49 |
ERBB4,SOX5,BMPR1B,TNIK,CTNND2,CAMK2G |
2.468e-02 | -3.70 | lung-carcinoma-bronchioloalveolar_adenocarcinoma | COSMIC cancer mutations | lung-carcinoma-bronchioloalveolar_adenocarcinoma | 778 | 6 | 16828 | 49 |
CTNND2,CAMK2G,TNIK,BMPR1B,ERBB4,SOX5 |
2.475e-02 | -3.70 | small_cell_carcinoma | COSMIC cancer mutations | small_cell_carcinoma | 9913 | 36 | 16828 | 49 |
GPC5,QKI,NTM,ATP1A2,CTNND2,HPSE2,ATP13A4,SOX5,PAMR1,BMPR1B,TNIK,CST3,RORA,GPM6A,SLC4A4,SPARCL1,RYR3,LRIG1,CLU,CAMK2G,DTNA,PARD3B,CDH20,FBXL7,ZNRF3,ARHGAP24,PITPNC1,NEBL,NKAIN3,PREX2,NPAS3,MSI2,ERBB4,COL5A3,NRXN1,ITPR2 |
2.476e-02 | -3.70 | Sudden Infant Death Syndrome (SIDS) Susceptibility Pathways | WikiPathways | WP706 | 162 | 3 | 5310 | 21 |
SLC1A3,AQP4,RORA |
2.483e-02 | -3.70 | H2BC13 (H2B clustered histone 13) | protein interactions | 8340 | 95 | 2 | 19454 | 50 |
ARHGAP24,GPM6A |
2.483e-02 | -3.70 | STRIP1 (striatin interacting protein 1) | protein interactions | 85369 | 95 | 2 | 19454 | 50 |
TNIK,CAMK2G |
2.483e-02 | -3.70 | DDX3Y (DEAD-box helicase 3 Y-linked) | protein interactions | 8653 | 95 | 2 | 19454 | 50 |
WWOX,ARHGAP24 |
2.484e-02 | -3.70 | vesicle | cellular component | GO:0031982 | 4141 | 17 | 19108 | 49 |
SLC4A4,CST3,SLC1A2,ATP1A2,NRXN1,SLC1A3,GLUL,TNIK,NEBL,CKB,PTGDS,CLU,ATP13A4,GPM6A,AQP4,CAMK2G,ITPR2 |
2.491e-02 | -3.69 | behavior | biological process | GO:0007610 | 619 | 5 | 18204 | 49 |
NRXN1,ATP1A2,PREX2,SLC1A2,SLC1A3 |
2.496e-02 | -3.69 | regulation of nucleotide metabolic process | biological process | GO:0006140 | 91 | 2 | 18204 | 49 |
SLC4A4,ZBTB20 |
2.501e-02 | -3.69 | Band_3_cyto | pfam domains | PF07565 | 9 | 1 | 17795 | 50 |
SLC4A4 |
2.501e-02 | -3.69 | Activin_recp | pfam domains | PF01064 | 9 | 1 | 17795 | 50 |
BMPR1B |
2.504e-02 | -3.69 | upper_aerodigestive_tract-mouth-carcinoma-adenoid_cystic_carcinoma | COSMIC cancer mutations | upper_aerodigestive_tract-mouth-carcinoma-adenoid_cystic_carcinoma | 383 | 4 | 16828 | 49 |
CKB,ERBB4,CAMK2G,TNIK |
2.504e-02 | -3.69 | upper_aerodigestive_tract-carcinoma | COSMIC cancer mutations | upper_aerodigestive_tract-carcinoma | 383 | 4 | 16828 | 49 |
ERBB4,CKB,TNIK,CAMK2G |
2.504e-02 | -3.69 | upper_aerodigestive_tract-head_neck-carcinoma-adenoid_cystic_carcinoma | COSMIC cancer mutations | upper_aerodigestive_tract-head_neck-carcinoma-adenoid_cystic_carcinoma | 383 | 4 | 16828 | 49 |
CAMK2G,TNIK,ERBB4,CKB |
2.504e-02 | -3.69 | upper_aerodigestive_tract-lymph_node-carcinoma-adenoid_cystic_carcinoma | COSMIC cancer mutations | upper_aerodigestive_tract-lymph_node-carcinoma-adenoid_cystic_carcinoma | 383 | 4 | 16828 | 49 |
TNIK,CAMK2G,ERBB4,CKB |
2.504e-02 | -3.69 | salivary_gland-carcinoma | COSMIC cancer mutations | salivary_gland-carcinoma | 383 | 4 | 16828 | 49 |
TNIK,CAMK2G,ERBB4,CKB |
2.519e-02 | -3.68 | chemical synaptic transmission | biological process | GO:0007268 | 415 | 4 | 18204 | 49 |
SLC1A3,SLC1A2,DTNA,NRXN1 |
2.519e-02 | -3.68 | anterograde trans-synaptic signaling | biological process | GO:0098916 | 415 | 4 | 18204 | 49 |
SLC1A3,NRXN1,SLC1A2,DTNA |
2.532e-02 | -3.68 | DUSP19 (dual specificity phosphatase 19) | protein interactions | 142679 | 96 | 2 | 19454 | 50 |
CKB,ERBB4 |
2.532e-02 | -3.68 | PDIA5 (protein disulfide isomerase family A member 5) | protein interactions | 10954 | 96 | 2 | 19454 | 50 |
ARHGAP24,NTM |
2.532e-02 | -3.68 | SOCS2 (suppressor of cytokine signaling 2) | protein interactions | 8835 | 96 | 2 | 19454 | 50 |
ERBB4,GLUL |
2.534e-02 | -3.68 | g-Secretase Mediated ErbB4 Signalling Pathway | SMPDB pathways | SMP0089975 | 7 | 1 | 1369 | 5 |
ERBB4 |
2.537e-02 | -3.67 | HNRNPL (heterogeneous nuclear ribonucleoprotein L) | protein interactions | 3191 | 1958 | 10 | 19454 | 50 |
DTNA,CKB,ARHGAP24,PARD3B,BMPR1B,WWOX,MSI2,QKI,ZBTB20,PON2 |
2.539e-02 | -3.67 | Signaling by EGFR | REACTOME pathways | R-HSA-177929 | 364 | 4 | 10285 | 32 |
LRIG1,ERBB4,CAMK2G,ITPR2 |
2.541e-02 | -3.67 | PTPRT (protein tyrosine phosphatase receptor type T) | protein interactions | 11122 | 10 | 1 | 19454 | 50 |
ERBB4 |
2.541e-02 | -3.67 | EREG (epiregulin) | protein interactions | 2069 | 10 | 1 | 19454 | 50 |
ERBB4 |
2.541e-02 | -3.67 | Mrpl13 (mitochondrial ribosomal protein L13) | protein interactions | 68537 | 10 | 1 | 19454 | 50 |
QKI |
2.541e-02 | -3.67 | Hsp90aa1 (heat shock protein 90, alpha (cytosolic), class A member 1) | protein interactions | 15519 | 10 | 1 | 19454 | 50 |
QKI |
2.541e-02 | -3.67 | BANK1 (B cell scaffold protein with ankyrin repeats 1) | protein interactions | 55024 | 10 | 1 | 19454 | 50 |
ITPR2 |
2.541e-02 | -3.67 | Smurf2 (SMAD specific E3 ubiquitin protein ligase 2) | protein interactions | 66313 | 10 | 1 | 19454 | 50 |
GLIS3 |
2.541e-02 | -3.67 | SLC8A2 (solute carrier family 8 member A2) | protein interactions | 6543 | 10 | 1 | 19454 | 50 |
GPM6A |
2.541e-02 | -3.67 | ZNF135 (zinc finger protein 135) | protein interactions | 7694 | 10 | 1 | 19454 | 50 |
WWOX |
2.541e-02 | -3.67 | ALKAL2 (ALK and LTK ligand 2) | protein interactions | 285016 | 10 | 1 | 19454 | 50 |
PON2 |
2.541e-02 | -3.67 | GSG1 (germ cell associated 1) | protein interactions | 83445 | 10 | 1 | 19454 | 50 |
PITPNC1 |
2.541e-02 | -3.67 | CALB2 (calbindin 2) | protein interactions | 794 | 10 | 1 | 19454 | 50 |
GPM6A |
2.541e-02 | -3.67 | ZNF852 (zinc finger protein 852) | protein interactions | 285346 | 10 | 1 | 19454 | 50 |
ARHGAP24 |
2.541e-02 | -3.67 | ZNF606 (zinc finger protein 606) | protein interactions | 80095 | 10 | 1 | 19454 | 50 |
ARHGAP24 |
2.548e-02 | -3.67 | protein tetramerization | biological process | GO:0051262 | 92 | 2 | 18204 | 49 |
AQP4,RYR3 |
2.551e-02 | -3.67 | lipid binding | molecular function | GO:0008289 | 861 | 6 | 18094 | 48 |
ATP1A2,PARD3B,PTGDS,PITPNC1,ITPR2,RORA |
2.566e-02 | -3.66 | GS | smart domains | SM00467 | 7 | 1 | 9717 | 36 |
BMPR1B |
2.580e-02 | -3.66 | Aldosterone synthesis and secretion | KEGG pathways | hsa04925 | 82 | 2 | 7161 | 22 |
CAMK2G,ITPR2 |
2.580e-02 | -3.66 | Aldosterone synthesis and secretion | KEGG pathways | ko04925 | 82 | 2 | 7161 | 22 |
CAMK2G,ITPR2 |
2.586e-02 | -3.66 | parotid | COSMIC cancer mutations | parotid | 578 | 5 | 16828 | 49 |
RYR3,CKB,ERBB4,CAMK2G,TNIK |
2.591e-02 | -3.65 | skin-chest-malignant_melanoma-superficial_spreading | COSMIC cancer mutations | skin-chest-malignant_melanoma-superficial_spreading | 9 | 1 | 16828 | 49 |
PREX2 |
2.591e-02 | -3.65 | skin-upper_leg-malignant_melanoma-superficial_spreading | COSMIC cancer mutations | skin-upper_leg-malignant_melanoma-superficial_spreading | 9 | 1 | 16828 | 49 |
PREX2 |
2.616e-02 | -3.64 | muscle contraction | biological process | GO:0006936 | 238 | 3 | 18204 | 49 |
RYR3,ATP1A2,DTNA |
2.621e-02 | -3.64 | oesophagus-carcinoma-adenocarcinoma | COSMIC cancer mutations | oesophagus-carcinoma-adenocarcinoma | 13112 | 44 | 16828 | 49 |
NEBL,SLC1A3,ARHGAP24,ZNRF3,ITPR2,ERBB4,NPAS3,PARD3B,CKB,PTGDS,CAMK2G,PON2,CLU,CST3,LRIG1,RYR3,SLC4A4,NTM,GPC5,QKI,BMPR1B,PAMR1,SOX5,HPSE2,SFXN5,NRXN1,COL5A3,SLC1A2,NKAIN3,PREX2,LSAMP,AQP4,FBXL7,CDH20,GPM6A,RORA,TNIK,SPARCL1,ZBTB20,NHSL1,ATP13A4,CTNND2,GLIS3,ATP1A2 |
2.622e-02 | -3.64 | phosphatidylinositol transfer activity | molecular function | GO:0008526 | 10 | 1 | 18094 | 48 |
PITPNC1 |
2.622e-02 | -3.64 | polyamine transmembrane transporter activity | molecular function | GO:0015203 | 10 | 1 | 18094 | 48 |
ATP13A4 |
2.631e-02 | -3.64 | MED27 (mediator complex subunit 27) | protein interactions | 9442 | 98 | 2 | 19454 | 50 |
QKI,SOX5 |
2.631e-02 | -3.64 | DNAAF2 (dynein axonemal assembly factor 2) | protein interactions | 55172 | 98 | 2 | 19454 | 50 |
LSAMP,GPM6A |
2.646e-02 | -3.63 | human chr2p13.2 | chromosome location | human chr2p13.2 | 14 | 1 | 26134 | 50 |
SFXN5 |
2.646e-02 | -3.63 | human chr2p16.3 | chromosome location | human chr2p16.3 | 14 | 1 | 26134 | 50 |
NRXN1 |
2.653e-02 | -3.63 | haematopoietic_neoplasm | COSMIC cancer mutations | haematopoietic_neoplasm | 11082 | 39 | 16828 | 49 |
RORA,TNIK,LRIG1,RYR3,SPARCL1,SLC4A4,GPC5,QKI,NTM,NHSL1,PAMR1,BMPR1B,WWOX,SOX5,CTNND2,HPSE2,ATP13A4,SFXN5,ATP1A2,GLIS3,SLC1A3,NEBL,ARHGAP24,NRXN1,ITPR2,ERBB4,MSI2,SLC1A2,COL5A3,NKAIN3,PREX2,NPAS3,DTNA,PARD3B,LSAMP,CAMK2G,PON2,FBXL7,CDH20 |
2.654e-02 | -3.63 | upper_arm | COSMIC cancer mutations | upper_arm | 582 | 5 | 16828 | 49 |
ERBB4,PARD3B,ITPR2,SLC4A4,PREX2 |
2.660e-02 | -3.63 | regulation of mesenchymal stem cell differentiation | biological process | GO:2000739 | 10 | 1 | 18204 | 49 |
SOX5 |
2.660e-02 | -3.63 | neuronal action potential propagation | biological process | GO:0019227 | 10 | 1 | 18204 | 49 |
ATP1A2 |
2.660e-02 | -3.63 | learned vocalization behavior or vocal learning | biological process | GO:0098598 | 10 | 1 | 18204 | 49 |
NRXN1 |
2.660e-02 | -3.63 | establishment of centrosome localization | biological process | GO:0051660 | 10 | 1 | 18204 | 49 |
PARD3B |
2.660e-02 | -3.63 | postsynaptic density assembly | biological process | GO:0097107 | 10 | 1 | 18204 | 49 |
NRXN1 |
2.660e-02 | -3.63 | release of sequestered calcium ion into cytosol by endoplasmic reticulum | biological process | GO:1903514 | 10 | 1 | 18204 | 49 |
RYR3 |
2.660e-02 | -3.63 | postsynaptic membrane assembly | biological process | GO:0097104 | 10 | 1 | 18204 | 49 |
NRXN1 |
2.660e-02 | -3.63 | action potential propagation | biological process | GO:0098870 | 10 | 1 | 18204 | 49 |
ATP1A2 |
2.660e-02 | -3.63 | otolith development | biological process | GO:0048840 | 10 | 1 | 18204 | 49 |
LRIG1 |
2.660e-02 | -3.63 | mitochondrial fragmentation involved in apoptotic process | biological process | GO:0043653 | 10 | 1 | 18204 | 49 |
ERBB4 |
2.666e-02 | -3.62 | Ig_sub2 | interpro domains | IPR003598 | 239 | 3 | 18521 | 50 |
NTM,LRIG1,LSAMP |
2.668e-02 | -3.62 | MIP_CS | interpro domains | IPR022357 | 10 | 1 | 18521 | 50 |
AQP4 |
2.668e-02 | -3.62 | PAS_fold_3 | interpro domains | IPR013655 | 10 | 1 | 18521 | 50 |
NPAS3 |
2.668e-02 | -3.62 | HCO3_transpt-like_TM_dom | interpro domains | IPR011531 | 10 | 1 | 18521 | 50 |
SLC4A4 |
2.668e-02 | -3.62 | HCO3_transpt_euk | interpro domains | IPR003020 | 10 | 1 | 18521 | 50 |
SLC4A4 |
2.668e-02 | -3.62 | PTrfase/Anion_transptr | interpro domains | IPR016152 | 10 | 1 | 18521 | 50 |
SLC4A4 |
2.683e-02 | -3.62 | ATPase-coupled transmembrane transporter activity | molecular function | GO:0042626 | 96 | 2 | 18094 | 48 |
ATP1A2,ATP13A4 |
2.693e-02 | -3.61 | NCK2 (NCK adaptor protein 2) | protein interactions | 8440 | 252 | 3 | 19454 | 50 |
ERBB4,TNIK,NHSL1 |
2.695e-02 | -3.61 | lung-carcinoma-non_small_cell_carcinoma | COSMIC cancer mutations | lung-carcinoma-non_small_cell_carcinoma | 5198 | 22 | 16828 | 49 |
RORA,TNIK,LRIG1,SPARCL1,QKI,SOX5,BMPR1B,ATP13A4,CTNND2,PITPNC1,SLC1A3,ARHGAP24,COL5A3,ERBB4,MSI2,ITPR2,NPAS3,PREX2,LSAMP,CLU,CAMK2G,FBXL7 |
2.695e-02 | -3.61 | non_small_cell_carcinoma | COSMIC cancer mutations | non_small_cell_carcinoma | 5198 | 22 | 16828 | 49 |
RORA,TNIK,LRIG1,SPARCL1,QKI,BMPR1B,SOX5,ATP13A4,CTNND2,PITPNC1,SLC1A3,ARHGAP24,ITPR2,COL5A3,MSI2,ERBB4,NPAS3,PREX2,LSAMP,CAMK2G,CLU,FBXL7 |
2.701e-02 | -3.61 | anchoring junction | cellular component | GO:0070161 | 902 | 6 | 19108 | 49 |
CTNNA2,ATP1A2,CDH20,CTNND2,ARHGAP24,PARD3B |
2.704e-02 | -3.61 | calcium ion transmembrane import into cytosol | biological process | GO:0097553 | 95 | 2 | 18204 | 49 |
ITPR2,RYR3 |
2.731e-02 | -3.60 | EDEM2 (ER degradation enhancing alpha-mannosidase like protein 2) | protein interactions | 55741 | 100 | 2 | 19454 | 50 |
HPSE2,CLU |
2.731e-02 | -3.60 | ATP4A (ATPase H+/K+ transporting subunit alpha) | protein interactions | 495 | 100 | 2 | 19454 | 50 |
ATP1A2,GPM6A |
2.733e-02 | -3.60 | Heparan sulfate degradation | KEGG pathways | M00078 | 9 | 1 | 7161 | 22 |
HPSE2 |
2.733e-02 | -3.60 | Heparan sulfate degradation | KEGG pathways | hsa_M00078 | 9 | 1 | 7161 | 22 |
HPSE2 |
2.758e-02 | -3.59 | ErbB signaling pathway | KEGG pathways | ko04012 | 85 | 2 | 7161 | 22 |
ERBB4,CAMK2G |
2.758e-02 | -3.59 | ErbB signaling pathway | KEGG pathways | hsa04012 | 85 | 2 | 7161 | 22 |
CAMK2G,ERBB4 |
2.758e-02 | -3.59 | Insulin secretion | KEGG pathways | hsa04911 | 85 | 2 | 7161 | 22 |
CAMK2G,ATP1A2 |
2.767e-02 | -3.59 | Terminal pathway of complement | REACTOME pathways | R-HSA-166665 | 9 | 1 | 10285 | 32 |
CLU |
2.767e-02 | -3.59 | Synthesis of 5-eicosatetraenoic acids | REACTOME pathways | R-HSA-2142688 | 9 | 1 | 10285 | 32 |
PON2 |
2.775e-02 | -3.58 | HCO3_cotransp | pfam domains | PF00955 | 10 | 1 | 17795 | 50 |
SLC4A4 |
2.775e-02 | -3.58 | PAS_3 | pfam domains | PF08447 | 10 | 1 | 17795 | 50 |
NPAS3 |
2.780e-02 | -3.58 | signaling | biological process | GO:0023052 | 4968 | 20 | 18204 | 49 |
SPARCL1,BMPR1B,SLC1A3,NRXN1,TNIK,SLC1A2,CTNND2,ARHGAP24,PITPNC1,PREX2,CAMK2G,ITPR2,ATP1A2,ERBB4,CLU,RORA,WWOX,ZNRF3,RYR3,DTNA |
2.786e-02 | -3.58 | platelet dense tubular network | cellular component | GO:0031094 | 11 | 1 | 19108 | 49 |
ITPR2 |
2.792e-02 | -3.58 | Gtf2e2 (general transcription factor II E, polypeptide 2 (beta subunit)) | protein interactions | 68153 | 11 | 1 | 19454 | 50 |
NHSL1 |
2.792e-02 | -3.58 | MSRB1 (methionine sulfoxide reductase B1) | protein interactions | 51734 | 11 | 1 | 19454 | 50 |
CLU |
2.792e-02 | -3.58 | VOPP1 (VOPP1 WW domain binding protein) | protein interactions | 81552 | 11 | 1 | 19454 | 50 |
WWOX |
2.792e-02 | -3.58 | IL7 (interleukin 7) | protein interactions | 3574 | 11 | 1 | 19454 | 50 |
QKI |
2.792e-02 | -3.58 | PTGDR (prostaglandin D2 receptor) | protein interactions | 5729 | 11 | 1 | 19454 | 50 |
PTGDS |
2.792e-02 | -3.58 | AQP5 (aquaporin 5) | protein interactions | 362 | 11 | 1 | 19454 | 50 |
ATP1A2 |
2.792e-02 | -3.58 | ZNF726 (zinc finger protein 726) | protein interactions | 730087 | 11 | 1 | 19454 | 50 |
ARHGAP24 |
2.792e-02 | -3.58 | SYTL1 (synaptotagmin like 1) | protein interactions | 84958 | 11 | 1 | 19454 | 50 |
NRXN1 |
2.792e-02 | -3.58 | IRAG1 (inositol 1,4,5-triphosphate receptor associated 1) | protein interactions | 10335 | 11 | 1 | 19454 | 50 |
ITPR2 |
2.792e-02 | -3.58 | SYN3 (synapsin III) | protein interactions | 8224 | 11 | 1 | 19454 | 50 |
GPM6A |
2.792e-02 | -3.58 | GAL3ST1 (galactose-3-O-sulfotransferase 1) | protein interactions | 9514 | 11 | 1 | 19454 | 50 |
LRIG1 |
2.792e-02 | -3.58 | DAZ1 (deleted in azoospermia 1) | protein interactions | 1617 | 11 | 1 | 19454 | 50 |
QKI |
2.810e-02 | -3.57 | amino acid transmembrane transport | biological process | GO:0003333 | 97 | 2 | 18204 | 49 |
SLC1A3,SLC1A2 |
2.810e-02 | -3.57 | nerve development | biological process | GO:0021675 | 97 | 2 | 18204 | 49 |
SLC1A3,LRIG1 |
2.814e-02 | -3.57 | basolateral plasma membrane | cellular component | GO:0016323 | 257 | 3 | 19108 | 49 |
SLC4A4,AQP4,ERBB4 |
2.819e-02 | -3.57 | PRMT5 (protein arginine methyltransferase 5) | protein interactions | 10419 | 450 | 4 | 19454 | 50 |
GLIS3,ARHGAP24,WWOX,RORA |
2.832e-02 | -3.56 | human chr10p12.31 | chromosome location | human chr10p12.31 | 15 | 1 | 26134 | 50 |
NEBL |
2.832e-02 | -3.56 | human chr8q12.3 | chromosome location | human chr8q12.3 | 15 | 1 | 26134 | 50 |
NKAIN3 |
2.832e-02 | -3.56 | MIR7-1 (microRNA 7-1) | protein interactions | 407043 | 102 | 2 | 19454 | 50 |
QKI,MSI2 |
2.832e-02 | -3.56 | KRTAP6-1 (keratin associated protein 6-1) | protein interactions | 337966 | 102 | 2 | 19454 | 50 |
CAMK2G,GLIS3 |
2.842e-02 | -3.56 | trans-synaptic signaling | biological process | GO:0099537 | 431 | 4 | 18204 | 49 |
SLC1A3,SLC1A2,DTNA,NRXN1 |
2.847e-02 | -3.56 | regulation of synapse organization | biological process | GO:0050807 | 246 | 3 | 18204 | 49 |
GPM6A,CTNNA2,NRXN1 |
2.875e-02 | -3.55 | skin-back-malignant_melanoma-nodular | COSMIC cancer mutations | skin-back-malignant_melanoma-nodular | 10 | 1 | 16828 | 49 |
PREX2 |
2.875e-02 | -3.55 | chiasm | COSMIC cancer mutations | chiasm | 10 | 1 | 16828 | 49 |
QKI |
2.880e-02 | -3.55 | sulfur amino acid transmembrane transporter activity | molecular function | GO:0000099 | 11 | 1 | 18094 | 48 |
SLC1A2 |
2.880e-02 | -3.55 | acetylcholine receptor binding | molecular function | GO:0033130 | 11 | 1 | 18094 | 48 |
NRXN1 |
2.884e-02 | -3.55 | RAB6B (RAB6B, member RAS oncogene family) | protein interactions | 51560 | 103 | 2 | 19454 | 50 |
GPM6A,BMPR1B |
2.885e-02 | -3.55 | inorganic ion homeostasis | biological process | GO:0098771 | 433 | 4 | 18204 | 49 |
ATP13A4,SLC1A3,RYR3,ATP1A2 |
2.893e-02 | -3.54 | amino acid transmembrane transporter activity | molecular function | GO:0015171 | 100 | 2 | 18094 | 48 |
SLC1A3,SLC1A2 |
2.897e-02 | -3.54 | large_intestine-caecum-adenoma | COSMIC cancer mutations | large_intestine-caecum-adenoma | 229 | 3 | 16828 | 49 |
HPSE2,CTNND2,ERBB4 |
2.906e-02 | -3.54 | HNRNPK (heterogeneous nuclear ribonucleoprotein K) | protein interactions | 3190 | 675 | 5 | 19454 | 50 |
QKI,ARHGAP24,DTNA,WWOX,CKB |
2.920e-02 | -3.53 | LCK (LCK proto-oncogene, Src family tyrosine kinase) | protein interactions | 3932 | 455 | 4 | 19454 | 50 |
DTNA,CAMK2G,ERBB4,CTNND2 |
2.922e-02 | -3.53 | cellular response to caffeine | biological process | GO:0071313 | 11 | 1 | 18204 | 49 |
RYR3 |
2.922e-02 | -3.53 | establishment or maintenance of transmembrane electrochemical gradient | biological process | GO:0010248 | 11 | 1 | 18204 | 49 |
ATP1A2 |
2.922e-02 | -3.53 | positive regulation of extrinsic apoptotic signaling pathway in absence of ligand | biological process | GO:2001241 | 11 | 1 | 18204 | 49 |
WWOX |
2.922e-02 | -3.53 | lactone metabolic process | biological process | GO:1901334 | 11 | 1 | 18204 | 49 |
ATP1A2 |
2.922e-02 | -3.53 | polyamine transport | biological process | GO:0015846 | 11 | 1 | 18204 | 49 |
ATP13A4 |
2.922e-02 | -3.53 | antral ovarian follicle growth | biological process | GO:0001547 | 11 | 1 | 18204 | 49 |
BMPR1B |
2.922e-02 | -3.53 | intracellular mRNA localization | biological process | GO:0008298 | 11 | 1 | 18204 | 49 |
QKI |
2.922e-02 | -3.53 | L-ascorbic acid metabolic process | biological process | GO:0019852 | 11 | 1 | 18204 | 49 |
ATP1A2 |
2.927e-02 | -3.53 | blood vessel morphogenesis | biological process | GO:0048514 | 435 | 4 | 18204 | 49 |
ARHGAP24,RORA,GLUL,QKI |
2.931e-02 | -3.53 | Fib_collagen_C | interpro domains | IPR000885 | 11 | 1 | 18521 | 50 |
COL5A3 |
2.936e-02 | -3.53 | CYP2C9 (cytochrome P450 family 2 subfamily C member 9) | protein interactions | 1559 | 104 | 2 | 19454 | 50 |
ITPR2,WWOX |
2.936e-02 | -3.53 | HUNK (hormonally up-regulated Neu-associated kinase) | protein interactions | 30811 | 104 | 2 | 19454 | 50 |
CLU,SPARCL1 |
2.997e-02 | -3.51 | calcium ion transport | biological process | GO:0006816 | 251 | 3 | 18204 | 49 |
ITPR2,RYR3,GPM6A |
3.000e-02 | -3.51 | Helical hairpin bin | gene3d domains | 1.10.287.570 | 10 | 1 | 14470 | 44 |
SLC4A4 |
3.003e-02 | -3.51 | Protein digestion and absorption | KEGG pathways | hsa04974 | 89 | 2 | 7161 | 22 |
ATP1A2,COL5A3 |
3.003e-02 | -3.51 | Protein digestion and absorption | KEGG pathways | ko04974 | 89 | 2 | 7161 | 22 |
COL5A3,ATP1A2 |
3.021e-02 | -3.50 | response to organic substance | biological process | GO:0010033 | 2498 | 12 | 18204 | 49 |
ITPR2,PTGDS,ATP1A2,CLU,RORA,RYR3,AQP4,GLUL,SLC1A3,ZBTB20,TNIK,SLC1A2 |
3.022e-02 | -3.50 | LIPOCALIN | prints domains | PR00179 | 8 | 1 | 5227 | 20 |
PTGDS |
3.027e-02 | -3.50 | regulation of synapse structure or activity | biological process | GO:0050803 | 252 | 3 | 18204 | 49 |
CTNNA2,NRXN1,GPM6A |
3.030e-02 | -3.50 | cell communication | biological process | GO:0007154 | 5010 | 20 | 18204 | 49 |
RORA,CLU,ATP1A2,ERBB4,ZNRF3,WWOX,CAMK2G,ITPR2,DTNA,RYR3,NRXN1,SLC1A2,TNIK,BMPR1B,SPARCL1,SLC1A3,PREX2,PITPNC1,ARHGAP24,CTNND2 |
3.030e-02 | -3.50 | abdomen | COSMIC cancer mutations | abdomen | 603 | 5 | 16828 | 49 |
PREX2,CTNND2,ERBB4,LRIG1,ITPR2 |
3.035e-02 | -3.49 | banded collagen fibril | cellular component | GO:0098643 | 12 | 1 | 19108 | 49 |
COL5A3 |
3.035e-02 | -3.49 | fibrillar collagen trimer | cellular component | GO:0005583 | 12 | 1 | 19108 | 49 |
COL5A3 |
3.035e-02 | -3.49 | sodium:potassium-exchanging ATPase complex | cellular component | GO:0005890 | 12 | 1 | 19108 | 49 |
ATP1A2 |
3.042e-02 | -3.49 | BAMBI (BMP and activin membrane bound inhibitor) | protein interactions | 25805 | 12 | 1 | 19454 | 50 |
BMPR1B |
3.042e-02 | -3.49 | LOC102724560 (cystathionine beta-synthase like) | protein interactions | 102724560 | 12 | 1 | 19454 | 50 |
ARHGAP24 |
3.042e-02 | -3.49 | LGR5 (leucine rich repeat containing G protein-coupled receptor 5) | protein interactions | 8549 | 12 | 1 | 19454 | 50 |
ZNRF3 |
3.042e-02 | -3.49 | LMP-1 (latent membrane protein LMP-1) | protein interactions | 3783750 | 12 | 1 | 19454 | 50 |
TNIK |
3.042e-02 | -3.49 | ART4 (ADP-ribosyltransferase 4 (inactive) (Dombrock blood group)) | protein interactions | 420 | 12 | 1 | 19454 | 50 |
GPM6A |
3.042e-02 | -3.49 | MMP25 (matrix metallopeptidase 25) | protein interactions | 64386 | 12 | 1 | 19454 | 50 |
CLU |
3.042e-02 | -3.49 | SMIM20 (small integral membrane protein 20) | protein interactions | 389203 | 12 | 1 | 19454 | 50 |
ERBB4 |
3.042e-02 | -3.49 | PTPN20 (protein tyrosine phosphatase non-receptor type 20) | protein interactions | 26095 | 12 | 1 | 19454 | 50 |
ERBB4 |
3.042e-02 | -3.49 | CA4 (carbonic anhydrase 4) | protein interactions | 762 | 12 | 1 | 19454 | 50 |
SLC4A4 |
3.042e-02 | -3.49 | ZNF91 (zinc finger protein 91) | protein interactions | 7644 | 12 | 1 | 19454 | 50 |
ARHGAP24 |
3.042e-02 | -3.49 | ORF17.5 (ORF17.5) | protein interactions | 4961482 | 12 | 1 | 19454 | 50 |
WWOX |
3.042e-02 | -3.49 | IL15 (interleukin 15) | protein interactions | 3600 | 12 | 1 | 19454 | 50 |
LRIG1 |
3.042e-02 | -3.49 | ZNF235 (zinc finger protein 235) | protein interactions | 9310 | 12 | 1 | 19454 | 50 |
ARHGAP24 |
3.042e-02 | -3.49 | TREM2 (triggering receptor expressed on myeloid cells 2) | protein interactions | 54209 | 12 | 1 | 19454 | 50 |
CLU |
3.042e-02 | -3.49 | UGT1A9 (UDP glucuronosyltransferase family 1 member A9) | protein interactions | 54600 | 12 | 1 | 19454 | 50 |
PON2 |
3.049e-02 | -3.49 | LRRCT | pfam domains | PF01463 | 11 | 1 | 17795 | 50 |
LRIG1 |
3.049e-02 | -3.49 | COLFI | pfam domains | PF01410 | 11 | 1 | 17795 | 50 |
COL5A3 |
3.058e-02 | -3.49 | CTNNB1 (catenin beta 1) | protein interactions | 1499 | 926 | 6 | 19454 | 50 |
CTNNA2,DTNA,NHSL1,PARD3B,ARHGAP24,CTNND2 |
3.060e-02 | -3.49 | CYSTATIN | prosite domains | PS00287 | 9 | 1 | 12186 | 42 |
CST3 |
3.069e-02 | -3.48 | Negative regulation of activity of TFAP2 (AP-2) family transcription factors | REACTOME pathways | R-HSA-8866904 | 10 | 1 | 10285 | 32 |
WWOX |
3.069e-02 | -3.48 | Bicarbonate transporters | REACTOME pathways | R-HSA-425381 | 10 | 1 | 10285 | 32 |
SLC4A4 |
3.069e-02 | -3.48 | PI3K events in ERBB4 signaling | REACTOME pathways | R-HSA-1250342 | 10 | 1 | 10285 | 32 |
ERBB4 |
3.083e-02 | -3.48 | response to stimulus | biological process | GO:0050896 | 7803 | 28 | 18204 | 49 |
SPARCL1,BMPR1B,SLC1A3,NRXN1,TNIK,SLC1A2,CTNND2,CTNNA2,ITPR2,SOX5,WWOX,PTGDS,AQP4,CST3,RYR3,DTNA,ZBTB20,GPM6A,ARHGAP24,PON2,PREX2,PITPNC1,ATP1A2,ERBB4,CLU,RORA,ZNRF3,GLUL |
3.092e-02 | -3.48 | POMK (protein O-mannose kinase) | protein interactions | 84197 | 266 | 3 | 19454 | 50 |
PON2,BMPR1B,CLU |
3.122e-02 | -3.47 | Phase I biotransformations, non P450 | WikiPathways | WP136 | 8 | 1 | 5310 | 21 |
PON2 |
3.138e-02 | -3.46 | inositol 1,4,5 trisphosphate binding | molecular function | GO:0070679 | 12 | 1 | 18094 | 48 |
ITPR2 |
3.147e-02 | -3.46 | BIN1 (bridging integrator 1) | protein interactions | 274 | 108 | 2 | 19454 | 50 |
CLU,GPM6A |
3.149e-02 | -3.46 | PFN1 (profilin 1) | protein interactions | 5216 | 466 | 4 | 19454 | 50 |
ARHGAP24,NHSL1,CKB,CAMK2G |
3.151e-02 | -3.46 | RET (ret proto-oncogene) | protein interactions | 5979 | 268 | 3 | 19454 | 50 |
PTGDS,CLU,CKB |
3.151e-02 | -3.46 | protein complex oligomerization | biological process | GO:0051259 | 256 | 3 | 18204 | 49 |
RYR3,AQP4,SLC1A2 |
3.155e-02 | -3.46 | regulation of multicellular organismal process | biological process | GO:0051239 | 3113 | 14 | 18204 | 49 |
SFXN5,CLU,RORA,ERBB4,ATP1A2,PTGDS,CAMK2G,SOX5,GLUL,CST3,NRXN1,BMPR1B,ZBTB20,QKI |
3.158e-02 | -3.46 | skin-hand-malignant_melanoma-acral_lentiginous | COSMIC cancer mutations | skin-hand-malignant_melanoma-acral_lentiginous | 11 | 1 | 16828 | 49 |
PREX2 |
3.158e-02 | -3.46 | skin-back-malignant_melanoma-superficial_spreading | COSMIC cancer mutations | skin-back-malignant_melanoma-superficial_spreading | 11 | 1 | 16828 | 49 |
PREX2 |
3.184e-02 | -3.45 | negative regulation of collagen metabolic process | biological process | GO:0010713 | 12 | 1 | 18204 | 49 |
CST3 |
3.184e-02 | -3.45 | microglia differentiation | biological process | GO:0014004 | 12 | 1 | 18204 | 49 |
QKI |
3.184e-02 | -3.45 | positive regulation of extrinsic apoptotic signaling pathway via death domain receptors | biological process | GO:1902043 | 12 | 1 | 18204 | 49 |
BMPR1B |
3.184e-02 | -3.45 | regulation of blood vessel remodeling | biological process | GO:0060312 | 12 | 1 | 18204 | 49 |
CST3 |
3.184e-02 | -3.45 | mammalian oogenesis stage | biological process | GO:0022605 | 12 | 1 | 18204 | 49 |
BMPR1B |
3.184e-02 | -3.45 | sulfur amino acid transport | biological process | GO:0000101 | 12 | 1 | 18204 | 49 |
SLC1A2 |
3.192e-02 | -3.44 | GnRH signaling pathway | KEGG pathways | hsa04912 | 92 | 2 | 7161 | 22 |
CAMK2G,ITPR2 |
3.192e-02 | -3.44 | GnRH signaling pathway | KEGG pathways | ko04912 | 92 | 2 | 7161 | 22 |
CAMK2G,ITPR2 |
3.193e-02 | -3.44 | TGFB_receptor | interpro domains | IPR000333 | 12 | 1 | 18521 | 50 |
BMPR1B |
3.193e-02 | -3.44 | Lipocalin_CS | interpro domains | IPR022272 | 12 | 1 | 18521 | 50 |
PTGDS |
3.193e-02 | -3.44 | Lipocalin | interpro domains | IPR002345 | 12 | 1 | 18521 | 50 |
PTGDS |
3.193e-02 | -3.44 | haematopoietic_and_lymphoid_tissue-haematopoietic_neoplasm-acute_myeloid_leukaemia | COSMIC cancer mutations | haematopoietic_and_lymphoid_tissue-haematopoietic_neoplasm-acute_myeloid_leukaemia | 10418 | 37 | 16828 | 49 |
SLC1A3,NEBL,ARHGAP24,NRXN1,ITPR2,ERBB4,MSI2,COL5A3,SLC1A2,NKAIN3,PREX2,NPAS3,LSAMP,PARD3B,CAMK2G,PON2,FBXL7,CDH20,RORA,TNIK,LRIG1,RYR3,SPARCL1,SLC4A4,GPC5,QKI,NTM,NHSL1,PAMR1,WWOX,SOX5,HPSE2,CTNND2,ATP13A4,ATP1A2,GLIS3,SFXN5 |
3.193e-02 | -3.44 | acute_myeloid_leukaemia | COSMIC cancer mutations | acute_myeloid_leukaemia | 10418 | 37 | 16828 | 49 |
WWOX,SOX5,NHSL1,PAMR1,SFXN5,ATP1A2,GLIS3,HPSE2,CTNND2,ATP13A4,QKI,GPC5,NTM,RYR3,LRIG1,SLC4A4,SPARCL1,RORA,TNIK,CDH20,FBXL7,LSAMP,PARD3B,PON2,CAMK2G,ERBB4,MSI2,COL5A3,SLC1A2,NRXN1,ITPR2,NKAIN3,PREX2,NPAS3,SLC1A3,NEBL,ARHGAP24 |
3.200e-02 | -3.44 | ZNRF4 (zinc and ring finger 4) | protein interactions | 148066 | 109 | 2 | 19454 | 50 |
PON2,ITPR2 |
3.200e-02 | -3.44 | MIR34B (microRNA 34b) | protein interactions | 407041 | 109 | 2 | 19454 | 50 |
MSI2,QKI |
3.200e-02 | -3.44 | NHSL3 (NHS like 3) | protein interactions | 57648 | 109 | 2 | 19454 | 50 |
WWOX,NHSL1 |
3.207e-02 | -3.44 | bile_duct | COSMIC cancer mutations | bile_duct | 15095 | 48 | 16828 | 49 |
RORA,GPM6A,TNIK,SPARCL1,ZBTB20,NHSL1,GLIS3,ATP1A2,CTNND2,ATP13A4,PITPNC1,GLUL,COL5A3,SLC1A2,NRXN1,PREX2,DTNA,AQP4,LSAMP,CDH20,FBXL7,CST3,RYR3,LRIG1,SLC4A4,GPC5,QKI,NTM,WWOX,SOX5,PAMR1,BMPR1B,SFXN5,HPSE2,SLC1A3,NEBL,ZNRF3,ARHGAP24,ERBB4,MSI2,ITPR2,NPAS3,CKB,PARD3B,CLU,PON2,CAMK2G,PTGDS |
3.207e-02 | -3.44 | biliary_tract-bile_duct-carcinoma-adenocarcinoma | COSMIC cancer mutations | biliary_tract-bile_duct-carcinoma-adenocarcinoma | 15095 | 48 | 16828 | 49 |
QKI,GPC5,NTM,WWOX,SOX5,BMPR1B,PAMR1,SFXN5,HPSE2,CST3,RYR3,LRIG1,SLC4A4,CKB,PARD3B,PON2,CLU,CAMK2G,PTGDS,SLC1A3,NEBL,ZNRF3,ARHGAP24,ERBB4,MSI2,ITPR2,NPAS3,ZBTB20,NHSL1,GLIS3,ATP1A2,CTNND2,ATP13A4,RORA,GPM6A,TNIK,SPARCL1,DTNA,LSAMP,AQP4,CDH20,FBXL7,PITPNC1,GLUL,COL5A3,SLC1A2,NRXN1,PREX2 |
3.240e-02 | -3.43 | EF-hand-dom_pair | interpro domains | IPR011992 | 258 | 3 | 18521 | 50 |
DTNA,RYR3,SPARCL1 |
3.251e-02 | -3.43 | neural precursor cell proliferation | biological process | GO:0061351 | 105 | 2 | 18204 | 49 |
RORA,SOX5 |
3.254e-02 | -3.43 | ZNF581 (zinc finger protein 581) | protein interactions | 51545 | 110 | 2 | 19454 | 50 |
WWOX,SOX5 |
3.256e-02 | -3.42 | SNCA (synuclein alpha) | protein interactions | 6622 | 696 | 5 | 19454 | 50 |
CKB,CAMK2G,GPM6A,CLU,TNIK |
3.271e-02 | -3.42 | HSPE1 (heat shock protein family E (Hsp10) member 1) | protein interactions | 3336 | 272 | 3 | 19454 | 50 |
CKB,ERBB4,ARHGAP24 |
3.275e-02 | -3.42 | regulation of plasma membrane bounded cell projection organization | biological process | GO:0120035 | 666 | 5 | 18204 | 49 |
CTNNA2,TNIK,GPM6A,ARHGAP24,CAMK2G |
3.276e-02 | -3.42 | steroid binding | molecular function | GO:0005496 | 107 | 2 | 18094 | 48 |
ATP1A2,RORA |
3.287e-02 | -3.42 | FOLN | smart domains | SM00274 | 9 | 1 | 9717 | 36 |
SPARCL1 |
3.291e-02 | -3.41 | ST3GAL5 (ST3 beta-galactoside alpha-2,3-sialyltransferase 5) | protein interactions | 8869 | 13 | 1 | 19454 | 50 |
PON2 |
3.291e-02 | -3.41 | Rbm47 (RNA binding motif protein 47) | protein interactions | 245945 | 13 | 1 | 19454 | 50 |
QKI |
3.291e-02 | -3.41 | NPR2 (natriuretic peptide receptor 2) | protein interactions | 4882 | 13 | 1 | 19454 | 50 |
CAMK2G |
3.291e-02 | -3.41 | ZNF718 (zinc finger protein 718) | protein interactions | 255403 | 13 | 1 | 19454 | 50 |
ARHGAP24 |
3.291e-02 | -3.41 | PLPPR4 (phospholipid phosphatase related 4) | protein interactions | 9890 | 13 | 1 | 19454 | 50 |
ZNRF3 |
3.291e-02 | -3.41 | TBCC (tubulin folding cofactor C) | protein interactions | 6903 | 13 | 1 | 19454 | 50 |
NTM |
3.291e-02 | -3.41 | MYO16 (myosin XVI) | protein interactions | 23026 | 13 | 1 | 19454 | 50 |
NRXN1 |
3.291e-02 | -3.41 | RAB3C (RAB3C, member RAS oncogene family) | protein interactions | 115827 | 13 | 1 | 19454 | 50 |
GPM6A |
3.299e-02 | -3.41 | Post-translational modification: synthesis of GPI-anchored proteins | REACTOME pathways | R-HSA-163125 | 92 | 2 | 10285 | 32 |
NTM,LSAMP |
3.347e-02 | -3.40 | plasma membrane bounded cell projection organization | biological process | GO:0120036 | 1152 | 7 | 18204 | 49 |
BMPR1B,TNIK,NRXN1,GPM6A,CTNND2,CTNNA2,PREX2 |
3.363e-02 | -3.39 | EDA (ectodysplasin A) | protein interactions | 1896 | 112 | 2 | 19454 | 50 |
GPM6A,ERBB4 |
3.363e-02 | -3.39 | ENAH (ENAH actin regulator) | protein interactions | 55740 | 112 | 2 | 19454 | 50 |
WWOX,ARHGAP24 |
3.371e-02 | -3.39 | Creatine metabolism | REACTOME pathways | R-HSA-71288 | 11 | 1 | 10285 | 32 |
CKB |
3.387e-02 | -3.39 | skin-arm-malignant_melanoma | COSMIC cancer mutations | skin-arm-malignant_melanoma | 1308 | 8 | 16828 | 49 |
PARD3B,NTM,ZBTB20,ERBB4,COL5A3,ATP1A2,NPAS3,SLC4A4 |
3.389e-02 | -3.38 | human chr18q21.33 | chromosome location | human chr18q21.33 | 18 | 1 | 26134 | 50 |
CDH20 |
3.395e-02 | -3.38 | MIP | prosite domains | PS00221 | 10 | 1 | 12186 | 42 |
AQP4 |
3.395e-02 | -3.38 | transforming growth factor beta receptor activity | molecular function | GO:0005024 | 13 | 1 | 18094 | 48 |
BMPR1B |
3.395e-02 | -3.38 | potassium ion binding | molecular function | GO:0030955 | 13 | 1 | 18094 | 48 |
ATP1A2 |
3.395e-02 | -3.38 | monoatomic cation:bicarbonate symporter activity | molecular function | GO:0140410 | 13 | 1 | 18094 | 48 |
SLC4A4 |
3.400e-02 | -3.38 | calcium ion binding | molecular function | GO:0005509 | 683 | 5 | 18094 | 48 |
SPARCL1,ITPR2,RYR3,NRXN1,PAMR1 |
3.405e-02 | -3.38 | NR3C1 (nuclear receptor subfamily 3 group C member 1) | protein interactions | 2908 | 950 | 6 | 19454 | 50 |
CTNND2,PON2,ATP13A4,ZBTB20,SLC1A3,CAMK2G |
3.418e-02 | -3.38 | GFI1B (growth factor independent 1B transcriptional repressor) | protein interactions | 8328 | 113 | 2 | 19454 | 50 |
DTNA,ZNRF3 |
3.425e-02 | -3.37 | ZDHHC17 (zinc finger DHHC-type palmitoyltransferase 17) | protein interactions | 23390 | 277 | 3 | 19454 | 50 |
NEBL,GPM6A,SLC1A3 |
3.439e-02 | -3.37 | regulation of canonical Wnt signaling pathway | biological process | GO:0060828 | 265 | 3 | 18204 | 49 |
GPC5,CTNND2,ZNRF3 |
3.440e-02 | -3.37 | central_nervous_system-fourth_ventricle-glioma-astrocytoma_Grade_I | COSMIC cancer mutations | central_nervous_system-fourth_ventricle-glioma-astrocytoma_Grade_I | 12 | 1 | 16828 | 49 |
QKI |
3.440e-02 | -3.37 | skin-abdomen-malignant_melanoma-nodular | COSMIC cancer mutations | skin-abdomen-malignant_melanoma-nodular | 12 | 1 | 16828 | 49 |
PREX2 |
3.444e-02 | -3.37 | negative regulation of cytosolic calcium ion concentration | biological process | GO:0051481 | 13 | 1 | 18204 | 49 |
ATP1A2 |
3.444e-02 | -3.37 | regulation of respiratory gaseous exchange by nervous system process | biological process | GO:0002087 | 13 | 1 | 18204 | 49 |
ATP1A2 |
3.444e-02 | -3.37 | negative regulation of amyloid fibril formation | biological process | GO:1905907 | 13 | 1 | 18204 | 49 |
CLU |
3.444e-02 | -3.37 | prepulse inhibition | biological process | GO:0060134 | 13 | 1 | 18204 | 49 |
CTNNA2 |
3.444e-02 | -3.37 | postsynaptic specialization assembly | biological process | GO:0098698 | 13 | 1 | 18204 | 49 |
NRXN1 |
3.444e-02 | -3.37 | olfactory bulb interneuron differentiation | biological process | GO:0021889 | 13 | 1 | 18204 | 49 |
ERBB4 |
3.444e-02 | -3.37 | cerebellar Purkinje cell differentiation | biological process | GO:0021702 | 13 | 1 | 18204 | 49 |
RORA |
3.444e-02 | -3.37 | T-helper 17 cell differentiation | biological process | GO:0072539 | 13 | 1 | 18204 | 49 |
RORA |
3.452e-02 | -3.37 | Circadian entrainment | KEGG pathways | hsa04713 | 96 | 2 | 7161 | 22 |
CAMK2G,RYR3 |
3.452e-02 | -3.37 | Circadian entrainment | KEGG pathways | ko04713 | 96 | 2 | 7161 | 22 |
RYR3,CAMK2G |
3.456e-02 | -3.37 | animal organ development | biological process | GO:0048513 | 2846 | 13 | 18204 | 49 |
SOX5,ERBB4,LRIG1,ATP1A2,RORA,WWOX,CKB,GPM6A,CTNNA2,BMPR1B,COL5A3,NEBL,SLC1A2 |
3.459e-02 | -3.36 | small molecule binding | molecular function | GO:0036094 | 6197 | 23 | 18094 | 48 |
SLC1A3,ZNRF3,ATP1A2,GLIS3,GLUL,NRXN1,RORA,BMPR1B,PITPNC1,SPARCL1,SLC1A2,ITPR2,DTNA,TNIK,CKB,PAMR1,RYR3,CAMK2G,ERBB4,PTGDS,ATP13A4,ZBTB20,PON2 |
3.466e-02 | -3.36 | synaptic signaling | biological process | GO:0099536 | 459 | 4 | 18204 | 49 |
NRXN1,SLC1A2,DTNA,SLC1A3 |
3.466e-02 | -3.36 | small molecule biosynthetic process | biological process | GO:0044283 | 459 | 4 | 18204 | 49 |
SLC1A3,QKI,PTGDS,GLUL |
3.481e-02 | -3.36 | long-chain fatty acid metabolic process | biological process | GO:0001676 | 109 | 2 | 18204 | 49 |
PTGDS,QKI |
3.481e-02 | -3.36 | postsynapse organization | biological process | GO:0099173 | 109 | 2 | 18204 | 49 |
NRXN1,CTNND2 |
3.481e-02 | -3.36 | positive regulation of tumor necrosis factor production | biological process | GO:0032760 | 109 | 2 | 18204 | 49 |
CLU,ZBTB20 |
3.488e-02 | -3.36 | PXMP2 (peroxisomal membrane protein 2) | protein interactions | 5827 | 279 | 3 | 19454 | 50 |
WWOX,GPM6A,ITPR2 |
3.500e-02 | -3.35 | Ion_trans_dom | interpro domains | IPR005821 | 109 | 2 | 18521 | 50 |
ITPR2,RYR3 |
3.506e-02 | -3.35 | EV release from cardiac cells and their functional effects | WikiPathways | WP3297 | 9 | 1 | 5310 | 21 |
ERBB4 |
3.518e-02 | -3.35 | Inflammatory mediator regulation of TRP channels | KEGG pathways | ko04750 | 97 | 2 | 7161 | 22 |
CAMK2G,ITPR2 |
3.518e-02 | -3.35 | Inflammatory mediator regulation of TRP channels | KEGG pathways | hsa04750 | 97 | 2 | 7161 | 22 |
ITPR2,CAMK2G |
3.520e-02 | -3.35 | TSG101 (tumor susceptibility 101) | protein interactions | 7251 | 280 | 3 | 19454 | 50 |
WWOX,QKI,GLIS3 |
3.527e-02 | -3.34 | ACTB (actin beta) | protein interactions | 60 | 958 | 6 | 19454 | 50 |
NHSL1,SFXN5,ARHGAP24,NEBL,CKB,DTNA |
3.530e-02 | -3.34 | SMAD7 (SMAD family member 7) | protein interactions | 4092 | 115 | 2 | 19454 | 50 |
SOX5,BMPR1B |
3.530e-02 | -3.34 | LYZ (lysozyme) | protein interactions | 4069 | 115 | 2 | 19454 | 50 |
CLU,WWOX |
3.532e-02 | -3.34 | chromaffin granule | cellular component | GO:0042583 | 14 | 1 | 19108 | 49 |
CLU |
3.540e-02 | -3.34 | CTSO (cathepsin O) | protein interactions | 1519 | 14 | 1 | 19454 | 50 |
CST3 |
3.540e-02 | -3.34 | Nedd4 (neural precursor cell expressed, developmentally down-regulated 4) | protein interactions | 17999 | 14 | 1 | 19454 | 50 |
GLIS3 |
3.540e-02 | -3.34 | RSPO1 (R-spondin 1) | protein interactions | 284654 | 14 | 1 | 19454 | 50 |
ZNRF3 |
3.540e-02 | -3.34 | Stag2 (STAG2 cohesin complex component) | protein interactions | 20843 | 14 | 1 | 19454 | 50 |
CLU |
3.540e-02 | -3.34 | Plekhg5 (pleckstrin homology domain containing, family G (with RhoGef domain) member 5) | protein interactions | 269608 | 14 | 1 | 19454 | 50 |
CKB |
3.540e-02 | -3.34 | SLC1A2 (solute carrier family 1 member 2) | protein interactions | 6506 | 14 | 1 | 19454 | 50 |
SLC1A2 |
3.540e-02 | -3.34 | RHEBL1 (RHEB like 1) | protein interactions | 121268 | 14 | 1 | 19454 | 50 |
BMPR1B |
3.540e-02 | -3.34 | SYT5 (synaptotagmin 5) | protein interactions | 6861 | 14 | 1 | 19454 | 50 |
NRXN1 |
3.540e-02 | -3.34 | C9 (complement C9) | protein interactions | 735 | 14 | 1 | 19454 | 50 |
CLU |
3.540e-02 | -3.34 | CHAT (choline O-acetyltransferase) | protein interactions | 1103 | 14 | 1 | 19454 | 50 |
CAMK2G |
3.540e-02 | -3.34 | Aifm1 (apoptosis-inducing factor, mitochondrion-associated 1) | protein interactions | 26926 | 14 | 1 | 19454 | 50 |
CLU |
3.540e-02 | -3.34 | TPSAB1 (tryptase alpha/beta 1) | protein interactions | 7177 | 14 | 1 | 19454 | 50 |
CAMK2G |
3.558e-02 | -3.34 | LYN (LYN proto-oncogene, Src family tyrosine kinase) | protein interactions | 4067 | 713 | 5 | 19454 | 50 |
DTNA,SLC1A3,ERBB4,MSI2,TNIK |
3.559e-02 | -3.34 | side of membrane | cellular component | GO:0098552 | 715 | 5 | 19108 | 49 |
NTM,DTNA,LSAMP,GPC5,AQP4 |
3.574e-02 | -3.33 | human chr6q24.1 | chromosome location | human chr6q24.1 | 19 | 1 | 26134 | 50 |
NHSL1 |
3.574e-02 | -3.33 | human chr11q25 | chromosome location | human chr11q25 | 19 | 1 | 26134 | 50 |
NTM |
3.574e-02 | -3.33 | human chr5p15.2 | chromosome location | human chr5p15.2 | 19 | 1 | 26134 | 50 |
CTNND2 |
3.576e-02 | -3.33 | LAMTOR1 (late endosomal/lysosomal adaptor, MAPK and MTOR activator 1) | protein interactions | 55004 | 714 | 5 | 19454 | 50 |
CKB,WWOX,DTNA,SLC1A3,TNIK |
3.586e-02 | -3.33 | RBBP8 (RB binding protein 8, endonuclease) | protein interactions | 5932 | 116 | 2 | 19454 | 50 |
CLU,CTNNA2 |
3.586e-02 | -3.33 | SKIL (SKI like proto-oncogene) | protein interactions | 6498 | 116 | 2 | 19454 | 50 |
GLUL,SPARCL1 |
3.590e-02 | -3.33 | - | gene3d domains | 3.10.450.50 | 12 | 1 | 14470 | 44 |
CAMK2G |
3.590e-02 | -3.33 | Alpha-catenin/vinculin-like | gene3d domains | 1.20.120.230 | 12 | 1 | 14470 | 44 |
CTNNA2 |
3.593e-02 | -3.33 | regulation of cell projection organization | biological process | GO:0031344 | 683 | 5 | 18204 | 49 |
GPM6A,ARHGAP24,CAMK2G,CTNNA2,TNIK |
3.603e-02 | -3.32 | stomach-adenocarcinoma | COSMIC cancer mutations | stomach-adenocarcinoma | 4101 | 18 | 16828 | 49 |
PAMR1,CDH20,ATP1A2,ATP13A4,CTNND2,PARD3B,GPC5,QKI,PON2,SLC1A2,COL5A3,ERBB4,LRIG1,ITPR2,SLC4A4,PREX2,RORA,NEBL |
3.610e-02 | -3.32 | skin-trunk-malignant_melanoma | COSMIC cancer mutations | skin-trunk-malignant_melanoma | 2647 | 13 | 16828 | 49 |
LSAMP,CDH20,ATP1A2,ATP13A4,HPSE2,CTNND2,SOX5,NEBL,SLC1A3,PREX2,RYR3,ERBB4,NRXN1 |
3.612e-02 | -3.32 | chromophobe_renal_cell_carcinoma | COSMIC cancer mutations | chromophobe_renal_cell_carcinoma | 430 | 4 | 16828 | 49 |
BMPR1B,ERBB4,CAMK2G,TNIK |
3.612e-02 | -3.32 | kidney-carcinoma-chromophobe_renal_cell_carcinoma | COSMIC cancer mutations | kidney-carcinoma-chromophobe_renal_cell_carcinoma | 430 | 4 | 16828 | 49 |
BMPR1B,ERBB4,CAMK2G,TNIK |
3.619e-02 | -3.32 | cell migration | biological process | GO:0016477 | 921 | 6 | 18204 | 49 |
GPM6A,ARHGAP24,CTNNA2,GPC5,ERBB4,CDH20 |
3.642e-02 | -3.31 | ZBTB33 (zinc finger and BTB domain containing 33) | protein interactions | 10009 | 117 | 2 | 19454 | 50 |
CTNND2,WWOX |
3.646e-02 | -3.31 | skin-scalp-malignant_melanoma | COSMIC cancer mutations | skin-scalp-malignant_melanoma | 634 | 5 | 16828 | 49 |
PREX2,CAMK2G,ERBB4,NEBL,NTM |
3.647e-02 | -3.31 | TNPO1 (transportin 1) | protein interactions | 3842 | 284 | 3 | 19454 | 50 |
WWOX,ARHGAP24,QKI |
3.647e-02 | -3.31 | Dppa3 (developmental pluripotency-associated 3) | protein interactions | 73708 | 284 | 3 | 19454 | 50 |
CAMK2G,MSI2,ATP1A2 |
3.670e-02 | -3.31 | phosphatidylinositol binding | molecular function | GO:0035091 | 276 | 3 | 18094 | 48 |
ITPR2,PITPNC1,PARD3B |
3.672e-02 | -3.30 | Defective EXT1 causes exostoses 1, TRPS2 and CHDS | REACTOME pathways | R-HSA-3656253 | 12 | 1 | 10285 | 32 |
GPC5 |
3.672e-02 | -3.30 | Defective EXT2 causes exostoses 2 | REACTOME pathways | R-HSA-3656237 | 12 | 1 | 10285 | 32 |
GPC5 |
3.680e-02 | -3.30 | P4HA1 (prolyl 4-hydroxylase subunit alpha 1) | protein interactions | 5033 | 285 | 3 | 19454 | 50 |
DTNA,WWOX,PON2 |
3.699e-02 | -3.30 | DDR1 (discoidin domain receptor tyrosine kinase 1) | protein interactions | 780 | 118 | 2 | 19454 | 50 |
CLU,WWOX |
3.702e-02 | -3.30 | arm | COSMIC cancer mutations | arm | 1331 | 8 | 16828 | 49 |
ATP1A2,SLC4A4,NPAS3,ERBB4,COL5A3,NTM,PARD3B,ZBTB20 |
3.704e-02 | -3.30 | glutathione biosynthetic process | biological process | GO:0006750 | 14 | 1 | 18204 | 49 |
SLC1A2 |
3.704e-02 | -3.30 | cerebrospinal fluid circulation | biological process | GO:0090660 | 14 | 1 | 18204 | 49 |
AQP4 |
3.704e-02 | -3.30 | relaxation of cardiac muscle | biological process | GO:0055119 | 14 | 1 | 18204 | 49 |
ATP1A2 |
3.704e-02 | -3.30 | protein localization to postsynaptic specialization membrane | biological process | GO:0099633 | 14 | 1 | 18204 | 49 |
ERBB4 |
3.704e-02 | -3.30 | neurotransmitter receptor localization to postsynaptic specialization membrane | biological process | GO:0099645 | 14 | 1 | 18204 | 49 |
ERBB4 |
3.704e-02 | -3.30 | negative regulation of sodium ion transmembrane transporter activity | biological process | GO:2000650 | 14 | 1 | 18204 | 49 |
ATP1A2 |
3.704e-02 | -3.30 | cellular response to purine-containing compound | biological process | GO:0071415 | 14 | 1 | 18204 | 49 |
RYR3 |
3.704e-02 | -3.30 | cellular response to ethanol | biological process | GO:0071361 | 14 | 1 | 18204 | 49 |
ITPR2 |
3.704e-02 | -3.30 | regulation of skeletal muscle adaptation | biological process | GO:0014733 | 14 | 1 | 18204 | 49 |
CAMK2G |
3.715e-02 | -3.29 | Neurexin-like | interpro domains | IPR003585 | 14 | 1 | 18521 | 50 |
NRXN1 |
3.715e-02 | -3.29 | Aquaporin-like | interpro domains | IPR023271 | 14 | 1 | 18521 | 50 |
AQP4 |
3.715e-02 | -3.29 | MIP | interpro domains | IPR000425 | 14 | 1 | 18521 | 50 |
AQP4 |
3.717e-02 | -3.29 | positive regulation of tumor necrosis factor superfamily cytokine production | biological process | GO:1903557 | 113 | 2 | 18204 | 49 |
CLU,ZBTB20 |
3.721e-02 | -3.29 | skin-scalp-malignant_melanoma-nodular | COSMIC cancer mutations | skin-scalp-malignant_melanoma-nodular | 13 | 1 | 16828 | 49 |
PREX2 |
3.721e-02 | -3.29 | skin-shoulder-malignant_melanoma-nodular | COSMIC cancer mutations | skin-shoulder-malignant_melanoma-nodular | 13 | 1 | 16828 | 49 |
PREX2 |
3.721e-02 | -3.29 | central_nervous_system-hypothalamus-glioma-astrocytoma_Grade_I | COSMIC cancer mutations | central_nervous_system-hypothalamus-glioma-astrocytoma_Grade_I | 13 | 1 | 16828 | 49 |
QKI |
3.728e-02 | -3.29 | NC1_FIB | prosite domains | PS51461 | 11 | 1 | 12186 | 42 |
COL5A3 |
3.728e-02 | -3.29 | LIPOCALIN | prosite domains | PS00213 | 11 | 1 | 12186 | 42 |
PTGDS |
3.729e-02 | -3.29 | soft_tissue-striated_muscle-rhabdomyosarcoma-embryonal | COSMIC cancer mutations | soft_tissue-striated_muscle-rhabdomyosarcoma-embryonal | 2659 | 13 | 16828 | 49 |
PARD3B,AQP4,PON2,CAMK2G,GLIS3,CTNND2,RORA,ZNRF3,COL5A3,RYR3,NPAS3,PREX2,SPARCL1 |
3.729e-02 | -3.29 | embryonal | COSMIC cancer mutations | embryonal | 2659 | 13 | 16828 | 49 |
CAMK2G,PON2,AQP4,PARD3B,CTNND2,GLIS3,ZNRF3,RORA,SPARCL1,PREX2,NPAS3,RYR3,COL5A3 |
3.745e-02 | -3.28 | DHFR2 (dihydrofolate reductase 2) | protein interactions | 200895 | 287 | 3 | 19454 | 50 |
WWOX,SLC1A3,ITPR2 |
3.750e-02 | -3.28 | central_nervous_system-cerebellum-glioma-astrocytoma_Grade_I | COSMIC cancer mutations | central_nervous_system-cerebellum-glioma-astrocytoma_Grade_I | 105 | 2 | 16828 | 49 |
GPC5,QKI |
3.756e-02 | -3.28 | ENTREP3 (endosomal transmembrane epsin interactor 3) | protein interactions | 10712 | 119 | 2 | 19454 | 50 |
GPM6A,WWOX |
3.759e-02 | -3.28 | human chr8p21.1 | chromosome location | human chr8p21.1 | 20 | 1 | 26134 | 50 |
CLU |
3.764e-02 | -3.28 | Ion_trans | pfam domains | PF00520 | 109 | 2 | 17795 | 50 |
RYR3,ITPR2 |
3.764e-02 | -3.28 | HCO3TRNSPORT | prints domains | PR01231 | 10 | 1 | 5227 | 20 |
SLC4A4 |
3.768e-02 | -3.28 | ATP binding | molecular function | GO:0005524 | 1467 | 8 | 18094 | 48 |
BMPR1B,GLUL,ATP1A2,ATP13A4,TNIK,CKB,ERBB4,CAMK2G |
3.777e-02 | -3.28 | regulation of circadian rhythm | biological process | GO:0042752 | 114 | 2 | 18204 | 49 |
RORA,PTGDS |
3.779e-02 | -3.28 | NEDD4 (NEDD4 E3 ubiquitin protein ligase) | protein interactions | 4734 | 494 | 4 | 19454 | 50 |
ERBB4,GLIS3,TNIK,CKB |
3.780e-02 | -3.28 | axolemma | cellular component | GO:0030673 | 15 | 1 | 19108 | 49 |
SLC1A2 |
3.788e-02 | -3.27 | ZNF813 (zinc finger protein 813) | protein interactions | 126017 | 15 | 1 | 19454 | 50 |
ARHGAP24 |
3.788e-02 | -3.27 | TESPA1 (thymocyte expressed, positive selection associated 1) | protein interactions | 9840 | 15 | 1 | 19454 | 50 |
ITPR2 |
3.788e-02 | -3.27 | XIRP1 (xin actin binding repeat containing 1) | protein interactions | 165904 | 15 | 1 | 19454 | 50 |
NEBL |
3.788e-02 | -3.27 | RNASE13 (ribonuclease A family member 13 (inactive)) | protein interactions | 440163 | 15 | 1 | 19454 | 50 |
CLU |
3.788e-02 | -3.27 | TIAM2 (TIAM Rac1 associated GEF 2) | protein interactions | 26230 | 15 | 1 | 19454 | 50 |
TNIK |
3.788e-02 | -3.27 | IGSF1 (immunoglobulin superfamily member 1) | protein interactions | 3547 | 15 | 1 | 19454 | 50 |
BMPR1B |
3.788e-02 | -3.27 | ZNF616 (zinc finger protein 616) | protein interactions | 90317 | 15 | 1 | 19454 | 50 |
ARHGAP24 |
3.788e-02 | -3.27 | ZNF714 (zinc finger protein 714) | protein interactions | 148206 | 15 | 1 | 19454 | 50 |
ARHGAP24 |
3.788e-02 | -3.27 | TAFA5 (TAFA chemokine like family member 5) | protein interactions | 25817 | 15 | 1 | 19454 | 50 |
NEBL |
3.808e-02 | -3.27 | telencephalon development | biological process | GO:0021537 | 276 | 3 | 18204 | 49 |
SLC1A2,ATP1A2,ERBB4 |
3.809e-02 | -3.27 | thyroid-carcinoma | COSMIC cancer mutations | thyroid-carcinoma | 4126 | 18 | 16828 | 49 |
ATP13A4,CTNND2,ATP1A2,GLIS3,SOX5,AQP4,LSAMP,DTNA,GPC5,SPARCL1,LRIG1,ITPR2,NRXN1,COL5A3,RYR3,ERBB4,TNIK,ZNRF3 |
3.819e-02 | -3.27 | circulatory system development | biological process | GO:0072359 | 933 | 6 | 18204 | 49 |
NEBL,ERBB4,RORA,ARHGAP24,QKI,GLUL |
3.837e-02 | -3.26 | fatty acid biosynthetic process | biological process | GO:0006633 | 115 | 2 | 18204 | 49 |
PTGDS,QKI |
3.851e-02 | -3.26 | stomach-carcinoma | COSMIC cancer mutations | stomach-carcinoma | 439 | 4 | 16828 | 49 |
BMPR1B,ERBB4,CAMK2G,TNIK |
3.857e-02 | -3.26 | Glucagon signaling pathway | KEGG pathways | ko04922 | 102 | 2 | 7161 | 22 |
ITPR2,CAMK2G |
3.857e-02 | -3.26 | Glucagon signaling pathway | KEGG pathways | hsa04922 | 102 | 2 | 7161 | 22 |
CAMK2G,ITPR2 |
3.864e-02 | -3.25 | MIP | pfam domains | PF00230 | 14 | 1 | 17795 | 50 |
AQP4 |
3.880e-02 | -3.25 | skin-scalp-carcinoma-squamous_cell_carcinoma | COSMIC cancer mutations | skin-scalp-carcinoma-squamous_cell_carcinoma | 1596 | 9 | 16828 | 49 |
RORA,GPC5,LSAMP,ATP1A2,SLC4A4,ATP13A4,COL5A3,SOX5,NRXN1 |
3.881e-02 | -3.25 | bone-humerus-Ewings_sarcoma-peripheral_primitive_neuroectodermal_tumour | COSMIC cancer mutations | bone-humerus-Ewings_sarcoma-peripheral_primitive_neuroectodermal_tumour | 107 | 2 | 16828 | 49 |
NEBL,PARD3B |
3.908e-02 | -3.24 | filamin binding | molecular function | GO:0031005 | 15 | 1 | 18094 | 48 |
NEBL |
3.908e-02 | -3.24 | phosphatidylglycerol binding | molecular function | GO:1901611 | 15 | 1 | 18094 | 48 |
PITPNC1 |
3.908e-02 | -3.24 | tropomyosin binding | molecular function | GO:0005523 | 15 | 1 | 18094 | 48 |
NEBL |
3.919e-02 | -3.24 | homeostatic process | biological process | GO:0042592 | 1456 | 8 | 18204 | 49 |
ATP1A2,RORA,SLC4A4,ATP13A4,ZBTB20,SLC1A3,AQP4,RYR3 |
3.930e-02 | -3.24 | BRK1 (BRICK1 subunit of SCAR/WAVE actin nucleating complex) | protein interactions | 55845 | 122 | 2 | 19454 | 50 |
DTNA,NHSL1 |
3.930e-02 | -3.24 | HK2 (hexokinase 2) | protein interactions | 3099 | 122 | 2 | 19454 | 50 |
WWOX,PTGDS |
3.930e-02 | -3.24 | SLMAP (sarcolemma associated protein) | protein interactions | 7871 | 122 | 2 | 19454 | 50 |
TNIK,CAMK2G |
3.943e-02 | -3.23 | human chr13q31.3 | chromosome location | human chr13q31.3 | 21 | 1 | 26134 | 50 |
GPC5 |
3.947e-02 | -3.23 | testis-germ_cell_tumour-seminoma | COSMIC cancer mutations | testis-germ_cell_tumour-seminoma | 648 | 5 | 16828 | 49 |
CAMK2G,TNIK,PREX2,BMPR1B,ERBB4 |
3.948e-02 | -3.23 | bone-Ewings_sarcoma-peripheral_primitive_neuroectodermal_tumour | COSMIC cancer mutations | bone-Ewings_sarcoma-peripheral_primitive_neuroectodermal_tumour | 6023 | 24 | 16828 | 49 |
DTNA,PON2,CAMK2G,SLC1A3,NEBL,ERBB4,COL5A3,ITPR2,PREX2,NKAIN3,NPAS3,ZBTB20,SOX5,PAMR1,GLIS3,ATP1A2,CTNND2,ATP13A4,CST3,RORA,RYR3,LRIG1,SLC4A4,SPARCL1 |
3.959e-02 | -3.23 | NAD+ Signalling and Aging | SMPDB pathways | SMP0084271 | 11 | 1 | 1369 | 5 |
RORA |
3.963e-02 | -3.23 | lung-carcinoma-squamous_cell_carcinoma | COSMIC cancer mutations | lung-carcinoma-squamous_cell_carcinoma | 14664 | 47 | 16828 | 49 |
SPARCL1,TNIK,RORA,GPM6A,GLIS3,ATP1A2,CTNND2,ATP13A4,NHSL1,ZBTB20,NKAIN3,PREX2,SLC1A2,COL5A3,NRXN1,PITPNC1,GLUL,CDH20,FBXL7,DTNA,AQP4,LSAMP,SLC4A4,RYR3,LRIG1,SFXN5,HPSE2,WWOX,SOX5,BMPR1B,PAMR1,GPC5,QKI,NTM,NPAS3,ERBB4,MSI2,ITPR2,ZNRF3,ARHGAP24,SLC1A3,NEBL,CLU,PON2,CAMK2G,PTGDS,PARD3B |
3.964e-02 | -3.23 | system process | biological process | GO:0003008 | 2015 | 10 | 18204 | 49 |
AQP4,RYR3,DTNA,CTNNA2,SLC1A3,SLC4A4,ATP1A2,NRXN1,LRIG1,SLC1A2 |
3.964e-02 | -3.23 | intracellular potassium ion homeostasis | biological process | GO:0030007 | 15 | 1 | 18204 | 49 |
ATP1A2 |
3.964e-02 | -3.23 | negative regulation of sodium ion transmembrane transport | biological process | GO:1902306 | 15 | 1 | 18204 | 49 |
ATP1A2 |
3.964e-02 | -3.23 | sarcoplasmic reticulum calcium ion transport | biological process | GO:0070296 | 15 | 1 | 18204 | 49 |
RYR3 |
3.964e-02 | -3.23 | cerebellar Purkinje cell layer formation | biological process | GO:0021694 | 15 | 1 | 18204 | 49 |
RORA |
3.964e-02 | -3.23 | regulation of circadian sleep/wake cycle, sleep | biological process | GO:0045187 | 15 | 1 | 18204 | 49 |
PTGDS |
3.964e-02 | -3.23 | protein homotrimerization | biological process | GO:0070207 | 15 | 1 | 18204 | 49 |
SLC1A2 |
3.964e-02 | -3.23 | neuroblast division | biological process | GO:0055057 | 15 | 1 | 18204 | 49 |
SOX5 |
3.964e-02 | -3.23 | response to caffeine | biological process | GO:0031000 | 15 | 1 | 18204 | 49 |
RYR3 |
3.967e-02 | -3.23 | skin-head_neck-carcinoma-squamous_cell_carcinoma | COSMIC cancer mutations | skin-head_neck-carcinoma-squamous_cell_carcinoma | 14191 | 46 | 16828 | 49 |
FBXL7,CDH20,LSAMP,AQP4,DTNA,NRXN1,SLC1A2,COL5A3,NKAIN3,PREX2,GLUL,PITPNC1,NHSL1,ATP13A4,CTNND2,ATP1A2,GLIS3,ZBTB20,SPARCL1,GPM6A,RORA,TNIK,PARD3B,CKB,CAMK2G,PON2,CLU,ITPR2,ERBB4,NPAS3,NEBL,SLC1A3,ARHGAP24,ZNRF3,BMPR1B,PAMR1,SOX5,WWOX,HPSE2,SFXN5,NTM,GPC5,QKI,LRIG1,RYR3,SLC4A4 |
3.972e-02 | -3.23 | Passive transport by Aquaporins | REACTOME pathways | R-HSA-432047 | 13 | 1 | 10285 | 32 |
AQP4 |
3.972e-02 | -3.23 | ERBB2 Activates PTK6 Signaling | REACTOME pathways | R-HSA-8847993 | 13 | 1 | 10285 | 32 |
ERBB4 |
3.972e-02 | -3.23 | Activation of the TFAP2 (AP-2) family of transcription factors | REACTOME pathways | R-HSA-8866907 | 13 | 1 | 10285 | 32 |
WWOX |
3.972e-02 | -3.23 | CLEC7A (Dectin-1) induces NFAT activation | REACTOME pathways | R-HSA-5607763 | 13 | 1 | 10285 | 32 |
ITPR2 |
3.975e-02 | -3.23 | NTF2-like_dom_sf | interpro domains | IPR032710 | 15 | 1 | 18521 | 50 |
CAMK2G |
3.975e-02 | -3.23 | CNH_dom | interpro domains | IPR001180 | 15 | 1 | 18521 | 50 |
TNIK |
3.975e-02 | -3.23 | ATPase_P-typ_cation-transptr_C | interpro domains | IPR006068 | 15 | 1 | 18521 | 50 |
ATP1A2 |
4.003e-02 | -3.22 | COLFI | smart domains | SM00038 | 11 | 1 | 9717 | 36 |
COL5A3 |
4.008e-02 | -3.22 | PROTEIN_KINASE_ATP | prosite domains | PS00107 | 377 | 4 | 12186 | 42 |
ERBB4,CAMK2G,BMPR1B,TNIK |
4.015e-02 | -3.22 | rhabdomyosarcoma | COSMIC cancer mutations | rhabdomyosarcoma | 4150 | 18 | 16828 | 49 |
SLC1A3,RORA,ZNRF3,RYR3,COL5A3,PREX2,NPAS3,SPARCL1,AQP4,PARD3B,PON2,CLU,CAMK2G,NHSL1,PAMR1,GLIS3,CDH20,CTNND2 |
4.023e-02 | -3.21 | Prot_kinase_dom | interpro domains | IPR000719 | 480 | 4 | 18521 | 50 |
TNIK,ERBB4,CAMK2G,BMPR1B |
4.027e-02 | -3.21 | postsynaptic density, intracellular component | cellular component | GO:0099092 | 16 | 1 | 19108 | 49 |
TNIK |
4.033e-02 | -3.21 | trunk | COSMIC cancer mutations | trunk | 3554 | 16 | 16828 | 49 |
NEBL,SLC1A3,SPARCL1,NPAS3,PREX2,NRXN1,RYR3,ERBB4,LSAMP,ATP13A4,CTNND2,HPSE2,CDH20,ATP1A2,GLIS3,SOX5 |
4.035e-02 | -3.21 | SAPCD1 (suppressor APC domain containing 1) | protein interactions | 401251 | 16 | 1 | 19454 | 50 |
CTNNA2 |
4.035e-02 | -3.21 | DUS1L (dihydrouridine synthase 1 like) | protein interactions | 64118 | 16 | 1 | 19454 | 50 |
CAMK2G |
4.035e-02 | -3.21 | TWIST2 (twist family bHLH transcription factor 2) | protein interactions | 117581 | 16 | 1 | 19454 | 50 |
ZBTB20 |
4.035e-02 | -3.21 | SYTL2 (synaptotagmin like 2) | protein interactions | 54843 | 16 | 1 | 19454 | 50 |
NRXN1 |
4.035e-02 | -3.21 | FNDC8 (fibronectin type III domain containing 8) | protein interactions | 54752 | 16 | 1 | 19454 | 50 |
SPARCL1 |
4.035e-02 | -3.21 | SYT9 (synaptotagmin 9) | protein interactions | 143425 | 16 | 1 | 19454 | 50 |
NRXN1 |
4.035e-02 | -3.21 | TMEM134 (transmembrane protein 134) | protein interactions | 80194 | 16 | 1 | 19454 | 50 |
ERBB4 |
4.035e-02 | -3.21 | FZD4 (frizzled class receptor 4) | protein interactions | 8322 | 16 | 1 | 19454 | 50 |
ZNRF3 |
4.035e-02 | -3.21 | GALNT13 (polypeptide N-acetylgalactosaminyltransferase 13) | protein interactions | 114805 | 16 | 1 | 19454 | 50 |
TNIK |
4.035e-02 | -3.21 | CAMK1G (calcium/calmodulin dependent protein kinase IG) | protein interactions | 57172 | 16 | 1 | 19454 | 50 |
CAMK2G |
4.035e-02 | -3.21 | NBL1 (NBL1, DAN family BMP antagonist) | protein interactions | 4681 | 16 | 1 | 19454 | 50 |
LRIG1 |
4.035e-02 | -3.21 | SYT4 (synaptotagmin 4) | protein interactions | 6860 | 16 | 1 | 19454 | 50 |
NRXN1 |
4.035e-02 | -3.21 | TMEM92 (transmembrane protein 92) | protein interactions | 162461 | 16 | 1 | 19454 | 50 |
WWOX |
4.035e-02 | -3.21 | GMPR2 (guanosine monophosphate reductase 2) | protein interactions | 51292 | 16 | 1 | 19454 | 50 |
ARHGAP24 |
4.035e-02 | -3.21 | CDH12 (cadherin 12) | protein interactions | 1010 | 16 | 1 | 19454 | 50 |
CTNNA2 |
4.035e-02 | -3.21 | Sumo3 (small ubiquitin-like modifier 3) | protein interactions | 20610 | 16 | 1 | 19454 | 50 |
ITPR2 |
4.043e-02 | -3.21 | cell projection organization | biological process | GO:0030030 | 1200 | 7 | 18204 | 49 |
TNIK,PREX2,CTNNA2,NRXN1,GPM6A,CTNND2,BMPR1B |
4.053e-02 | -3.21 | superficial_spreading | COSMIC cancer mutations | superficial_spreading | 1110 | 7 | 16828 | 49 |
COL5A3,ERBB4,NTM,SLC4A4,PREX2,ATP13A4,CTNND2 |
4.065e-02 | -3.20 | membrane protein complex | cellular component | GO:0098796 | 1261 | 7 | 19108 | 49 |
CTNNA2,SLC1A2,ATP1A2,SLC1A3,CDH20,RYR3,BMPR1B |
4.079e-02 | -3.20 | H2BC9 (H2B clustered histone 9) | protein interactions | 8345 | 297 | 3 | 19454 | 50 |
ARHGAP24,HPSE2,PREX2 |
4.082e-02 | -3.20 | metal ion binding | molecular function | GO:0046872 | 4239 | 17 | 18094 | 48 |
GLUL,NRXN1,ATP13A4,ZBTB20,PON2,RORA,BMPR1B,GLIS3,ATP1A2,PAMR1,ZNRF3,RYR3,SLC1A3,DTNA,SPARCL1,SLC1A2,ITPR2 |
4.083e-02 | -3.20 | soft_tissue-striated_muscle-rhabdomyosarcoma-alveolar | COSMIC cancer mutations | soft_tissue-striated_muscle-rhabdomyosarcoma-alveolar | 2414 | 12 | 16828 | 49 |
SLC1A3,PARD3B,ZNRF3,CLU,PON2,RYR3,PAMR1,NHSL1,NPAS3,CDH20,PREX2,SPARCL1 |
4.083e-02 | -3.20 | alveolar | COSMIC cancer mutations | alveolar | 2414 | 12 | 16828 | 49 |
SLC1A3,ZNRF3,RYR3,SPARCL1,NPAS3,PREX2,PARD3B,CLU,PON2,PAMR1,NHSL1,CDH20 |
4.106e-02 | -3.19 | SOCS6 (suppressor of cytokine signaling 6) | protein interactions | 9306 | 125 | 2 | 19454 | 50 |
BMPR1B,ERBB4 |
4.106e-02 | -3.19 | TCHP (trichoplein keratin filament binding) | protein interactions | 84260 | 125 | 2 | 19454 | 50 |
WWOX,GLUL |
4.116e-02 | -3.19 | regulation of localization | biological process | GO:0032879 | 2028 | 10 | 18204 | 49 |
SLC1A2,ERBB4,ATP1A2,NKAIN3,CLU,GPC5,ITPR2,CAMK2G,GLUL,RYR3 |
4.117e-02 | -3.19 | secondary active transmembrane transporter activity | molecular function | GO:0015291 | 289 | 3 | 18094 | 48 |
SLC1A2,SLC4A4,SLC1A3 |
4.118e-02 | -3.19 | skin-extremity-malignant_melanoma | COSMIC cancer mutations | skin-extremity-malignant_melanoma | 1875 | 10 | 16828 | 49 |
HPSE2,FBXL7,ATP13A4,PREX2,CDH20,ERBB4,RYR3,COL5A3,PITPNC1,NEBL |
4.131e-02 | -3.19 | extremity | COSMIC cancer mutations | extremity | 1876 | 10 | 16828 | 49 |
PITPNC1,NEBL,ERBB4,COL5A3,RYR3,PREX2,CDH20,FBXL7,HPSE2,ATP13A4 |
4.134e-02 | -3.19 | CNH | pfam domains | PF00780 | 15 | 1 | 17795 | 50 |
TNIK |
4.134e-02 | -3.19 | Cation_ATPase_C | pfam domains | PF00689 | 15 | 1 | 17795 | 50 |
ATP1A2 |
4.163e-02 | -3.18 | misfolded protein binding | molecular function | GO:0051787 | 16 | 1 | 18094 | 48 |
CLU |
4.163e-02 | -3.18 | water channel activity | molecular function | GO:0015250 | 16 | 1 | 18094 | 48 |
AQP4 |
4.163e-02 | -3.18 | oxysterol binding | molecular function | GO:0008142 | 16 | 1 | 18094 | 48 |
RORA |
4.166e-02 | -3.18 | SYP (synaptophysin) | protein interactions | 6855 | 126 | 2 | 19454 | 50 |
PITPNC1,GPM6A |
4.166e-02 | -3.18 | RNF115 (ring finger protein 115) | protein interactions | 27246 | 126 | 2 | 19454 | 50 |
CST3,GLUL |
4.176e-02 | -3.18 | Glycerol uptake facilitator protein | gene3d domains | 1.20.1080.10 | 14 | 1 | 14470 | 44 |
AQP4 |
4.223e-02 | -3.16 | regulation of Wnt signaling pathway, planar cell polarity pathway | biological process | GO:2000095 | 16 | 1 | 18204 | 49 |
ZNRF3 |
4.223e-02 | -3.16 | locomotory exploration behavior | biological process | GO:0035641 | 16 | 1 | 18204 | 49 |
ATP1A2 |
4.223e-02 | -3.16 | asymmetric cell division | biological process | GO:0008356 | 16 | 1 | 18204 | 49 |
SOX5 |
4.223e-02 | -3.16 | nonribosomal peptide biosynthetic process | biological process | GO:0019184 | 16 | 1 | 18204 | 49 |
SLC1A2 |
4.223e-02 | -3.16 | glutamine family amino acid biosynthetic process | biological process | GO:0009084 | 16 | 1 | 18204 | 49 |
GLUL |
4.223e-02 | -3.16 | regulation of respiratory system process | biological process | GO:0044065 | 16 | 1 | 18204 | 49 |
ATP1A2 |
4.223e-02 | -3.16 | non-proteinogenic amino acid biosynthetic process | biological process | GO:0170043 | 16 | 1 | 18204 | 49 |
SLC1A3 |
4.223e-02 | -3.16 | neuron cell-cell adhesion | biological process | GO:0007158 | 16 | 1 | 18204 | 49 |
NRXN1 |
4.223e-02 | -3.16 | regulation of amino acid transmembrane transport | biological process | GO:1903789 | 16 | 1 | 18204 | 49 |
ATP1A2 |
4.223e-02 | -3.16 | regulation of amino acid import across plasma membrane | biological process | GO:0010958 | 16 | 1 | 18204 | 49 |
ATP1A2 |
4.223e-02 | -3.16 | wound healing, spreading of epidermal cells | biological process | GO:0035313 | 16 | 1 | 18204 | 49 |
ARHGAP24 |
4.223e-02 | -3.16 | large_intestine-adenoma | COSMIC cancer mutations | large_intestine-adenoma | 266 | 3 | 16828 | 49 |
CDH20,SOX5,RYR3 |
4.271e-02 | -3.15 | muscle cell differentiation | biological process | GO:0042692 | 289 | 3 | 18204 | 49 |
NEBL,QKI,RORA |
4.271e-02 | -3.15 | SHC1 events in ERBB4 signaling | REACTOME pathways | R-HSA-1250347 | 14 | 1 | 10285 | 32 |
ERBB4 |
4.273e-02 | -3.15 | apical dendrite | cellular component | GO:0097440 | 17 | 1 | 19108 | 49 |
CLU |
4.274e-02 | -3.15 | adenoid_cystic_carcinoma | COSMIC cancer mutations | adenoid_cystic_carcinoma | 1123 | 7 | 16828 | 49 |
RORA,CKB,CAMK2G,TNIK,RYR3,ERBB4,CTNND2 |
4.282e-02 | -3.15 | hypothalamus | COSMIC cancer mutations | hypothalamus | 15 | 1 | 16828 | 49 |
QKI |
4.282e-02 | -3.15 | SHD (Src homology 2 domain containing transforming protein D) | protein interactions | 56961 | 17 | 1 | 19454 | 50 |
ERBB4 |
4.282e-02 | -3.15 | ZNF557 (zinc finger protein 557) | protein interactions | 79230 | 17 | 1 | 19454 | 50 |
ARHGAP24 |
4.282e-02 | -3.15 | RASL12 (RAS like family 12) | protein interactions | 51285 | 17 | 1 | 19454 | 50 |
BMPR1B |
4.282e-02 | -3.15 | Shcbp1 (Shc SH2-domain binding protein 1) | protein interactions | 20419 | 17 | 1 | 19454 | 50 |
GPC5 |
4.282e-02 | -3.15 | FAM163B (family with sequence similarity 163 member B) | protein interactions | 642968 | 17 | 1 | 19454 | 50 |
CAMK2G |
4.282e-02 | -3.15 | Sqstm1 (sequestosome 1) | protein interactions | 18412 | 17 | 1 | 19454 | 50 |
BMPR1B |
4.282e-02 | -3.15 | MSANTD2 (Myb/SANT DNA binding domain containing 2) | protein interactions | 79684 | 17 | 1 | 19454 | 50 |
SOX5 |
4.282e-02 | -3.15 | KRTAP19-3 (keratin associated protein 19-3) | protein interactions | 337970 | 17 | 1 | 19454 | 50 |
CAMK2G |
4.282e-02 | -3.15 | Pef1 (penta-EF hand domain containing 1) | protein interactions | 67898 | 17 | 1 | 19454 | 50 |
QKI |
4.282e-02 | -3.15 | DPP6 (dipeptidyl peptidase like 6) | protein interactions | 1804 | 17 | 1 | 19454 | 50 |
GPM6A |
4.282e-02 | -3.15 | TAGAP (T cell activation RhoGTPase activating protein) | protein interactions | 117289 | 17 | 1 | 19454 | 50 |
DTNA |
4.282e-02 | -3.15 | PAX4 (paired box 4) | protein interactions | 5078 | 17 | 1 | 19454 | 50 |
NTM |
4.286e-02 | -3.15 | PPIB (peptidylprolyl isomerase B) | protein interactions | 5479 | 303 | 3 | 19454 | 50 |
ARHGAP24,CKB,WWOX |
4.311e-02 | -3.14 | human chr2q34 | chromosome location | human chr2q34 | 23 | 1 | 26134 | 50 |
ERBB4 |
4.313e-02 | -3.14 | Lactose Intolerance | SMPDB pathways | SMP0000458 | 12 | 1 | 1369 | 5 |
ATP1A2 |
4.313e-02 | -3.14 | Lactose Degradation | SMPDB pathways | SMP0000457 | 12 | 1 | 1369 | 5 |
ATP1A2 |
4.329e-02 | -3.14 | ovary-carcinoma-mucinous_carcinoma | COSMIC cancer mutations | ovary-carcinoma-mucinous_carcinoma | 456 | 4 | 16828 | 49 |
ERBB4,BMPR1B,TNIK,CAMK2G |
4.334e-02 | -3.14 | ovary-carcinoma-clear_cell_carcinoma | COSMIC cancer mutations | ovary-carcinoma-clear_cell_carcinoma | 665 | 5 | 16828 | 49 |
ERBB4,BMPR1B,TNIK,SPARCL1,CAMK2G |
4.346e-02 | -3.14 | CHD7 (chromodomain helicase DNA binding protein 7) | protein interactions | 55636 | 129 | 2 | 19454 | 50 |
SOX5,ZBTB20 |
4.346e-02 | -3.14 | Lima1 (LIM domain and actin binding 1) | protein interactions | 65970 | 129 | 2 | 19454 | 50 |
ZBTB20,ITPR2 |
4.350e-02 | -3.13 | cellular response to growth factor stimulus | biological process | GO:0071363 | 494 | 4 | 18204 | 49 |
BMPR1B,SOX5,ERBB4,WWOX |
4.352e-02 | -3.13 | skin-chest-malignant_melanoma | COSMIC cancer mutations | skin-chest-malignant_melanoma | 114 | 2 | 16828 | 49 |
ERBB4,PREX2 |
4.356e-02 | -3.13 | ATAD3A (ATPase family AAA domain containing 3A) | protein interactions | 55210 | 305 | 3 | 19454 | 50 |
ARHGAP24,WWOX,SOX5 |
4.362e-02 | -3.13 | bone-extraskeletal-Ewings_sarcoma-peripheral_primitive_neuroectodermal_tumour | COSMIC cancer mutations | bone-extraskeletal-Ewings_sarcoma-peripheral_primitive_neuroectodermal_tumour | 891 | 6 | 16828 | 49 |
ITPR2,LRIG1,PTGDS,SPARCL1,NPAS3,ATP1A2 |
4.366e-02 | -3.13 | channel activity | molecular function | GO:0015267 | 502 | 4 | 18094 | 48 |
GPM6A,RYR3,AQP4,ITPR2 |
4.388e-02 | -3.13 | mucinous_carcinoma | COSMIC cancer mutations | mucinous_carcinoma | 458 | 4 | 16828 | 49 |
CAMK2G,TNIK,BMPR1B,ERBB4 |
4.388e-02 | -3.13 | Z disc | cellular component | GO:0030018 | 130 | 2 | 19108 | 49 |
RYR3,NEBL |
4.392e-02 | -3.13 | passive transmembrane transporter activity | molecular function | GO:0022803 | 503 | 4 | 18094 | 48 |
GPM6A,ITPR2,AQP4,RYR3 |
4.407e-02 | -3.12 | RSPH1 (radial spoke head component 1) | protein interactions | 89765 | 130 | 2 | 19454 | 50 |
GLUL,CLU |
4.407e-02 | -3.12 | DVL1 (dishevelled segment polarity protein 1) | protein interactions | 1855 | 130 | 2 | 19454 | 50 |
WWOX,ZNRF3 |
4.419e-02 | -3.12 | CDH1 (cadherin 1) | protein interactions | 999 | 757 | 5 | 19454 | 50 |
CTNNA2,WWOX,NHSL1,CTNND2,NEBL |
4.428e-02 | -3.12 | clear_cell_carcinoma | COSMIC cancer mutations | clear_cell_carcinoma | 669 | 5 | 16828 | 49 |
SPARCL1,CAMK2G,TNIK,BMPR1B,ERBB4 |
4.481e-02 | -3.11 | protein trimerization | biological process | GO:0070206 | 17 | 1 | 18204 | 49 |
SLC1A2 |
4.481e-02 | -3.11 | cGMP metabolic process | biological process | GO:0046068 | 17 | 1 | 18204 | 49 |
RORA |
4.481e-02 | -3.11 | reverse cholesterol transport | biological process | GO:0043691 | 17 | 1 | 18204 | 49 |
CLU |
4.481e-02 | -3.11 | cell migration in hindbrain | biological process | GO:0021535 | 17 | 1 | 18204 | 49 |
CTNNA2 |
4.481e-02 | -3.11 | T-helper 17 type immune response | biological process | GO:0072538 | 17 | 1 | 18204 | 49 |
RORA |
4.481e-02 | -3.11 | regulation of inclusion body assembly | biological process | GO:0090083 | 17 | 1 | 18204 | 49 |
CLU |
4.481e-02 | -3.11 | membrane depolarization during cardiac muscle cell action potential | biological process | GO:0086012 | 17 | 1 | 18204 | 49 |
ATP1A2 |
4.481e-02 | -3.11 | mammary gland epithelial cell differentiation | biological process | GO:0060644 | 17 | 1 | 18204 | 49 |
ERBB4 |
4.481e-02 | -3.11 | cell communication by electrical coupling involved in cardiac conduction | biological process | GO:0086064 | 17 | 1 | 18204 | 49 |
ATP1A2 |
4.481e-02 | -3.11 | microvillus assembly | biological process | GO:0030033 | 17 | 1 | 18204 | 49 |
TNIK |
4.481e-02 | -3.11 | regulation of amyloid fibril formation | biological process | GO:1905906 | 17 | 1 | 18204 | 49 |
CLU |
4.481e-02 | -3.11 | cellular response to ATP | biological process | GO:0071318 | 17 | 1 | 18204 | 49 |
RYR3 |
4.493e-02 | -3.10 | Cystatin_dom | interpro domains | IPR000010 | 17 | 1 | 18521 | 50 |
CST3 |
4.507e-02 | -3.10 | ductal_carcinoma | COSMIC cancer mutations | ductal_carcinoma | 15798 | 49 | 16828 | 49 |
CKB,PARD3B,PON2,CLU,PTGDS,CAMK2G,NEBL,SLC1A3,ZNRF3,ARHGAP24,MSI2,ERBB4,ITPR2,NPAS3,NTM,QKI,GPC5,SOX5,WWOX,PAMR1,BMPR1B,SFXN5,HPSE2,CST3,RYR3,LRIG1,SLC4A4,AQP4,LSAMP,DTNA,CDH20,FBXL7,PITPNC1,GLUL,COL5A3,SLC1A2,NRXN1,NKAIN3,PREX2,ZBTB20,NHSL1,GLIS3,ATP1A2,ATP13A4,CTNND2,RORA,GPM6A,TNIK,SPARCL1 |
4.525e-02 | -3.10 | kinase activity | molecular function | GO:0016301 | 739 | 5 | 18094 | 48 |
BMPR1B,ERBB4,CAMK2G,TNIK,CKB |
4.529e-02 | -3.09 | AK9 (adenylate kinase 9) | protein interactions | 221264 | 18 | 1 | 19454 | 50 |
ARHGAP24 |
4.529e-02 | -3.09 | KLHL1 (kelch like family member 1) | protein interactions | 57626 | 18 | 1 | 19454 | 50 |
BMPR1B |
4.529e-02 | -3.09 | CYP2E1 (cytochrome P450 family 2 subfamily E member 1) | protein interactions | 1571 | 18 | 1 | 19454 | 50 |
CLU |
4.529e-02 | -3.09 | NKIRAS1 (NFKB inhibitor interacting Ras like 1) | protein interactions | 28512 | 18 | 1 | 19454 | 50 |
BMPR1B |
4.529e-02 | -3.09 | ACAP1 (ArfGAP with coiled-coil, ankyrin repeat and PH domains 1) | protein interactions | 9744 | 18 | 1 | 19454 | 50 |
NEBL |
4.529e-02 | -3.09 | Tgfbr1 (transforming growth factor, beta receptor I) | protein interactions | 21812 | 18 | 1 | 19454 | 50 |
BMPR1B |
4.529e-02 | -3.09 | ZNF100 (zinc finger protein 100) | protein interactions | 163227 | 18 | 1 | 19454 | 50 |
ARHGAP24 |
4.529e-02 | -3.09 | OPCML (opioid binding protein/cell adhesion molecule like) | protein interactions | 4978 | 18 | 1 | 19454 | 50 |
NTM |
4.529e-02 | -3.09 | PTGFR (prostaglandin F receptor) | protein interactions | 5737 | 18 | 1 | 19454 | 50 |
PTGDS |
4.530e-02 | -3.09 | STRN (striatin) | protein interactions | 6801 | 132 | 2 | 19454 | 50 |
CAMK2G,TNIK |
4.530e-02 | -3.09 | DDR2 (discoidin domain receptor tyrosine kinase 2) | protein interactions | 4921 | 132 | 2 | 19454 | 50 |
CLU,CKB |
4.534e-02 | -3.09 | VEGFR2 mediated cell proliferation | REACTOME pathways | R-HSA-5218921 | 258 | 3 | 10285 | 32 |
ERBB4,CAMK2G,ITPR2 |
4.547e-02 | -3.09 | phosphorylation | biological process | GO:0016310 | 729 | 5 | 18204 | 49 |
CKB,CAMK2G,BMPR1B,ERBB4,TNIK |
4.557e-02 | -3.09 | salivary_gland | COSMIC cancer mutations | salivary_gland | 1139 | 7 | 16828 | 49 |
RYR3,ERBB4,CTNND2,RORA,CKB,TNIK,CAMK2G |
4.563e-02 | -3.09 | upper_aerodigestive_tract-mouth-carcinoma | COSMIC cancer mutations | upper_aerodigestive_tract-mouth-carcinoma | 6426 | 25 | 16828 | 49 |
CDH20,FBXL7,PARD3B,CLU,ERBB4,COL5A3,SLC1A2,PREX2,NPAS3,SLC1A3,PITPNC1,SOX5,NHSL1,PAMR1,SFXN5,CTNND2,HPSE2,ZBTB20,GPC5,QKI,NTM,RYR3,SLC4A4,RORA,GPM6A |
4.565e-02 | -3.09 | ovary-carcinoma-endometrioid_carcinoma | COSMIC cancer mutations | ovary-carcinoma-endometrioid_carcinoma | 464 | 4 | 16828 | 49 |
BMPR1B,ERBB4,CAMK2G,TNIK |
4.569e-02 | -3.09 | carboxylic acid transport | biological process | GO:0046942 | 297 | 3 | 18204 | 49 |
SFXN5,SLC1A2,SLC1A3 |
4.569e-02 | -3.09 | muscle system process | biological process | GO:0003012 | 297 | 3 | 18204 | 49 |
RYR3,DTNA,ATP1A2 |
4.569e-02 | -3.09 | Cholinergic synapse | KEGG pathways | hsa04725 | 112 | 2 | 7161 | 22 |
ITPR2,CAMK2G |
4.570e-02 | -3.09 | ERBB2 Regulates Cell Motility | REACTOME pathways | R-HSA-6785631 | 15 | 1 | 10285 | 32 |
ERBB4 |
4.570e-02 | -3.09 | Synthesis of Prostaglandins (PG) and Thromboxanes (TX) | REACTOME pathways | R-HSA-2162123 | 15 | 1 | 10285 | 32 |
PTGDS |
4.606e-02 | -3.08 | extraskeletal | COSMIC cancer mutations | extraskeletal | 903 | 6 | 16828 | 49 |
ITPR2,LRIG1,PTGDS,SPARCL1,NPAS3,ATP1A2 |
4.607e-02 | -3.08 | organic acid transport | biological process | GO:0015849 | 298 | 3 | 18204 | 49 |
SFXN5,SLC1A2,SLC1A3 |
4.613e-02 | -3.08 | PDZ | pfam domains | PF00595 | 122 | 2 | 17795 | 50 |
PARD3B,PREX2 |
4.621e-02 | -3.07 | adenyl ribonucleotide binding | molecular function | GO:0032559 | 1528 | 8 | 18094 | 48 |
BMPR1B,ATP13A4,CKB,TNIK,ATP1A2,GLUL,ERBB4,CAMK2G |
4.629e-02 | -3.07 | Circadian rythm related genes | WikiPathways | WP3594 | 207 | 3 | 5310 | 21 |
PTGDS,CST3,RORA |
4.649e-02 | -3.07 | MFAP5-mediated ovarian cancer cell motility and invasiveness | WikiPathways | WP3301 | 12 | 1 | 5310 | 21 |
RYR3 |
4.649e-02 | -3.07 | Bone Morphogenic Protein (BMP) Signalling and Regulation | WikiPathways | WP1425 | 12 | 1 | 5310 | 21 |
BMPR1B |
4.652e-02 | -3.07 | cellular response to organonitrogen compound | biological process | GO:0071417 | 505 | 4 | 18204 | 49 |
ITPR2,SLC1A3,RYR3,SLC1A2 |
4.653e-02 | -3.07 | NUFIP1 (nuclear FMR1 interacting protein 1) | protein interactions | 26747 | 134 | 2 | 19454 | 50 |
NTM,GPM6A |
4.655e-02 | -3.07 | myelination | biological process | GO:0042552 | 128 | 2 | 18204 | 49 |
CLU,QKI |
4.662e-02 | -3.07 | ENO1 (enolase 1) | protein interactions | 2023 | 529 | 4 | 19454 | 50 |
CKB,WWOX,ARHGAP24,GLIS3 |
4.665e-02 | -3.07 | Trehalose Degradation | SMPDB pathways | SMP0000467 | 13 | 1 | 1369 | 5 |
ATP1A2 |
4.671e-02 | -3.06 | GABA receptor binding | molecular function | GO:0050811 | 18 | 1 | 18094 | 48 |
ERBB4 |
4.671e-02 | -3.06 | phosphatidylcholine transporter activity | molecular function | GO:0008525 | 18 | 1 | 18094 | 48 |
PITPNC1 |
4.671e-02 | -3.06 | heparan sulfate proteoglycan binding | molecular function | GO:0043395 | 18 | 1 | 18094 | 48 |
HPSE2 |
4.673e-02 | -3.06 | ZZ | pfam domains | PF00569 | 17 | 1 | 17795 | 50 |
DTNA |
4.673e-02 | -3.06 | Cystatin | pfam domains | PF00031 | 17 | 1 | 17795 | 50 |
CST3 |
4.674e-02 | -3.06 | GRB2 (growth factor receptor bound protein 2) | protein interactions | 2885 | 769 | 5 | 19454 | 50 |
PON2,ERBB4,MSI2,CLU,SLC1A2 |
4.680e-02 | -3.06 | ARIH2 (ariadne RBR E3 ubiquitin protein ligase 2) | protein interactions | 10425 | 314 | 3 | 19454 | 50 |
WWOX,CKB,GLUL |
4.716e-02 | -3.05 | BMP4 (bone morphogenetic protein 4) | protein interactions | 652 | 135 | 2 | 19454 | 50 |
BMPR1B,CLU |
4.716e-02 | -3.05 | NTRK2 (neurotrophic receptor tyrosine kinase 2) | protein interactions | 4915 | 135 | 2 | 19454 | 50 |
DTNA,ERBB4 |
4.716e-02 | -3.05 | Myo1c (myosin IC) | protein interactions | 17913 | 135 | 2 | 19454 | 50 |
ITPR2,CAMK2G |
4.720e-02 | -3.05 | response to organophosphorus | biological process | GO:0046683 | 129 | 2 | 18204 | 49 |
ITPR2,RYR3 |
4.722e-02 | -3.05 | central_nervous_system-brain-glioma-astrocytoma_Grade_IV | COSMIC cancer mutations | central_nervous_system-brain-glioma-astrocytoma_Grade_IV | 15813 | 49 | 16828 | 49 |
AQP4,LSAMP,DTNA,CDH20,FBXL7,PITPNC1,GLUL,SLC1A2,COL5A3,NRXN1,PREX2,NKAIN3,ZBTB20,NHSL1,GLIS3,ATP1A2,ATP13A4,CTNND2,RORA,GPM6A,TNIK,SPARCL1,CKB,PARD3B,PON2,CLU,PTGDS,CAMK2G,NEBL,SLC1A3,ZNRF3,ARHGAP24,ERBB4,MSI2,ITPR2,NPAS3,NTM,GPC5,QKI,SOX5,WWOX,BMPR1B,PAMR1,SFXN5,HPSE2,CST3,RYR3,LRIG1,SLC4A4 |
4.737e-02 | -3.05 | circulatory system process | biological process | GO:0003013 | 508 | 4 | 18204 | 49 |
SLC1A3,ATP1A2,SLC4A4,SLC1A2 |
4.738e-02 | -3.05 | receptor catabolic process | biological process | GO:0032801 | 18 | 1 | 18204 | 49 |
ZNRF3 |
4.738e-02 | -3.05 | myelin maintenance | biological process | GO:0043217 | 18 | 1 | 18204 | 49 |
CLU |
4.738e-02 | -3.05 | positive regulation of circadian rhythm | biological process | GO:0042753 | 18 | 1 | 18204 | 49 |
RORA |
4.738e-02 | -3.05 | dicarboxylic acid catabolic process | biological process | GO:0043649 | 18 | 1 | 18204 | 49 |
GLUL |
4.738e-02 | -3.05 | regulation of extracellular matrix disassembly | biological process | GO:0010715 | 18 | 1 | 18204 | 49 |
CST3 |
4.738e-02 | -3.05 | negative regulation of sodium ion transport | biological process | GO:0010766 | 18 | 1 | 18204 | 49 |
ATP1A2 |
4.738e-02 | -3.05 | response to misfolded protein | biological process | GO:0051788 | 18 | 1 | 18204 | 49 |
CLU |
4.738e-02 | -3.05 | dendritic spine morphogenesis | biological process | GO:0060997 | 18 | 1 | 18204 | 49 |
CTNND2 |
4.738e-02 | -3.05 | cardiac myofibril assembly | biological process | GO:0055003 | 18 | 1 | 18204 | 49 |
NEBL |
4.743e-02 | -3.05 | striated_muscle | COSMIC cancer mutations | striated_muscle | 4228 | 18 | 16828 | 49 |
COL5A3,RYR3,SPARCL1,PREX2,NPAS3,SLC1A3,RORA,ZNRF3,NHSL1,PAMR1,CTNND2,GLIS3,CDH20,AQP4,PARD3B,CAMK2G,CLU,PON2 |
4.752e-02 | -3.05 | Furin_repeat | interpro domains | IPR006212 | 18 | 1 | 18521 | 50 |
ERBB4 |
4.752e-02 | -3.05 | Leu-rich_rpt_Cys-con_subtyp | interpro domains | IPR006553 | 18 | 1 | 18521 | 50 |
FBXL7 |
4.752e-02 | -3.05 | Leu-rich_rpt_4 | interpro domains | IPR025875 | 18 | 1 | 18521 | 50 |
LRIG1 |
4.761e-02 | -3.04 | postsynaptic density | cellular component | GO:0014069 | 317 | 3 | 19108 | 49 |
ERBB4,TNIK,CTNND2 |
4.764e-02 | -3.04 | postsynaptic specialization, intracellular component | cellular component | GO:0099091 | 19 | 1 | 19108 | 49 |
TNIK |
4.764e-02 | -3.04 | cation-transporting ATPase complex | cellular component | GO:0090533 | 19 | 1 | 19108 | 49 |
ATP1A2 |
4.764e-02 | -3.04 | parallel fiber to Purkinje cell synapse | cellular component | GO:0098688 | 19 | 1 | 19108 | 49 |
GPM6A |
4.774e-02 | -3.04 | FBXO27 (F-box protein 27) | protein interactions | 126433 | 19 | 1 | 19454 | 50 |
CLU |
4.774e-02 | -3.04 | HBEGF (heparin binding EGF like growth factor) | protein interactions | 1839 | 19 | 1 | 19454 | 50 |
ERBB4 |
4.774e-02 | -3.04 | SYT7 (synaptotagmin 7) | protein interactions | 9066 | 19 | 1 | 19454 | 50 |
NRXN1 |
4.774e-02 | -3.04 | SPZ1 (spermatogenic leucine zipper 1) | protein interactions | 84654 | 19 | 1 | 19454 | 50 |
DTNA |
4.774e-02 | -3.04 | ZNF138 (zinc finger protein 138) | protein interactions | 7697 | 19 | 1 | 19454 | 50 |
ARHGAP24 |
4.774e-02 | -3.04 | LTC4S (leukotriene C4 synthase) | protein interactions | 4056 | 19 | 1 | 19454 | 50 |
CAMK2G |
4.774e-02 | -3.04 | C3orf62 (chromosome 3 open reading frame 62) | protein interactions | 375341 | 19 | 1 | 19454 | 50 |
ATP1A2 |
4.774e-02 | -3.04 | ZNF532 (zinc finger protein 532) | protein interactions | 55205 | 19 | 1 | 19454 | 50 |
ERBB4 |
4.774e-02 | -3.04 | INKA1 (inka box actin regulator 1) | protein interactions | 389119 | 19 | 1 | 19454 | 50 |
ZBTB20 |
4.774e-02 | -3.04 | RRAD (RRAD, Ras related glycolysis inhibitor and calcium channel regulator) | protein interactions | 6236 | 19 | 1 | 19454 | 50 |
CAMK2G |
4.774e-02 | -3.04 | PHYHIPL (phytanoyl-CoA 2-hydroxylase interacting protein like) | protein interactions | 84457 | 19 | 1 | 19454 | 50 |
GPM6A |
4.774e-02 | -3.04 | GCHFR (GTP cyclohydrolase I feedback regulator) | protein interactions | 2644 | 19 | 1 | 19454 | 50 |
NEBL |
4.774e-02 | -3.04 | MYOZ2 (myozenin 2) | protein interactions | 51778 | 19 | 1 | 19454 | 50 |
WWOX |
4.774e-02 | -3.04 | Mtx1 (metaxin 1) | protein interactions | 17827 | 19 | 1 | 19454 | 50 |
CAMK2G |
4.774e-02 | -3.04 | NLGN1 (neuroligin 1) | protein interactions | 22871 | 19 | 1 | 19454 | 50 |
NRXN1 |
4.779e-02 | -3.04 | NIBAN2 (niban apoptosis regulator 2) | protein interactions | 64855 | 136 | 2 | 19454 | 50 |
ARHGAP24,GLUL |
4.786e-02 | -3.04 | ensheathment of neurons | biological process | GO:0007272 | 130 | 2 | 18204 | 49 |
QKI,CLU |
4.786e-02 | -3.04 | axon ensheathment | biological process | GO:0008366 | 130 | 2 | 18204 | 49 |
QKI,CLU |
4.824e-02 | -3.03 | animal organ morphogenesis | biological process | GO:0009887 | 988 | 6 | 18204 | 49 |
BMPR1B,SOX5,ERBB4,LRIG1,CTNNA2,WWOX |
4.839e-02 | -3.03 | central_nervous_system-optic_nerve-glioma-astrocytoma_Grade_I | COSMIC cancer mutations | central_nervous_system-optic_nerve-glioma-astrocytoma_Grade_I | 17 | 1 | 16828 | 49 |
QKI |
4.839e-02 | -3.03 | optic_nerve | COSMIC cancer mutations | optic_nerve | 17 | 1 | 16828 | 49 |
QKI |
4.843e-02 | -3.03 | oligoastrocytoma_Grade_II | COSMIC cancer mutations | oligoastrocytoma_Grade_II | 121 | 2 | 16828 | 49 |
DTNA,CDH20 |
4.852e-02 | -3.03 | carboxylic acid transmembrane transport | biological process | GO:1905039 | 131 | 2 | 18204 | 49 |
SLC1A3,SLC1A2 |
4.856e-02 | -3.02 | protein-folding chaperone binding | molecular function | GO:0051087 | 133 | 2 | 18094 | 48 |
CLU,ATP1A2 |
4.859e-02 | -3.02 | human chr18q12.1 | chromosome location | human chr18q12.1 | 26 | 1 | 26134 | 50 |
DTNA |
4.867e-02 | -3.02 | GRB2 events in ERBB2 signaling | REACTOME pathways | R-HSA-1963640 | 16 | 1 | 10285 | 32 |
ERBB4 |
4.867e-02 | -3.02 | PI3K events in ERBB2 signaling | REACTOME pathways | R-HSA-1963642 | 16 | 1 | 10285 | 32 |
ERBB4 |
4.893e-02 | -3.02 | kidney-other-neoplasm | COSMIC cancer mutations | kidney-other-neoplasm | 10653 | 37 | 16828 | 49 |
CDH20,FBXL7,PON2,CLU,CAMK2G,DTNA,AQP4,LSAMP,NKAIN3,PREX2,NPAS3,ERBB4,SLC1A2,COL5A3,NRXN1,ITPR2,ARHGAP24,SLC1A3,NEBL,GLUL,SFXN5,ATP1A2,CTNND2,HPSE2,ATP13A4,SOX5,NHSL1,PAMR1,ZBTB20,QKI,GPC5,SPARCL1,RYR3,LRIG1,TNIK,RORA,GPM6A |
4.924e-02 | -3.01 | water transmembrane transporter activity | molecular function | GO:0005372 | 19 | 1 | 18094 | 48 |
AQP4 |
4.924e-02 | -3.01 | alkali metal ion binding | molecular function | GO:0031420 | 19 | 1 | 18094 | 48 |
ATP1A2 |
4.924e-02 | -3.01 | transmembrane receptor protein serine/threonine kinase activity | molecular function | GO:0004675 | 19 | 1 | 18094 | 48 |
BMPR1B |
4.933e-02 | -3.01 | parathyroid | COSMIC cancer mutations | parathyroid | 476 | 4 | 16828 | 49 |
RYR3,GPC5,GPM6A,PAMR1 |
4.941e-02 | -3.01 | LRR_4 | pfam domains | PF12799 | 18 | 1 | 17795 | 50 |
LRIG1 |
4.946e-02 | -3.01 | EF-hand | gene3d domains | 1.10.238.10 | 272 | 3 | 14470 | 44 |
DTNA,RYR3,SPARCL1 |
4.968e-02 | -3.00 | PTPRA (protein tyrosine phosphatase receptor type A) | protein interactions | 5786 | 139 | 2 | 19454 | 50 |
CKB,NHSL1 |
4.968e-02 | -3.00 | DUSP22 (dual specificity phosphatase 22) | protein interactions | 56940 | 139 | 2 | 19454 | 50 |
QKI,CTNNA2 |
4.977e-02 | -3.00 | DNM1L (dynamin 1 like) | protein interactions | 10059 | 322 | 3 | 19454 | 50 |
GPM6A,WWOX,CKB |
4.987e-02 | -3.00 | ligand-gated monoatomic cation channel activity | molecular function | GO:0099094 | 135 | 2 | 18094 | 48 |
RYR3,ITPR2 |
4.989e-02 | -3.00 | CCT7 (chaperonin containing TCP1 subunit 7) | protein interactions | 10574 | 541 | 4 | 19454 | 50 |
ATP1A2,ARHGAP24,GLUL,WWOX |
4.995e-02 | -3.00 | response to potassium ion | biological process | GO:0035864 | 19 | 1 | 18204 | 49 |
ATP1A2 |
4.995e-02 | -3.00 | regulation of amyloid-beta clearance | biological process | GO:1900221 | 19 | 1 | 18204 | 49 |
CLU |
4.995e-02 | -3.00 | regulation of neurotransmitter uptake | biological process | GO:0051580 | 19 | 1 | 18204 | 49 |
ATP1A2 |
4.995e-02 | -3.00 | regulation of circadian sleep/wake cycle | biological process | GO:0042749 | 19 | 1 | 18204 | 49 |
PTGDS |
4.995e-02 | -3.00 | excitatory synapse assembly | biological process | GO:1904861 | 19 | 1 | 18204 | 49 |
NRXN1 |
4.995e-02 | -3.00 | cerebellar Purkinje cell layer morphogenesis | biological process | GO:0021692 | 19 | 1 | 18204 | 49 |
RORA |
4.995e-02 | -3.00 | microvillus organization | biological process | GO:0032528 | 19 | 1 | 18204 | 49 |
TNIK |
4.995e-02 | -3.00 | vascular associated smooth muscle cell differentiation | biological process | GO:0035886 | 19 | 1 | 18204 | 49 |
QKI |
4.995e-02 | -3.00 | vocalization behavior | biological process | GO:0071625 | 19 | 1 | 18204 | 49 |
NRXN1 |